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Abstract 
 
The study was aimed at investigating Western Australian rickettsiae, delving deeper 
into the epidemiology of a recently described rickettsia, Rickettsia gravesii, and any 
other rickettsiae lurking in the Western Australian bush. Prior to the discovery of R. 
gravesii, only Rickettsia typhi was known to be endemic to Western Australia. With the 
addition  of  R.  gravesii  and  another  novel  rickettsia  named  candidatus  “Rickettsia 
antechini”,  understanding  and  investigation  of  the  potential  effects  these  organisms 
may have on human and animal health becomes paramount. This research adds to the 
limited  information  available  in  the  literature  pertaining  to  Australian  rickettsial 
organisms. 
 
Serotyping of R. gravesii in mice demonstrated distinct specificity differences between 
R. gravesii, Rickettsia massiliae, Rickettsia australis and Rickettsia honei. R. massiliae 
was chosen due to R. gravesii’s very close genotypic similarities to the R. massiliae 
sub-group. R. australis and R. honei were chosen for the possibility of them sharing a 
similar geographical distribution with R. gravesii. 
 
Collection of ectoparasites, in particular ticks, from humans and larger mammals in 
south-west Western Australian bush was performed to investigate the prevalence of R. 
gravesii in tick populations and also to investigate any other rickettsial organisms that 
may be present.  No other rickettsiae were uncovered except  for  R. gravesii among 
ixodid  ticks  collected.  Four  tick  species  collected  during  the  course  of  the  study 
harboured R. gravesii with prevalences of up to 15% in Amblyomma albolimbatum 
(n=45), 75% in Amblyomma triguttatum (n=187), 51% in Ixodes australiensis (n=63) 
and 25% in Ixodes fecialis (n=8). No rickettsial DNA was detected in Haemaphysalis iii 
 
longicornis, though only a single specimen was found. Transovarial transmission of R. 
gravesii in A. triguttatum ticks from infected females to viable larvae was observed by 
PCR.  Detection  of  R.  gravesii  in  the  salivary  glands,  ovaries  and  gut  suggests  the 
potential of horizontal, transovarial and transtadial transmission. 
 
Feral pigs (n=148) trapped within the water-catchment areas for Perth were tested for 
SFG rickettsiae and a prevalence of 49% was observed by microimmunofluorescence at 
titres of 1:128 and higher. A baseline control group made up of domestic farmed pigs 
(n=67) was used to determine the cut-off titre (1:128) where no non-specific antigen-
antibody detectable by microscopy was observed. 
 
Sero-prevalence in humans was also investigated. Volunteers that are exposed to ticks 
as  a  result  of  occupational  and  recreational  activities  were  recruited  over  a  3  year 
period.  Sera  were  collected  and  a  questionnaire  asking  about  participants’  bush 
activities was filled out. Two occupational groups were involved in the study, workers 
from Barrow Island (n=67) and Whiteman Park (n=12). The recreational group was 
made up of members of the Western Australian Rogaining Association (n=104). The 
control group used in the study was made up of volunteers among the staff and students 
of Murdoch University (n=60). Rickettsial prevalence was observed at higher levels in 
the occupational groups than recreational group participants; 44.8% in Barrow Island 
workers, 50% in Whiteman Park staff, 23.4% in rogainers and 1.7% in the control 
group. 
 
Analysis  of  the  questionnaires  filled  out  by  participants  from  the  human  sero-
prevalence  study  demonstrated  a  significant  association  between  bush  activity  and 
exposure to rickettsial organisms and their vectors. A follow-up of volunteers 10-14 iv 
 
months after the first serum collection from Whiteman Park staff (n=8) and among the 
rogainers (n=62) showed no significant rates of seroconversion or seroreversion. 
 
Odds ratio analysis (adjusted for age and gender) based on questionnaire results and 
sero-prevalence  of  rickettsial  antibodies  in  the  different  interest  groups  and  control 
cohort showed that the recreational group had an odds ratio of 13.70 (95% CI=1.73-
108.49). Odds ratio for the occupational group is 38.81 (95% CI=5.02-300.34). This 
shows  a  significant  risk  for  people  performing  activities  in  the  bush  for  extended 
periods of time, with occupational activities posing the highest risk, potentially due to 
the longer hours compared to recreational activities in general. 
 
The presence of R. gravesii in Western Australia and the data reported in this study 
underscores the lack of information available to public health authorities with regards 
to rickettsial organisms and their hosts. Even though no official reports of debilitating 
spotted  fever  infections  have  been  reported  in  WA  in  the  literature  thus  far,  the 
potential  of  it  happening  cannot  be  disregarded.  Increased  awareness  of  rickettsial 
organisms and infection need to be instilled among public health officials, doctors and 
veterinarians. Other animal populations and parts of Western Australia not covered in 
this study need to be further investigated. 
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1 - Introduction 
 
1.1  Thesis Introduction 
It has been barely 130 years since arthropods were shown to transmit human diseases 
and knowledge of zoonotic diseases now encompasses hundreds of viruses, bacteria, 
protozoa  and  helminthes.  Vector  borne  diseases  were  responsible  for  more  human 
disease and deaths in the 17
th to early 20
th centuries than all other causes combined. 
Only after effective preventive and control measures against known disease vectors 
were developed did the industrial development of the tropics during the 19
th and 20
th 
centuries take place.  
 
With the start of the 21
st century, there has been ongoing discovery of new species and 
strains of potentially pathogenic microbes. Most have turned out to be harmless but 
there are those that have caused severe mortality and morbidity on human and animal 
populations,  such  as  the  Nipah  virus  outbreaks  in  Malaysia,  Bangladesh  and  India 
between 2001 and 2008 and the SARS epidemic of 2003. The description of any new 
taxa requires extensive efforts on the part of the investigator(s) to fully differentiate a 
“new” organism from its most closely related phenotypic and genotypic relatives. Not 
only  is  there  a  need  to  catalogue  any  differences  or  unique  features,  but  also  the 
similarities  that  the  new  taxa  share  with  other  similar  organisms.  The  wealth  of 
accumulated information and knowledge of new aetiologic agents is essential to assist 
medical, veterinary and public health professionals in future encounters. 
 2 
 
The rate of new rickettsiae being “discovered” has increased exponentially over the 
years especially with  the advent  of molecular  methods  towards the end of the 20
th 
century. The discovery of a new species of Rickettsia by Helen Owen in 2005, named 
Rickettsia  gravesii  (strain  BWI-1),  left  many  questions  unanswered  (206-208).  The 
main  aim  of  this  thesis  will  be  to  reduce  the  gaps  in  our  knowledge  of  Western 
Australian rickettsial organisms and in particular their role as potential animal and/or 
human pathogens in Western Australia. An extensive review of Rickettsia sp. is crucial 
to provide a basic understanding of rickettsial organisms. Factors that make up their 
genotypic and phenotypic characteristics will be included, along with host-rickettsiae 
interactions, pathogenicity, disease diagnosis and distribution down to the species level. 
 
The design of the study aims and objectives was heavily influenced by the information 
documented by Helen Owen in her thesis (208). Continuity was the direction decided 
upon and of the two novel rickettsiae described by Owen (R. gravesii and R. antechini); 
R. gravesii was chosen as the focus of this work due to its hypothesized “abundance” in 
south-west  WA  native  fauna  and  arthropod  populations  and  suspected  higher 
pathogenicity potential. No “Candidatus R. antechini” was observed during the course 
of the current study. 
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1.2  Study Aims and Objectives 
The aim of the study was to address the following objectives derived from the literature 
on Western Australian rickettsiae. 
I.  To  characterise  phenotypic  traits  of  R.  gravesii  that  are  distinct  from  other 
rickettsiae. 
II.  To examine the arthropod host species known to harbour R. gravesii. 
III.  To determine the sero-prevalence of R. gravesii in a wild animal population. 
IV.  To identify the regions within south-west WA endemic for R. gravesii. 
V.  To  investigate  the  relationship  between  sero-prevalence  to  spotted  fever 
rickettsia in humans and their level of bush activity. 
VI.  To report and characterise any illness linked to Rickettsia sp. infection during 
the period of the study. 
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1.3  Rickettsia 
Zoonotic rickettsial infections occur in both urban and rural communities worldwide. 
Transmitted via vectors such as ticks,  fleas  and lice, rickettsial infections are often 
viewed as mild or are misdiagnosed as common ailments such as the common cold and 
flu (322). Through lack of understanding of the actual cause of disease, complications 
leading to organ failure and possibly even death can occur. 
 
The genus Rickettsia was first described by Howard Ricketts when he investigated an 
outbreak of Rocky Mountain spotted fever in  1906 and 1907 (257). His  work was 
instrumental in paving the way for modern rickettsiology (258). Most significant were 
the roles that ectoparasites were found to play as vectors of rickettsial infection and 
reservoirs  of  rickettsial  organisms  in  an  endemic  area.  Today  we  know  that  the 
rickettsial  life  cycle  involves  both  vertebrate  and  invertebrate  hosts.  Not  only  do 
haematophagous arthropods play an important role as vectors, they are also a primary 
reservoir and amplifying host, together with some small mammals such as rats and 
opossums (16). 
 
At present, three groups of organisms are commonly classified as causing rickettsial 
disease, (i) spotted fever group (SFG), (ii) typhus group (TG), and (iii) scrub typhus 
group (STG) (69, 324). The first two groups belong to the genus Rickettsia, while the 
third group belongs to the genus Orientia. A number of major changes to the taxonomy 
of rickettsia have been made in the past decade, as a result of the advent of molecular 
taxonomic methods such as 16S rRNA analysis (334). These changes have resulted in 
the  exclusion  of  a  myriad  of  other  organisms  from  being  classified  as  rickettsiae, 
although they continue to be described as rickettsia-like, such as Coxiella burnetii and 5 
 
Bartonella. These new techniques also enabled scientists to study intracellular bacteria 
that  express  few  of  the  phenotypic  characteristics  traditionally  used  in  taxonomy. 
Recently Fournier et al. proposed genetic guidelines for the classification of rickettsial 
isolates at the genus, group, and species levels by using sequences of the 16S rRNA 
(rrs) gene and four protein-coding genes; gltA (citrate synthase), ompA, ompB and sca4 
(gene D) (88).  
 
The Rickettsia genus currently includes more than 24 recognized species along with a 
substantial  number  of  as-yet  uncharacterized  strains  and  amplicons.  Of  the  known 
rickettsioses, 16 of these species have been implicated in human syndromes. However 
it is hypothesised that any rickettsiae found in arthropods capable of biting humans 
should be considered potent to be potential human pathogens (93). 
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1.3.1  Taxonomy 
The genus Rickettsia is split into two major groups, Spotted Fever Group (SFG) and 
Typhus Group (TG) (221). Rickettsial organisms within the two groups are small (ca. 
0.4 x 0.9 µm), Gram-negative, coccobacillary, aerobic α-Proteobacteria (268). They 
are classified as either SFG or TG rickettsiae based on their intracellular positions, 
optimal  growth  temperatures,  percent  G+C  DNA  contents,  clinical  features, 
epidemiological aspects and antigenic characteristics (absence of the outer membrane 
protein in TG) (244). Two other groups have recently been proposed; Ancestral Group 
(AG) and Transitional Group (TRG) (109, 295). 
 
Before  the  use  of  16S  rRNA  sequence  to  determine  the  phylogenetic  relationship 
between prokaryotes in the order Rickettsiales, a rigorous set of criteria for classical 
taxonomy was used. The evolutionary tree that the Rickettsia spp. belonged to was 
widely accepted, as described by Bergey’s Manual of Systematic Bacteriology (1939), 
showing  the  genus  Rickettsia  in  the  same  tribe,  Rickettsieae,  as  Coxiella  and 
Rochalimea. Rickettsieae was classified within the family Rickettsiaceae, together with 
Wolbachieae and Ehrlichieae. The families Bartonellaceae and Anaplasmataceae were 
also  grouped  within  the  order  Rickettsiales.  With  the  advent  of  new  molecular 
taxonomic methods, the classical taxonomy used was revised and the rickettsiae are 
now placed into subgroups of Proteobacteria. The genus Rickettsia has been placed in 
the ʱ-1 subgroup, while Bartonella is in the ʱ-2 subgroup (Figure 1.1). 7 
 
   
Legionella pneumophila 
Francisella persica 
Coxiella burnetii 
Brucella melitensis 
Bartonella bacilliformis 
Bartonella quintana 
Ehrlichia chaffeensis 
Ehrlichia canis 
Ehrlichia ruminantium 
Anaplasma phagocytophilum 
 
Anaplasma marginale 
Wolbachia pipientis 
 
Neorickettsia sennetsu 
 
Neorickettsia helminthica 
 
Rickettsia sp (SFG) 
rickettsii 
 
Rickettsia sp (TG) 
 
 
Orientia tsutsugamushi (Scrub Typhus) 
 
 
 1 
 2 
 
 
Figure  1.1  –  Tree  illustrating  genetic  relationships  between  the  different 
rickettsial/rickettsia-like  organisms  found  in  three  different  Proteobacteria 
divisions (69). 8 
 
The original classification of species within the genus Rickettsia into the SFG and TG 
groups  depended  on  a  variety  of  characteristics  including:  intracellular  localization, 
optimal growth temperature and the cross reaction of sera from an infected patient with 
somatic  antigens  of  three  strains  of  Proteus  (Weil-Felix  test)  (123).  The  advent  of 
modern  molecular  and  serological  techniques  both  reinforced  and  disputed  original 
classification of members of the genus and as such the last couple of decades have seen 
the restructuring of Rickettsia sp. Genomic analyses have now proposed the creation of 
2 new groups within the genus Rickettsia; Ancestral Group (AG) consisting of R. bellii 
and R. canadensis (295) and Transitional Group (TRG) consisting of R. akari and R. 
felis (109). 
 
Other  notable  rickettsiae  that  have  been  reclassified  are  Rickettsia  tsutsugamushi; 
which has been placed in its own genus, Orientia (Orientia tsutsugamushi), and is in 
the same ʱ-1 subgroup as the genus Rickettsia (Figure 1.1) (296). Coxiella burnetii 
(originally Rickettsia burnetii) has also been reclassified due to the findings that its 16S 
RNA sequence is more similar to members of the γ subgroup and it is no longer viewed 
as a true rickettsia (185).  
 
1.3.2  Genome 
Rickettsial genome sizes are comparatively much smaller than those of other bacteria. 
The circular genome ranges in size from 1.1 to 1.6 million base pairs (Table 1.1). 
Coding  regions  range  from  75.2%  (R.  canadensis)  to  85.2%  (R.  belii).  Genomic 
analysis of the eukaryotic mitochondrial genome suggests a close relationship between 
rickettsiae and mitochondria (338). Based on phylogenetic analysis, mitochondria have 
been  shown  to  have  evolved  from  the  ʱ-proteobacteria  and  more  specifically  from 
Rickettsiaceae (6, 283).  9 
 
 
R.  felis  was  the  first  obligate  intracellular  bacteria  reported  to  have  potential 
conjugative plasmids as part of its genome. The two R. felis plasmids identified were 
named pRF and pRFʴ, and are 62,829 bp and 39,263 bp in size respectively. The size 
of the main circular chromosome is 1,485,148 bp (197). 
 
Table 1.1 – Table summarising rickettsial organisms of the genus Rickettsia whose 
genomes have been fully sequenced. 
 
Species  Host 
Genome 
Size (bp) 
No. of 
Genes 
% 
G+C 
% 
Coding 
Group 
R. belii  Tick  1,522,076  1,429  31.7  85.2  Ancestral 
Group  R. canadensis  Tick  1,159,772  1,032  29.0  75.2 
R. prowazekii  Louse/Flea  1,111,523  872  28.9  76.2  Typhus 
Group  R. typhi  Flea  1,111,496  877  29.0  76.3 
R. akari  Mite  1,231,204  1,337  32.3  77.4  Transitional 
Group  R. felis  Flea  1,587,240*  1,512  32.5  83.6 
R. rickettsii  Tick  1,257,710  1,346  32.5  78.5 
Spotted 
Fever Group  R. conorii  Tick  1,268,755  1,412  32.4  81.5 
R. sibirica  Tick  1,250,021  1,234  32.5  77.8 
* Includes plasmid(s). 
 
Since the first description of plasmids in R. felis, other members of the groups TRG, 
SFG and AG have been published on with harbouring plasmids  (19, 20). With the 
discovery of rickettsial plasmids, it is now better understood how conjugative genes, 
widespread in the genus, are horizontally transferred (327). The presence of widespread 
and  potentially  mobile  plasmids  in  Rickettsia  has  epidemiologic  and  evolutionary 
implications.   10 
 
1.3.3  Spotted Fever Group (SFG) Rickettsiae 
The spotted fever group of the genus  Rickettsia is of major clinical significance to 
humans. There are currently 20 recognized species/strains (excluding R. felis and R. 
akari) of which 12 are recognized as the cause of rickettsioses (Table 1.2). With the 
recent proposal for a new group for R. felis (flea-borne) and R. akari (mite-borne), the 
spotted fever group would be exclusively tick-borne (109). 
 
The members of SFG exist  in free form  in  the cytoplasm  of their mammalian and 
arthropod  host  cells  (Figure  1.2).  Unlike  TG  rickettsiae,  SFG  rickettsiae  can  pass 
through the nuclear membrane of their host cell. Rickettsiae have a trilaminar cell wall 
with a periplasmic space separating the cell wall from the cytoplasm (121). Species-
specific antigens are located on a microcapsular layer on the outer leaflet of the cell 
wall. 
 
 
Figure 1.2 – Illustrations showing location of SFG and TG rickettsiae in the host 
cell. 
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Table 1.2 – Known pathogenic tick borne spotted fever group rickettsiae. 
 
Rickettsia spp 
Known or potential 
vectors 
 
Year of first 
identification 
in vectors 
 
Disease [Year of 
first clinical 
description] 
Ref 
 
Confirmed Pathogens 
 
       
  Rickettsia rickettsii  Dermacentor andersoni 
Dermacentor variabilis 
Rhipecephalus sanguineus 
Amblyomma cajennense 
Amblyomma aureolatum 
 
1906  Rocky Mountain 
spotted fever 
[1899] 
(257) 
  Rickettsia conorii 
    subsp. conorii    
 
Rhipicephalus sanguineus  1932  Mediterranean 
spotted fever 
[1910] 
 
(171) 
  Rickettsia sibirica 
    subsp. sibirica 
Dermacentor nuttali 
Dermacentor marginatus 
Dermacentor silvarum 
Haemaphysalis concinna 
 
Unknown  Siberian tick 
typhus [1934] 
(266) 
  Rickettsia parkeri  Amblyomma maculatum 
Amblyomma americanum 
Amblyomma triste 
 
1939  Unnamed [2004]  (212) 
  Rickettsia conorii 
    subsp. indica   
 
Rhipicephalus sanguineus  1950  Indian tick typhus  (271) 
  Rickettsia slovaca  Dermacentor marginatus 
Dermacentor reticulatus 
1968  Tick-borne 
lymphadenopathy 
[1997] 
Dermacentor-
borne necrosis 
and 
lymphadenopathy 
[1997] 
 
(280) 
  Rickettsia conorii  
    subsp. israelensis   
Rhipicephalus sanguineus  1974  Israeli spotted 
fever [1940] 
 
(110, 
310) 
  Rickettsia australis  Ixodes holocyclus 
Ixodes tasmani 
 
1974  Queensland tick 
typhus [1946] 
(45) 
  Rickettsia sibirica 
    subsp. mongolotimonae  
 
Dermacentor sinicus  1974  North Asian tick 
typhus [1960] 
 
(318) 
  Hyalomma asiaticum 
Hyalomma truncatum 
1991  Lymphangitis 
associated 
rickettsiosis 
[1996] 
 
(339) 
  Rickettsia heilongjiangensis  Dermacentor silvarum  1982  Far Eastern 
spotted fever 
[1992] 
 
(88) 12 
 
Table 1.2 – Continued.  
 
Rickettsia spp 
Known or potential 
vectors 
 
Year of first 
identification 
in ticks 
 
Disease [Year of 
first clinical 
description] 
Ref 
  Rickettsia africae 
 
Amblyomma hebraeum 
Amblyomma variegatum 
 
1990  African tick bite 
fever [1934] 
(144, 
156) 
  Rickettsia conorii 
    subsp. caspia  
Rhipicephalus sanguineus 
Rhipicephalus pumilio 
 
1992  Astrakhan fever 
[1970s] 
(74, 
297) 
  Rickettsia massiliae  Rhipicephalus sanguineus 
Rhipicephalus turanicus 
Rhipicephalus muhsamae 
Rhipicephalus lunulatus 
Rhipicephalus sulcatus 
 
1992  Unnamed [2005]  (23, 
315) 
  Rickettsia honei 
 
Bothriocroton (Aponomma) 
hydrosauri 
Amblyomma cajennense 
Ixodes granulatus 
 
1993  Flinders Island 
spotted fever 
[1991] 
(115, 
264) 
  Rickettsia japonica  Ixodes ovatus 
Dermacentor taiwanensis 
Haemaphysalis longicornis 
Haemaphysalis flava 
 
1996  Oriental or 
Japanese spotted 
fever [1984] 
(302) 
  Rickettsia aeschlimannii  Hyalomma marginatum 
marginatum 
Hyalomma marginatum 
rufipes 
Rhipicephalus appendiculatus 
 
1997  Unnamed [2002]  (25) 
  Rickettsia honei 
    strain marmionii 
Haemaphysalis novaeguineae  2005  Australian 
spotted fever 
[2005] 
 
(306) 
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1.3.4  Typhus Group (TG) Rickettsiae  
The  causes  of  epidemic  typhus  and  murine  typhus  are  Rickettsia  prowazekii  and 
Rickettsia typhi respectively. Only these two organisms have been classified within the 
typhus  group  thus  far  (188).  Occurrences  of  the  disease  are  worldwide  and 
transmissions  of  the  pathogens  are  by  the  human  body  louse  (Pediculus  humanus 
humanus) for R. prowazekii (80) and rat flea (Xenopsylla cheopis) for R. typhi (13). 
Recent publications have shown that the vector for R. typhi may not be limited to just 
the rat flea but may include other species of fleas such as the cat flea Ctenocephalides 
felis (194). 
 
1.3.5  Ancestral Group (AG) Rickettsiae 
Rickettsia bellii was demonstrated to share common characteristics with both SFG and 
TG rickettsiae by Stothard et al. (1994) but also to exhibit unique characteristics of its 
own. Comparison of the 23S rRNA sequences between R. bellii, R. rickettsii and R. 
prowazekii indicates that  R. bellii predates the divergence that created the SFG and TG 
genera (295).  
 
1.3.6  Transitional Group (TRG) Rickettsiae  
The transitional group was recently proposed by Gillespie et al. (2007) and is made up 
of R. akari and R. felis. Both rickettsial species are described as being genotypically 
and phenotypically divergent enough from SFG and TG rickettsiae, to warrant their 
own grouping (109). Genotypic analysis supports this hypothesis, showing that genes 
found in members of TRG were possibly acquired through conjugational exchanges 
with AG rickettsiae (109). R. australis was recently described phylogenetically as a 
member of TRG (316), however its LPS is antigenically similar to SFG. 14 
 
1.4  Rickettsial Vectors 
Arthropods  are  the  only  known  vectors  of  rickettsia.  They  are  also  reservoirs  and 
amplifiers  for  rickettsial  spread  throughout  invertebrate  and  vertebrate  populations. 
Maintenance of rickettsiae in an arthropod population occurs through transtadial and 
transovarial means (16). Vertical transmission plays an important survival role when 
the vector population is low (190). 
 
1.4.1  Ticks 
Ticks are obligate haematophagous arthropods that parasitise all classes of vertebrates 
and have a worldwide distribution. Recognized as human parasites for thousands of 
years,  ticks  have  been  described  by  ancient  writers  such  as  Aristotle  and  Homer. 
However, it was not known that ticks were capable of disease transmission until the end 
of the 19
th century. Ticks are currently considered the second most common vector of 
human infectious disease after the mosquito. The first demonstration of the potential of 
ticks as a disease vector (Texas cattle fever) was performed in 1893 (11) through the 
transmission of the protozoan Babesia bigemina by the tick Boophilus annulatus. It was 
not until the start of the 20
th century that ticks were associated with the transmission of 
bacterial diseases. Dutton and Todd demonstrated in 1905 (72) that tick relapsing fever 
was  caused  by  Borrelia  duttonii  and  transmitted  by  Ornithodoros  moubata,  and 
Ricketts  followed closely in 1909 showing that the wood tick Dermacentor andersoni, 
was involved in the transmission of Rickettsia rickettsii, the agent of Rocky Mountain 
Spotted  Fever  (RMSF)  (257).  Other  common  tick-borne  bacterial  diseases  include 
rickettsioses,  ehrlichioses,  anaplasmosis,  Lyme  disease,  some  relapsing  fever 
borrelioses (others are louse-borne), tularaemia and Q fever (78). 
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There are 2 major tick families; Ixodidae and Argasidae. Ixodidae, commonly known 
as hard ticks is the most abundant and medically important of the two tick families. 
Ixodid ticks have a sclerotized dorsal plate. Argasidae or soft ticks are named because 
of their flexible cuticle. A third much less common group known as Nuttalliellidae 
comprises a single species that has been collected in Africa, albeit rarely (154). The 
main tick vectors for rickettsiae are ixodid ticks. Argasid ticks have previously only 
been  implicated  with  the  non-pathogenic  rickettsia  R.  bellii.  Recent  work  had 
uncovered the presence of an SFG rickettsiae in soft ticks in Japan (153) and Rickettsia 
hoogstraalii in the soft tick Cario carpensis in the US (66). 
 
Since the first description of rickettsia by Howard Ricketts, a considerable amount of 
information on tick-borne rickettsiae has been uncovered via extensive studies of the 
ticks Dermacentor andersoni and Dermacentor variabilis, the vectors for R. rickettsii 
(Rocky Mountain spotted fever) (257, 288, 335). Ticks not only serve as vectors for R. 
rickettsii, they also act as reservoirs. Maintenance of R. rickettsii in a tick population 
occurs  by  both  transtadial,  transovarial  and  horizontal  transmission  (219,  280). 
Transtadial transmission within a tick refers to the maintenance of viable rickettsiae 
from one stage of a tick lifecycle to the next without affecting the viability of the tick or 
rickettsial organisms. Rickettsia rickettsii can be acquired by non-infected ticks from 
rickettsaemic  animal  hosts.  The  animal  hosts  that  can  attain  a  sufficient  level  of 
rickettsaemia  and  further  transmit  the  bacteria  are  limited  to  certain  species  (37). 
Sexual transmission of rickettsiae by ticks during mating have been observed however 
females infected by sexual transmission were unable to transmit the rickettsiae to their 
progeny (122). 
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Findings from the early studies of R. rickettsii transmission were also observed in other 
rickettsiae, such as R. slovaca (65). However variations do exist with some other tick-
borne  rickettsiae.  For  example,  the  inability  of  R.  rhipicephali  to  be  transmitted 
transovarially (177), which was not observed beyond the first generation.  
 
1.4.2  Fleas 
Fleas have a worldwide distribution, are found principally on mammals, and act as 
important vectors for zoonotic diseases including Yersinia pestis the causative agent of 
plague,  Bartonella  quintana  the  causative  agent  of  bacillary  angiomatosis  and 
Bartonella henselae the causative agent of cat scratch disease (15). Only two members 
of the genus Rickettsia are known to be transmitted by fleas. Rickettsia typhi of TG and 
R. felis of TRG. The transmission of R. typhi by the flea species Xenopsylla cheopis (rat 
flea)  was  first  described  by  Maxcy  (183).  Since  then,  R.  typhi  has  been  recovered 
worldwide in areas with rat infestation and on other flea species such as the cat flea 
Ctenocephalides felis and the mouse flea Leptopsyllia segnis. Transmission of R. felis 
to humans has been attributed via exposure to flea saliva, differing from R. typhi which 
has been shown to be transmitted to humans via entry of flea faeces into the flea-bite 
site or skin abrasions, inhalation or the contamination of the conjunctiva (15). 17 
 
1.4.3  Lice 
Lice are well recorded as parasites and are host specific, for example - the human body 
lice is specific only to humans. Infestations of humans are known as pediculosis. The 
human body louse (Pediculus humanus humanus and Pediculus humanus corporis) is 
also  recognised  as  a  vector  of  at  least  three  diseases;  epidemic  typhus  (Rickettsia 
prowazekii),  louse-borne  relapsing  fever  (Borrelia  recurrentis)  and  trench  fever 
(Bartonella quintana) (245). Various outbreaks  and epidemics of the three diseases 
carried by the human body louse are testament to its close co-evolution with humans. 
Some of the most famous outbreaks attributed to human body lice as a vector for R. 
prowazekii  include  the  Napoleonic  Wars  where  20%  of  Napoleon’s  troops  died  of 
typhus and the 12 million infected Russians between 1917 and 1925 of whom 3 million 
died (222, 251). 
 
The  human  body  louse  does  not  act  as  a  reservoir  for  R.  prowazekii  and  becomes 
infected as a result of feeding on a bacteraemic host. Infected lice usually die within 7 
days as a result of damaged epithelial cells caused by R. prowazekii (133). This lethal 
characteristic of R. prowazekii, for its vector, makes it the only member of the genus 
Rickettsia  not  transmitted  transovarially  in  its  vector  population.  In  spite  of  this 
limitation, epidemic typhus continues to be reported at the start of the 21
st century, 
especially in the homeless and low-hygiene populations of developed countries. Some 
factors  contributing to the re-emerging threat of epidemic typhus  are as a result of 
increasing  incidences  of  human  body  louse  infestations  due  to  declining  social 
structures and hygiene practices as a result of wars, economic instability and natural 
catastrophes (41). 18 
 
1.4.4  Mites 
Only one member of the genus Rickettsia has been described as being transmitted by 
mites; Rickettsia akari by the mouse mite Liponyssoides sanguineus (211). However R. 
akari  has  also  been  isolated  from  other  rodents  in  the  U.S.A,  Eurasia  and  Africa 
including  the  brown  rat,  gray  dwarf  hamster,  golden  spiny  mouse,  large-eared 
dormouse and bushy-tailed jird (213). Suggestions of L. sanguineus having a larger 
host range, including larger vertebrate hosts have been supported with the discovery of 
antibodies against R. akari in dogs and cats in the U.S.A (54). 
 
Rickettsia akari can be maintained within L. sanguineus populations by transovarial 
transmission.  L.  sanguineus  mites  have  five  life  stages;  egg,  larva,  protonymph, 
deutonymph and adult (97). Each stage requires a blood meal for the mite to moult and 
progress to the next stage. With the multiple blood meals within its life cycle, the mite 
has the opportunity to pass on R. akari to infected vertebrate hosts several times. 19 
 
1.5  Rickettsia Pathogenesis 
Rickettsial disease or rickettsioses are caused by known pathogenic rickettsiae from the 
SFG, TG and TRG. Although all differ in transmission, rickettsiae-host interactions and 
pathology, much of the pathogenesis of the three groups is similar. 
 
1.5.1  Transmission 
All  pathogenic  rickettsiae  require  arthropods  for  transmission;  however  how  the 
rickettsia is transmitted from the arthropod to humans can differ. Tick and mite borne 
rickettsiae rely on the transfer of rickettsiae during feeding. Rickettsiae are transferred 
to the host via the tick or mite saliva at the bite site. Cases of transmission of rickettsiae 
via  the  conjunctiva  have  occurred  with  exposure  of  infected  tick  haemolymph  on 
fingers after crushing an infected tick. Flea and louse borne rickettsiae are transmitted 
via faeces that enter the host via bite site or cuts on the skin. Inoculation via inhalation 
is possible and has happened in the laboratory (323). Although target cells at the site of 
inoculation  are  currently  unknown,  rickettsiae  possibly  infect  dermal  cells  such  as 
vascular  endothelium  (main  cell  infected),  fibroblasts,  lymphatic  endothelium  and 
macrophages (321). 
 
1.5.2  Rickettsiae-Host Interactions 
Recently with the advent of new culture techniques and imagery technology, a better 
understanding of the interactions between the rickettsiae and their host has been gained. 
Severity of rickettsial disease can be attributed to patient age as the main consistent 
factor in almost all cases. Initial hypothesis for rickettsioses having a higher fatality in 
males (esp. for Rocky Mountain spotted fever) has been disproved by recent studies 
(320). Other factors affecting rickettsiae-host interaction would be underlying patient 20 
 
diseases and enhanced oxidative stress increasing the severity of illness. Mediterranean 
spotted fever shows greater virulence in patients with diabetes mellitus (323). 
 
1.5.2.1 Routes of Spread 
Rickettsiae appear to target any nucleated cell at the site of inoculation. Cells possibly 
targeted  would  include  vascular  and  lymphatic  endothelium,  dermal  dendritic  cells, 
fibroblasts  and  macrophages  (323).  Once  rickettsiae  have  penetrated  and  initiated 
infection,  spread  throughout  the  host  is  facilitated  via  the  lymphatic  and  vascular 
systems. The presence of lymphadenopathy in the same region as the site of inoculation 
supports the hypothesis of antigenic spread via the lymphatic system. The spread of 
rickettsiae into susceptible cells is believed to occur mainly by vascular location though 
the action of rickettsial adhesions acting on specific receptors on host cells do play a 
significant role (181, 323). 
 
Entry  of  rickettsiae  into  a  vertebrate  or  arthropod  host  cell  is  via  the  binding  of 
rickettsial ligands (outer membrane proteins A and B) with host cell protein Ku70 (173, 
181, 304). Adhesions of outer membrane protein B (OmpB) with  Ku70 result in a 
cascade reaction which involves the migration of more Ku70 and ubiquitin ligase to the 
binding site, resulting in the focal-induced endocytosis of the adherent rickettsia into 
the host cell. Sca1 and Sca2 of the SFG had recently been reported to promote adhesion 
to mammalian cells (46, 260). The protein complex Arp2/3 has been associated with 
changes induced in the cytoskeletal actin at the entry site. Proteins involved in the 
activation of the Arp2/3 complex include GTPase, Cdc 42, protein tyrosine kinase, 
phosphoinositide 3-kinase and Src-family kinase (180). Once inside the cell, rickettsiae 
exit the phagosome into the cytosol by digesting the phagosomal membrane via the 
action of the enzymes phospholipase D and hemolysin C (TlyC) (256, 331). 21 
 
 
Movement  of  some  rickettsiae  from  one  host  cell  to  another  is  facilitated  by  actin 
polymerization, shown to be present in all spotted fever group rickettsiae except R. 
peacockii. Activation of the actin polymerization occurs at one pole of the bacterium, 
and  the  continuous  conversion  of  globular  actin  to  filamentous  actin  propels  the 
rickettsia through the cytosol eventually hitting the host cell membrane  (124, 298). 
Upon collision with the cell membrane there are two possible outcomes; (i) bounce off 
the  inner  surface  of  the  cell  membrane,  or  (ii)  deformation  of  the  membrane  and 
formation of a filopodium. Should the rickettsia exit the cell in a filopodium, a couple 
of different possibilities could occur depending on what is on the other side of the cell 
membrane; rickettsiae enter adjacent cells, or exit as a luminal filopodium entering the 
blood stream (125). The actin-based mobility seen in SFG rickettsiae has been shown to 
be initiated by the rickettsial protein RickA and mediated by Sca2 (120, 161). RickA 
has been described as a WASP-family (Wiskott-Aldrich Syndrome Protein) like protein 
with  similarities  such  as  carboxy  terminal  domains  and  activation  of  the  Arp2/3 
complex (111, 142). The gene rickA is however absent in both R. prowazekii and R. 
typhi. This is consistent with the lack of actin polymerization in TG rickettsiae and the 
burst  release  model.  Erratic  actin  based  mobility  has  been  observed  in  R.  typhi 
suggesting that members of the genus use multiple redundant mechanisms for actin 
polymerization which has yet to be clarified (142). 
 
1.5.2.2 Immune Response and Clearance 
Innate and adaptive immune responses to rickettsial infection have been a focus of 
research recently to better understand the rickettsia-host interactions during infection 
and clearance from the host. In spite of the wealth of information reported, there is still 
much  that  is  not  fully  understood.  In  vitro  studies  have  identified  a  few  critical 22 
 
components making up the host response; gamma interferon (IFN-γ), tumor necrosis 
factor alpha (TNF-ʱ) and CD8 T cells (81, 82). 
 
Host innate immune response at the onset of rickettsial infection has been observed 
with the activation of local natural killer (NK) cells. Production of IFN-γ has been 
associated  with  the  NK  cell  activation.  Type  I  interferon  production  has  also  been 
found to be stimulated, however its exact role in response to infection is believed to be 
indirect (30). Effects of type I interferon (IFN-ʱ and IFN-β) production include NK cell 
activation, maturation of dendritic cells and production of interleukin-12 (IL-12). In 
vitro infection of human endothelial cells with R. conorii resulted in the production of 
IL-1,  IL-6,  IL-8  and  monocyte  chemotactic  protein-1  (MCP-1)  while  infected 
macrophages were shown to secrete TNF-ʱ (150). General vasculitis as a result of R. 
conorii infection (MSF) could be attributed to the secretion of the above cytokines, 
which are pro-inflammatory (150, 176, 255). 
 
1.5.3  Pathology 
Increased vascular permeability as a result of Rickettsia infection have been associated 
with bacterial load and TNF-ʱ causing disrupted endothelial cell junctions (309, 336). 
Perivascular T lymphocytes and macrophages are heavily involved in the clearance of 
rickettsial infections. As most rickettsial infection is localized and not widespread, the 
result  of  vasculitis  is  not  usually  severe  except  in  the  most  serious  of  cases. 
Perivascular lymphohistiocytic infiltrate has been observed in the organs affected by 
rickettsial infection including the brain, lung, heart, kidney, skin, gastrointestinal tract, 
pancreas, gall bladder, skeletal muscle and testes (319).  
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Destruction of endothelial cells as a result of multifocal rickettsial infection usually 
results in the impairment of normal anticoagulation functions. The occurrence of fibrin-
platelet thrombi in both living and dead patients is rare (58). Haemostatic plugs are 
only observed in the foci of severe rickettsial inflicted vascular injury. In spite of the 
general hypothesis that thrombosis is the cause of organ infarction and tissue damage 
among patients, pathological and experimental evidence proves otherwise. Although 
infarction of organs seldom occurs, it has been observed in the white matter of the 
brain. Tissue damage to kidneys is usually the result of poor perfusion. Gangrene and 
cutaneous  necrosis  have  also  been  observed  in  some  cases  of  severe  rickettsioses 
resulting  in  extensive  damage  to  the  vascular  microcirculation  of  the  affected  area 
(317). 
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1.6  Diagnosis and Treatment 
Diagnosis of rickettsial infections can be hard without appropriate diagnostic assays. 
Prior to the advent of modern diagnostic methods, identifying rickettsial infections and 
prompt treatment relied heavily on the physician’s knowledge of endemic rickettsial 
diseases in their locality. A classic indicator is the presence of an attached arthropod or 
inflamed  arthropod  bite  on  the  patient.  But  the  development  of  symptoms  usually 
occurs about a week following infection, which may result in the unspecific symptoms 
being  misdiagnosed  as  another  ailment.  The  two  classic  symptoms  that  usually 
differentiate rickettsioses from other ailments would be the presence of an eschar at the 
arthropod  bite  site  and  a  rash.  Other  major  symptoms  such  as  myalgia,  fever, 
headaches, and local lymphadenopathy could be attributed to a myriad of other diseases 
(40). There have been reports of “spotless” spotted fever and “escharless” rickettsioses, 
major symptoms are similar for most rickettsial diseases, variations that do occur can 
vary greatly from classic symptoms. Thus there is a great need for prompt and accurate 
laboratory tests to assist physicians with diagnosis of rickettsial disease.  
 
Confirmation of a rickettsial disease is achieved via one of three methods. Eschars and 
blood samples are screened by serology and PCR or culture respectively (Figure 1.3). 
Although seldom performed, the biting arthropod can be screened directly by PCR 
and/or culture for evidence of rickettsiae. 25 
 
Figure  1.3 –  Figure illustrating the methods  used in the detection  and 
diagnosis  of  rickettsiosis  in human/animal/arthropod  samples.  Adapted 
from Fenollar et al. (83). 
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1.6.1  Serological Methods 
One of the earliest tests developed to serologically diagnose rickettsial infection was 
the  Weil-Felix  test  (326).  The  Weil-Felix  test  was  originally  designed  to  detect 
antibodies  to  Proteus  antigens  based  on  the  principle  that  they  cross-reacts  with 
rickettsial antigens. Whole cells of  Proteus vulgaris OX-2 react strongly with SFG 
positive sera except for sera from RMSF patients (R. rickettsii). Typhus Group and 
RMSF positive sera react strongly with whole cell P. vulgaris OX-19.  Whole cell 
preparations of Proteus mirabilis OX-K were later found to be reactive with antibodies 
from scrub typhus patients. The Weil-Felix test works on the principle of agglutination 
to detect antibodies in sera 5-10 days after the onset of symptoms. It is however not 
applicable to patients suffering from Brill-Zinsser disease or infected with R. akari due 
to the inability of the antibodies to agglutinate with the Proteus whole cell preparation 
used. The antibody type detected in the test is mainly IgM (3). The Weil-Felix test is 
now considered to be obsolete with the development of rickettsial IF techniques. The 
poor specificity and sensitivity of the Weil-Felix test is well documented and it would 
only be used now in rudimentary clinical laboratories (44, 123, 201, 240). The Weil-
Felix method has also been shown to have cross-reactivity when Rickettsia positive sera 
are tested against Legionella sp. and Proteus sp. (242). 
 
Immunofluorescence Assay 
Philip, 1978, suggested the use of immunofluorescence assays (IFA) for the detection 
of rickettsiae using serology as a replacement to the Weil-Felix method (227). IFA 
serology has now become the most widely accepted method of detection and is used 
frequently in providing rapid diagnosis to suspected rickettsial infections (165).  
 27 
 
IFA is highly sensitive but it faces the problem of the lack of intra-rickettsial group 
specificity. Diagnosis of rickettsiosis by IFA is fast and accurate but differentiation 
between species of rickettsiae as the cause of infection is often impossible due to cross 
reacting  antibodies.  This  is  further  complicated  by  the  variability  in  antibody  titre 
determination due to operator subjectivity. A method that has been suggested by the 
Australian Rickettsial Reference Laboratory is to increase the cut-off value of antibody 
titre to 1:128 thus reducing the incidence of false positives (307). Current cut off values 
used by the Unité des Rickettsies are 1:64 for IgG and 1:32 for IgM (87). In spite of its 
short-comings, IFA is usually used as the only tool of diagnosis for rickettsial disease.  
 
1.6.2  Cell Culture 
The ability to isolate a microbial pathogen in culture is definitive in disease diagnosis 
and crucial in characterizing the microbes’ genotypic and phenotypic features. In fact, 
being  able  to  culture  a  disease  causing  microorganism  forms  the  second  and  third 
criteria of Koch’s postulates (135). With the advent of modern molecular biological 
techniques in the last couple of decades, the presence of a pathogen’s genetic material 
in  a  host’s  tissue  sample  would  be  enough  for  a  diagnosis.  However,  molecular 
techniques alone are currently unable to provide crucial information obtainable only via 
culture such as pathogen-host cell interactions. 
 
The shell vial technique is one of the most effective methods of isolating rickettsial 
organisms from extracts of blood, animal and human tissue (313). It was originally 
adapted from the a similarly named technique used in isolating viruses and is now one 
of the most effective methods available to researchers for isolating Rickettsia sp. and 
other rickettsia-like organisms (238, 241). Even so, conventional cell culture using a 
confluent monolayer of either mammalian (L929, Vero and HEL), amphibian (XTC-2) 28 
 
or  insect  (DAE100,  Aa23  and  Sua5B)  cell  lines  acting  as  host  to  the  rickettsial 
organism is still popular and well accepted (189, 276). 
 
1.6.3  Polymerase Chain Reaction (PCR) 
The application of PCR has revolutionised the detection and diagnosis of rickettsial 
infections (5). With access to a proper laboratory equipped to perform PCRs on patient 
samples, accurate diagnosis can be obtained before seroconversion of patient and prior 
to growth in culture. Samples used for PCR are preferably fresh but tissues that have 
been preserved in paraffin or fixed to a slide can also be used (290). Various assays 
have been developed allowing for rapid detection of Rickettsia sp. with most targeting 
well-described genes such as citrate synthase (gltA) (269), OmpA (ompA) (85), OmpB 
(ompB) (270), 16S rRNA (268) and geneD (sca4) (279). The implementation of real-
time PCR (qPCR) in rickettsial detection further increased the sensitivity of PCR assays 
and allows for the quantitation of rickettsiae in a sample (216). Speciation of rickettsiae 
can now be performed using criteria proposed by Fournier et al. (88) (Figure 1.4) and 
which have since been adopted worldwide as the standard for identifying rickettsial 
species by PCR. 
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Figure  1.4  –  Figure  showing  the  amplification  and  sequence  similarities 
requirement  of  5  rickettsial  genes  to  determine  group/  species/novelty  of  a 
Rickettsia isolate. Adapted from Fournier et al. (88). 
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1.6.4  Treatment 
A rickettsiosis is in some cases a self limiting disease that can be of minor clinical 
significance  or  asymptomatic  and  not  require  treatment.  However,  there  have  been 
multiple cases of severe rickettsiosis and treatment with antibiotics such as tetracycline 
or chloramphenicol is essential to avoid morbidity and mortality (87, 106). These drugs 
however  do  cause  significant  side  effects  in  children  such  as  staining  of  teeth  by 
tetracyclines and bone marrow toxicity by chloramphenicol (8). Symptoms relating to 
rickettsial  infection  usually  resolve  within  48  to  72  hours  of  treatment.  Treatment 
regimens last from between 5 to 14 days depending on the severity of the disease. 
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1.7  Tick-Borne Rickettsioses 
Despite the close similarities between the members of the SFG, there are differences 
that make them distinct enough to warrant separate species classification. The diseases 
caused by the various members of tick-borne Rickettsia vary in severity though they do 
share many common symptoms. All tick-borne Rickettsia are currently classified as 
belonging to the spotted fever group and considered potentially pathogenic to human. 
Eleven forms of SFG rickettsiosis as a result of infection by an SFG Rickettsia have 
been  documented  in  literature  outside  of  Australia  since  the  beginning  of  the  20
th 
century. Australian rickettsioses will be covered in section 1.9. 
 
1.7.1  Rickettsia rickettsii 
Records of spotted fever illness in western Montana, USA, date back to 1873 and were 
first described by Wilson and Chowning in 1904 (202). Misconception of the aetiologic 
agent, initially thought to be Pyroplasma hominis (an intraerythrocytic parasite), made 
by  Wilson  and  Chowning  was  later  corrected  by  Howard  T.  Ricketts  who  further 
expanded  the  global  medical  scientific  community’s  understanding  of  rickettsioses. 
Ricketts  demonstrated  that  the  aetiologic  agent  for  Rocky  Mountain  spotted  fever 
(RMSF) was a rickettsia that was transmitted by the tick Dermacentor andersoni. Since 
Ricketts’ initial publications, a huge interest in rickettsial infections among physicians 
and scientists has resulted in a more accurate understanding of the aetiologic agent, R. 
rickettsii and the disease it causes. 
 
Several tick species including Dermacentor, Rhipicephalus and Amblyomma act as the 
reservoirs for R. rickettsii (62, 119). Vertebrate amplifying hosts of R. rickettsii include 
domestic dogs and small mammals such as cotton rats (Sigmodon hispidus), ground 
squirrels  (Spermophilus  lateralis),  opossums  (Didelphis  virginiana)  and  capybaras 32 
 
(Hydrochoerus hydrochaeris) (184, 287). Cases of RMSF and isolation of R. rickettsii 
from their arthropod vectors have been reported in North, Central and South America 
(51). The clinical symptoms of RMSF appear approximately 3-12 days after rickettsial 
inoculation from a tick bite. RMSF begins with fever followed by a maculopapular rash 
that develops on the second to fourth day after the onset of fever. Other accompanying 
symptoms include nausea, vomiting, anorexia, headaches and generalized myalgia (49, 
175). In more severe cases of RMSF, pathophysiological manifestations of the disease 
include vascular permeability leading to pulmonary or cerebral oedema, renal failure, 
myocarditis and gangrene (51). Rickettsia rickettsii is the most virulent of all known 
spotted fever rickettsiae with a 70% mortality rate among the earliest recorded cases. 
Rates of mortality declined with the discovery of antibiotics however rates are affected 
by the promptness of appropriate treatment and correct diagnosis of the disease. This 
was evident with the high mortality rate of 40% in Brazil in the 1980s (99, 160). The 
mortality rate for RMSF in the USA has dropped significantly in the later part of the 
20
th century, now hovering between 2-6% (210). 
 
1.7.2  Rickettsia conorii 
Rickettsia conorii, the causative agent of Mediterranean spotted fever (MSF), was first 
described in Tunisia in 1910 by Conor and Brush (56, 171). Since then, R. conorii has 
been  reported  from  locations  around  the  Mediterranean,  central  Europe,  India,  the 
Middle East and central and southern Africa. The main vector for R. conorii is the 
brown dog tick Rhipicephalus sanguineus, which has a worldwide distribution as a 
result of the global spread of domesticated dogs along with human populations. There 
are several known sub-species of R. conorii transmitted by the tick Rh. sanguineus. 
These include; R. conorii conorii (agent for MSF), R. conorii israelensis (agent for 
Israeli spotted fever, ISF), R. conorii caspia (agent for Astrakhan fever, AF) and R. 33 
 
conorii indica (agent for Indian tick typhus, ITT). The clinical symptoms for all four 
diseases are varied in severity and presentation. Patients infected with MSF have been 
reported to present with an eschar, high fever (>39°C) and flu-like symptoms (10). 
Mortality as a result of disease is extremely rare, about 2.5% at its highest. The severity 
of disease is attributed to the susceptibility of the host and the virulence of the infecting 
strain (4).  
 
ISF was first described in 1946 and its vector and agent later isolated in 1971 (110, 
310). Isolates proved to be closely related to R. conorii but slightly different, which led 
to the proposal by Zhu et al. (2005) to classify it as a sub species of R. conorii; R. 
conorii israelensis. The distribution of R. conorii israelensis has been reported as far as 
Portugal  and  Sicily  (59,  104).  Ninety  percent  of  ISF  cases  do  not  have  an  eschar 
present, the site of inoculation appearing as a small pinkish papule (117).  
 
AF is a more recent spotted fever that was reported first in 1972. Patients were initially 
reported from the rural areas of Astrakhan, Russia, adjacent to the Caspian Sea (297). 
An isolate obtained from a patient in 1991 showed identical genomic patterns with that 
of R. conorii israelensis (74). The causative agent for AF is now classified as a sub 
species of R. conorii, R. conorii caspia (341). Other than Rhipicephalus sanguineus, R. 
conorii caspia has been found in Rh. pumilio and its area of distribution may include 
Kosovo and Chad (75, 89, 90). Symptoms for AF are similar to that of MSF, with most 
patients  presenting  with  maculopapular  rash,  myalgia  and  headaches  however  the 
presence of an eschar is infrequent with most cases being without an eschar. Other 
symptoms such as conjunctivitis and hepatomegaly are relatively common (297).  
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The agent for ITT was first isolated in 1950 (209, 271). Since then it has been shown to 
differ  antigenically  from  R.  conorii,  but  there  was  no  doubt  that  the  agent  is  of 
rickettsial spotted fever origin (227). Zhu et al. (2005) recently suggested that the ITT 
agent be classified as a sub species of R. conorii as R. conorii indica (341). There are 
few differences between ITT and MSF, with the main differences being that rash in ITT 
is  purpuric  and  the  presence  of  an  eschar  is  rarely  observed  (141).  ITT  has  been 
reported outside of India, with cases appearing in Thailand and Laos (220, 228). 
 
1.7.3  Rickettsia africae 
Rickettsia  africae  is  the  causative  agent  of  African  tick  bite  fever  (ATBF)  and  is 
endemic in rural sub-Saharan Africa and the Caribbean (144, 156). The first recorded 
cases date back to the early 20
th century in Mozambique and South Africa (144). Ticks 
belonging to the genus Amblyomma have been reported as the main vector. R. africae 
transmission by A. hebraeum in southern Africa and A. variegatum in West, Central 
and East Africa are well documented  (24). Amblyomma variegatum is also the tick 
vector for R. africae in the Caribbean (157). 
 
Infection with R. africae is believed to be asymptomatic in 50% of cases with most 
cases  being  asymptomatic  or  clinically  mild  and  self-limited  (143).  In  cases  where 
symptoms  are  present,  they  usually  include  fever,  nausea,  headache  and  myalgia, 
similar to other spotted fever illness. An eschar is usually seen and multiple eschars are 
common (247). Complications with ATBF are rare but cases with long lasting fever, 
subacute neuropathy, chronic fatigue and myocarditis have been reported (27, 145). 
There has been no reported mortality as a result of infection or disease. 
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1.7.4  Rickettsia sibirica 
The  species  R.  sibirica  is  made  up  of  two  sub  species;  R.  sibirica  sibirica  and  R. 
sibirica  mongolotimonae.  Both  are  recognized  aetiologic  agents  for  spotted  fever 
rickettsioses with R. sibirica sibirica being the agent for Siberian tick typhus (STT) or 
North  Asian  tick  typhus,  and  R.  sibirica  mongolotimonae  being  the  agent  for 
lymphangitis-associated  rickettsiosis  (LAR)  (91,  187).  There  are  few  similarities 
between the two sub species, and the main reason for putting them within the same 
species is the genotypic similarities they share (88). 
 
Siberian tick typhus (STT) was first recorded in Russia in the 1930s. Since then it has 
been  found  in  various  parts  of  north  Asia  with  recorded  cases  in  Kazakhstan, 
Kyrgyzstan, Mongolia and China (266). Tick vectors for the aetiologic agent include 
Demacentor  nuttali,  Dermacentor  marginatus,  Haemaphysalis  concinna  and 
Dermacentor silvarum (18). Presence of R. sibirica sibirica in small mammals has also 
been demonstrated, giving rise to the possibility of them acting as a reservoir (50). 
Common STT symptoms include eschar, maculopapular rash, high fever, arthralgia and 
myalgia (244). 
 
Rickettsia sibirica mongolotimonae was first reported in 1991 with an isolate from the 
tick  species  Hyalomma  asiaticum  from  Inner  Mongolia  in  China  (339).  Its  next 
recorded isolation was from Marseille, France, in 1996 from a human patient (243). 
Since these two cases were reported, R. sibirica mongolotimonae has been associated 
with the occurrence of lymphangitis-associated rickettsiosis (LAR) in Europe, Africa 
and  China.  Other  than  Hyalomma  asiaticum,  it  has  been  isolated  from  other  tick 
species;  H.  truncatum,  H.  anatolicum  excavatum  and  Rh.  pusillus  (61,  218,  236). 
Common symptoms for LAR include rash, multiple eschars, fever and lymphangitis 36 
 
between  the  inoculation  eschar  and  the  draining  lymph  node  thus  giving  its  name 
lymphangitis-associated rickettsiosis (91). However it was reported that less than 50% 
of cases had lymphangitis, which is not uncommon among other rickettsiosis (91). 
 
1.7.5  Rickettsia heilongjiangensis 
Rickettsia heilongjiangensis is the aetiologic agent for Far-Eastern tick typhus. It was 
initially mistaken for STT and was only recently described as a new species of spotted 
fever group rickettsia (88). R. heilongjiangensis is grouped within the same cluster as 
R. japonica phylogenetically. Several tick species have been identified as vectors of the 
rickettsia, including D. sylvarum and H. concinna (186). The clinical symptoms of Far-
Eastern tick typhus include eschar, fever, headache, rash, regional lymphadenopathy 
and conjunctivitis. The disease is relatively mild in patients and most cases observed 
occur in the elderly, with only one case under the age of 45 (244). 
 
1.7.6  Rickettsia japonica 
The first observed cases of R. japonica infection (Japanese/Oriental spotted fever) were 
in 1984. The disease closely resembles scrub typhus (ST) however disease occurrence 
was in a geographical area non-endemic for ST and the high affinity of antibodies for 
SFG rickettsial antigens gave reason for it to be described as a new SFG rickettsiosis 
(302). The new species of spotted fever group rickettsia, R. japonica, was later isolated 
from  patients  in  1985  (303).  Several  ticks  have  been  found  to  carry  R.  japonica, 
including  Haemaphysalis  longicornis,  Haemaphysalis  flava,  D.  taiwanensis,  I. 
persulcatus,  I.  monospinosus  and  I.  ovatus  (86).  Clinical  symptoms  include  fever, 
chills,  macular  rash,  headache  and  eschar.  Severe  cases  are  not  uncommon  with 
fatalities occurring due to encephalitis, multi organ failure and acute respiratory distress 
syndrome (162). Recently, several genotypic variants of R. japonica have been found in 37 
 
Korea,  leading  the  hypothesis  that  there  are  several  regional  geno-variants  of  this 
rickettsia in east Asia (53, 169). 
 
1.7.7  Rickettsia slovaca 
Rickettsia slovaca was first isolated in 1968 in Slovakia (then Czechoslovakia) and has 
since been classified as a novel member of spotted fever Rickettsia (280). It has been 
isolated from the ticks Dermacentor marginatus and D. reticulatus. The first recorded 
case of rickettsiosis as a result of R. slovaca infection was not until 1997, almost 30 
years after the discovery of the aetiologic agent and it was given the name tick-borne 
lymphadenopathy (TIBOLA) (167). Signs associated with TIBOLA include eschar and 
enlarged cervical lymph nodes with sequelae involving alopecia and asthenia. Classic 
spotted  fever  symptoms  of  fever  and  rash  were  uncommon  among  patients  (249). 
Another disease associated with R. slovaca infection is Dermacentor-borne-necrosis-
erythema-lymphadenopathy (DEBONEL). Some of the signs and symptoms recorded 
from patients diagnosed with DEBONEL include eschar, painful lymphadenopathy and 
a slight fever (205). Most eschars observed on patients with TIBOLA and DEBONEL 
were found on the scalp. TIBOLA and DEBONEL, and their aetiologic agent have 
been reported from Europe only so far. 
 
1.7.8  Rickettsia aeschlimanii 
Rickettsia aeschlimanii was first isolated in 1992, but it wasn’t until 1997 that it was 
deemed to be a novel species of SFG rickettsia (25). First isolated from Hyalomma 
marginatum  marginatum  ticks,  it  has  been  found  in  other  ticks  species,  including 
Hyalomma  marginatum  rufipes  and  Rhipicephalus  appendiculatus  (218,  235).  The 
geographic distribution of R. aeschlimanii coincides with the tick species that harbours 
it,  specifically  southern  Europe,  north  Africa  and  south  Africa.  The  first  human 38 
 
infection was reported in 2002 and the patient presented with multiple eschars and a 
maculopapular rash (248).  
 
1.7.9  Rickettsia massiliae 
Rickettsia  massiliae  is  one  of  the  many  spotted  fever  rickettsiae  whose  clinical 
significance is relatively unclear. It was first isolated from Rh. sanguineus ticks near 
Marseille, France, in 1992 (23). Since then, it has been found in 4 other tick species 
which act as reservoirs; Rh. sanguineus, Rh. muhsamae, Rh. lunulatus, Rh. sulcatus and 
Rh. turanicus. The geographical distribution of R. massiliae has been determined to be 
central  and southern Europe, central Africa, North and South America  (17, 70, 76, 
101). First recorded human infection by R. massiliae was in 1985 from Palermo, Italy, 
but the identification of R. massiliae as the aetiologic agent was only obtained in 2005. 
The patient presented with fever, eschar, maculopapular rash and hepatomegaly (315). 
 
1.7.10 Rickettsia honei 
Although this species was first characterised in Australia in 1991 (115, 294) (section 
1.9), it was recognised but not identified in other locations around the world many 
years beforehand. The first isolation of R. honei was in 1962 from a pool of Ixodes sp. 
and Rhipicehalus sp. ticks collected off common rats in Thailand and was designated as 
TT-118 (264). The novel rickettsia was coined Thai tick typhus by its discoverers. This 
find was later reproduced when R. honei DNA was isolated from Ixodes granulatus off 
R. rattus in 1974 from Thailand (163). The first recorded case of human Thai tick 
typhus was in a febrile patient in 2005 (146), from whom R. honei DNA was extracted 
from  their  serum.  R.  honei  has  also  been  detected  in  the  USA  from  Amblyomma 
cajennense ticks off cattle, although no reports of human rickettsiosis has been reported 
in the USA to date (29).  39 
 
 
1.7.11 Rickettsia parkeri 
Rickettsia parkeri was not recognised as a cause of rickettsiosis until 65 years after it 
was first described. For 65 years R. parkeri was thought to be non-pathogenic until 
recent work demonstrated otherwise (212). The “newly” discovered pathogenic nature 
of R. parkeri emphasises the lack of current knowledge on rickettsial virulence for 
humans. Even though a large wealth of information had been uncovered in the last 
century, our understanding on the pathogenicity of rickettsiae worldwide is still limited. 
The geographic distribution of R. parkeri has since been determined to stretch from the 
U.S.A and all the way down to central South America (215, 299). Rickettsiosis as a 
result of  R. parkeri infection has  been observed to  be milder than RMSF. Patients 
present with fever, an eschar and a maculopapular rash (212, 214, 330). 
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1.8  Non Tick-Borne Rickettsiosis 
There are four  known non-tick borne rickettsioses  and they split  into two different 
groups. Typhus group rickettsia consists of R. typhi and R. prowazekii and the recently 
proposed  Transitional  group  rickettsia  consists  of  R.  akari  and  R.  felis.  Two  other 
known rickettsiae that are not tick-borne, R. canadensis and R. bellii (members of AG) 
have  so  far  been  considered  as  non-pathogenic  to  humans;  however  the  current 
perception is due to limited evidence to prove them as human pathogens and not due to 
any in depth studies to prove non-pathogenicity (38, 198). The rickettsiosis caused by 
members  of  TG  and  TRG  vary  in  severity,  though  they  do  share  some  clinical 
similarities to the rickettsiosis of tick-borne/SFG rickettsia 
.  
1.8.1  Rickettsia typhi 
Rickettsia typhi is the causative agent of murine (or endemic) typhus. It is one of the 
two members of the Typhus group along with R. prowazekii. The vector of R. typhi has 
been established as the rat flea, Xenopsylla cheopis and its distribution is worldwide 
and its incidence is higher in the developing parts of the world where hygiene and rat 
control is inadequate (13, 71, 105). Other vectors that have been shown to transmit or 
carry R. typhi include the fleas, most notably the cat flea (Ctenocephalides felis), and 
also lice, mites and ticks (14, 52, 77, 289). The primary reservoir for R. typhi are rats 
belonging to the genus Rattus, mainly Rattus rattus and R. norvegicus. Other rodents 
and small mammals have also been implicated as reservoirs for R. typhi, including rats, 
mice, cats and opossums (48, 285, 333). 
  
The first description of the disease typhus was  by Fracastoro in 1546 and the first 
documentation of typhus in literature was published in 1917 (192).  Presentations of 
clinical symptoms usually occur approximately 6 to 14 days after inoculation. Clinical 41 
 
manifestations as a result of R. typhi infection include; fever, rash, chills, nausea and 
headaches (105). The rash reported are usually macular in appearance, but there has 
been instances where the rash appearance were maculopapular, papular, petechial or 
morbilliform (68). More severe forms of murine typhus are not uncommon and usually 
resulting in meningoencephalitis and interstitial pneumonia with other signs including 
hepatomegaly,  splenomegaly,  pulmonary  pleural  effusion,  respiratory  failure,  acute 
renal failure and cardiac dysfunction (68, 282). The rate of mortality is very low and 
has been recorded to be less than 5% at worst (in the pre-antibiotic era). 
 
1.8.2  Rickettsia prowazekii 
The rickettsiosis that results from infection with R. prowazekii is known by various 
names some of which include “Jail fever”, “epidemic typhus” or just simply “typhus”. 
Epidemic typhus has been attributed to be the cause of uncountable deaths in human 
recorded history, going as far back as the Napoleonic wars and most notable during the 
First World War where 3 million Russians died as a result of infection between 1917 
and 1925 (222). 
 
The  natural  vector for  R. prowazekii is the human body louse (Pediculus  humanus 
humanus or P. h. corporis) (118). The reservoir for R. prowazekii in North America is 
the flying squirrel. Another purported reservoir for R. prowazekii is recrudescence in 
humans (116). The geographical distribution of the human body louse is global with 
major infestations coinciding with over-crowded and unhygienic human populations 
(134).  Clinical  manifestations  of  epidemic  typhus  appear  from  10-14  days  after 
infection and include malaise, anorexia, chills, headache, myalgias, arthralgias, rash 
and fever (225). Rash appears as either macular, maculopapular or petechial. Severe 
cases of epidemic typhus have been reported with gangrene, seizures, coma, hearing 42 
 
loss, myocarditis, jaundice, pulmonary complications and hepatitis. Rate of mortality in 
untreated individual can be as high as 30% (64, 95). 
 
1.8.3  Rickettsia akari  
Rickettsia akari is the only member of the genus Rickettsia to have mites exclusively as 
a vector. First observed in 1946 in New York, USA, almost 100 more cases followed 
closely in the same area within the same year (213). The established vector for R. akari 
is the mouse mite Liponyssoides sanguineus. Lice have been shown to harbour R. akari 
although they are unable to transmit the rickettsial agent to humans (328). The natural 
amplifying host for R. akari is the mouse, Mus musculus. Other rodents and small 
mammals have been shown to have the potential to act as hosts including the rat Rattus 
norvegicus  and  the  Korean  reed  vole,  Microtus  fortis  pelliceus  (139).  The  known 
geographic distribution of R. akari is in north America, Europe and Africa (41, 103, 
274). 
 
Clinical manifestations of rickettsialpox appear 10-15 days after initial infection (213). 
Lesions  are  commonly  found  at  the  bite  site  about  2  days  after  inoculation  before 
clinical manifestations such as headache, myalgia, high fever and papulovesicular rash 
(151). Severe cases of rickettsialpox are rare and no deaths as a result of infection by R. 
akari have been reported (211).  
 
1.8.4  Rickettsia felis 
Rickettsia felis was first discovered in C. felis in 1918 (284), which has since been 
established as the major carrier of R. felis worldwide. Other flea species associated with 
R. felis are Ctenocephalides canis, Pulex irritans, Anomiopsyllus nudata, Xenopsylla 
cheopis  and  Archaeopsylla  erinacei  (15,  31,  147,  220).  A  recent  study  into  the 43 
 
prevalence of R. felis in Western Australia has added two more flea species to the list; 
Echidnophaga  gallinacean  and  Spilopsyllus  cuniculi  (277).  The  current  known 
reservoirs of R. felis included more than twenty species of fleas, ticks, lice and mites 
(Table 1.3). The large number of reservoirs and potential vectors has made R. felis a 
growing cause for concern as an emerging health threat worldwide (224, 254). The first 
report  of  human  infections  in  Australia  was  by  Williams  et  al.  (332).  Clinical 
manifestations of cat flea typhus include fever, fatigue, headache, maculopapular rash 
and a lesion at the site of infection (bite) (246). Cat flea typhus is not known to have 
any serious complications and represents a milder form of rickettsioses. No mortality 
has ever been reported (342). 44 
 
Table 1.3 – Invertebrate hosts of Rickettsia felis, some of which carry other potential bacterial pathogens. 
Invertebrate Host  Vertebrate Host  Location (Identified)  Other Potential Pathogens*  Disease  Reference 
Fleas           
  Ctenocephalides felis  Dog, Cat, Rodents, 
Monkey, Opossums 
Argentina, Australia, Brazil, Canada, Chile, Cyprus, France, 
Gabon, Germany, Israel, Mexico, New Zealand, Peru, Spain, 
Taiwan, Thailand, UK, USA, Uruguay 
Rickettsia typhi 
Bartonella sp. 
Murine typhus 
Cat-scratch disease 
(22, 31, 32, 108, 149, 158, 
159, 166, 179, 191, 200, 
220, 237, 265, 267, 277, 
300, 312, 333, 340) 
  Ctenocephalides canis  Dog, Cat  Algeria, Brazil, France, Spain , Thailand, Uruguay  Bartonella sp.  Cat-scratch disease  (31, 34, 107, 130, 220, 
312) 
  Pulex Irritans  Human and mammals  DR Congo, USA  Rickettsia typhi 
Yersinia pestis 
Murine typhus 
Plague 
(15, 273) 
  Xenopsylla cheopis  Rodents, Shrew  Indonesia, USA  Rickettsia typhi 
Yersinia pestis 
Murine typhus 
Plague 
(77, 147) 
  Anomiopsyllus nudata  Rodents  USA  -  -  (293) 
  Archaeopsylla erinacei  Hedgehog, Dog, Cat  Algeria, France, Germany  -  -  (31, 107, 108) 
  Echidnophaga gallinacean  Poultry, Dog, Cat  Australia, DR Congo  Rickettsia sp.  Spotted fever  (273, 277) 
  Spilopsyllus cuniculi  Cat, Rabbit  Australia  -  -  (277) 
  Ctenophthalmus sp.  Rodent  Portugal  Rickettsia typhi 
Bartonella sp. 
Murine typhus 
Cat-scratch disease 
(60) 
  Xenopsylla brasiliensis  Rodent  Brazil  Yersinia pestis  Plague  (273) 
  Tunga penetrans  Human, Dog, Cat, Pig  Brazil  -  -  (273) 
  Polygenis atopus  Dog, Cat, Opossum  Brazil  -  -  (131) 
Ticks           
  Haemaphysalis flava  Cat  Japan  Rickettsia japonica  Japanese spotted 
fever 
(136) 
  Haemaphysalis kitaokai  Cattle, Deer  Japan  -  -  (136) 
  Rhipicephalus sanguineus  Dog, Horse  Brazil, Japan  Rickettsia sp. 
Anaplasma sp. 
Spotted fever 
Anaplasmosis 
(136, 199) 
  Amblyomma cajennense  Dog, Horse  Japan  Rickettsia sp.  Spotted fever  (136) 
  Ixodes granulatus  Shrew  Taiwan  Rickettsia sp. 
Ehrlichia sp. 
Spotted fever 
Ehrlichiosis 
(301) 
  Ixodes ovatus  Cat  Japan  Rickettsia sp.  Spotted fever  (136) 
  Carios capensis  Seabird  USA  Coxiella sp. 
Rickettsia hoogstraalii 
Unknown 
Spotted fever 
(67, 252) 
  Haemaphysalis sulcata  Sheep, Goat   Croatia  Rickettsia hoogstraalii  Unknown spotted  
fever 
(67) 
Mites           
  Trombiculid  Wild Rodents   South Korea  Orientia tsutsugamushi  Scrub typhus  (52) 
  Leptotrombidium deliense  Rat  Taiwan  Orientia tsutsugamushi  Scrub typhus  (301) 
  Mesostigmata  Rat  Taiwan  -  -  (301) 
Lice           
  Liposcelis bostrychophila  -  Canada  -  -  (26) 
* Multiple bacterial pathogens present in the same host are simplified with genus only. Fields with no bacterial pathogens listed denotes no record in literature. 45 
 
1.8.5  Orientia tsutsugamushi 
Orientia  tsutsugamushi  (originally  Rickettsia  tsutsugamushi)  though  no  longer 
classified as a member of the genus  Rickettsia is still considered to be a rickettsial 
organism with significant public health implications (296). Its main reservoir and vector 
are  mites  belonging  to  the  trombiculid  family,  more  specifically,  the  species 
Leptotrombidium deliense. The geographical range of O. tsutsugamushi appears to be 
restricted only to Asia, Oceania and Australia. In Asia, scrub typhus has been described 
as  far  north  as  Japan  (296),  and  covering  the  whole  of  South-East  Asia  (228)  and 
spreading west-wards to Afghanistan. Scrub typhus has so far been reported from the 
northern part of Australia, in the states of Western Australia, Northern Territories and 
Queensland (112, 114). 
 
The  recent  discovery  of  a  novel  isolate  of  an  Orientia-like  organism  has  seen  the 
addition  of  a  second  member  to  the  genus  (137).  The  organism’s  name  has  been 
proposed  as  Orientia  chuto,  isolated  from  an  Australian  tourist  returning  from  the 
United Arab Emirates, where she was believed to have been infected. This places O. 
chuto outside the traditional geographic area of O. tsutsugamushi.   46 
 
1.9  The Australian Situation 
Recorded  rickettsial  infections  in  Australia  go as  far back  as  the early  20
th century 
approximately 15 years after Rickett’s discovery of Rickettsia rickettsii was published 
(128).  There  are  four  members  of  the  Rickettsia  genus  in  Australia  that  has  been 
described thus far, two of them believed to be native to the continent (R. australis and 
R. honei) and another two (R. typhi and R felis) believed to have been introduced to 
Australia by migration of humans and their accompanying animals and possibly rodents 
that  followed.  There  have  been  a  few  reports  of  distinctly  different  Rickettsia-like 
organisms  that  are  currently  being  investigated  to  determine  their  relation  to  other 
members of their suspected genus. Other rickettsial/rickettsia-like organisms reported 
from  the  Australian  continent  but  not  investigated  in  this  thesis  include  Bartonella 
henselae, Bartonella quintana, Bartonella australis, Anaplasma marginale, Anaplasma 
platys, Coxiella burnetii and O. tsutsugamushi  (43, 84, 92, 182, 337).  
 
Rickettsia australis 
The first spotted fever rickettsiosis reported in Australia was described as Queensland 
tick typhus from 13 cases around Cairns in the state of Queensland (7, 39) (Figure 1.5). 
It was later established that the agent was related to R. typhi and other members of the 
genus Rickettsia but distinct enough to be described as a new species and thus named R. 
australis (98, 226, 234). The vectors for QTT were not established until the mid 1970s, 
the  three  tick  species  that  has  been  identified  as  vectors  of  R.  australis  are  Ixodes 
tasmani, Ixodes holocyclus and Ixodes cornuatus (45, 115). The distribution of the ticks 
that  have  been  found  to  harbour  R.  australis  ranges  from  the  Torres  Strait  islands, 
northern  Queensland,  Sydney,  New  South  Wales  and  south-eastern  Victoria  (231). 
Symptoms attributed to QTT include headaches, chills, malaise, fever, maculopapular 47 
 
rash and an eschar at the site of the tick bite. Of the 40 cases reported in the literature 
since the first QTT incident, there have been 2 cases of documented mortality (231).  
 
Rickettsia honei 
Rickettsiosis as a result of R. honei infection was first reported in Australia in 1991 on 
Flinders  Island.  It  was  originally thought  to  be QTT (caused by  R. australis), even 
though there were initial clinical and epidemiological differences. Some of the clinical 
illness  presented  includes  fever,  myalgia,  headache,  cough  and  rash  (294).  The 
rickettsiosis  was  named Flinders  Island spotted fever  (FISF) and the  rickettsia after 
Frank Sandland Hone, the first Australian rickettsiologist. The vector for R. honei had 
been determined to be the reptile tick Bothriocroton hydrosauri (previously of the genus 
Aponomma) which can be found in South Australia (SA), Victoria, Tasmania and New 
South Wales (Figure 1.5). However, the known geographical distribution in Australia 
for R. honei is limited to South Australia and Tasmania (113, 263). 
 
Unsworth et al. (306) reported the isolation of a R. honei-like rickettsia that causes 
rickettsiosis in humans in 2007. The isolate was closely related to R. honei and was thus 
designated R. honei strain “marmionii”. Since then the rickettsiosis has been named 
Australian spotted fever (Figure 1.5). R. honei strain “marmionii” has also been isolated 
from the blood of two patients diagnosed with chronic fatigue syndrome (CFS)  (305) 
giving support to the hypothesis that some cases of CFS may be as a result of chronic 
rickettsiosis. The name “marmionii” was given to honour the Australian rickettsiologist 
Barrie Marmion, who developed the Q fever vaccine.   48 
 
   
A  B 
C  D 
E  Figure  1.5  –  Geographic  distribution  of 
known rickettsial organisms in Australia; 
(A) R. australis, (B) R. honei, (C) R. honei 
strain “marmionii”, (D) R. typhi, and (E) 
O.  tsutsugamushi.  Courtesy  of  the 
Australian  Rickettsial  Reference 
Laboratory (ARRL). 49 
 
Rickettsia felis 
The presence of R. felis was undocumented in Australia until 2006, when a study by 
Schloderer et al. (277) demonstrated the presence of R. felis DNA in fleas. There were 
two flea species isolated from dogs and cats which were identified as novel carriers of 
the  rickettsia;  Echidnophaga  gallinacean  and  Spilopsyllus  cuniculi.  This  discovery 
further  added  to  the  growing  list  of  rickettsiae  in  Australia,  especially  in  Western 
Australia where the knowledge of rickettsial epidemiology is least advanced. No other 
information pertaining to R. felis has been reported since from WA. 
 
The presence of R. felis has recently been reported in several locations in the Eastern 
states of Australia in fleas and ticks collected off animals (21, 314). A cluster of cases 
involving 6 patients in Lara, Victoria were the first human reported cases of rickettsiosis 
attributed to R. felis in Australia (332). All cases had evidence for C. felis as the vector 
of R. felis. These recent findings and clinical cases highlight the need for rickettsiosis 
(cat flea typhus) to be seriously considered as differential diagnoses for cases presenting 
with fever and rash.  
 
Rickettsia typhi 
The first R. typhi infections in Australia were first described as a “typhus-like illness” 
during an outbreak among South Australian waterside workers in 1922 (127-129). Soon 
after the report on the initial outbreak of endemic typhus in Adelaide, a similar outbreak 
was  reported  from  Toowoomba  district  in  Queensland  (329).  A  second  outbreak 
involving 44 cases in Toowoomba was reported between 1948 and 1959 (63).  
 
The  first  recorded  case  of  murine/endemic  typhus  in  Western  Australia  (WA)  was 
reported in 1927. A total of 1332 cases were reported since then until 1952 with 50 50 
 
deaths, mostly among the elderly. The geographic distribution of disease occurrence 
was centred on Perth and Fremantle, but also included other centres of high human 
habitation in the south west of the state, Geraldton and Albany (275). The most recent 
WA cases of recorded murine typhus in humans were a cluster of six cases in Albany 
between 1995 and 1996 (155, 195). A serosurvey conducted in the Kimberley (northern 
WA) showed evidence of seroprevalence for typhus group antibodies in humans (112). 
The  latest  human  case  of  endemic/murine  typhus  in  Australia  was  reported  from 
Geelong, Victoria in 2004 (148). R. typhi is thought to be endemic throughout the whole 
of Australia (Figure 1.5). 
 
Rickettsia gravesii sp. nov.  
Rickettsia gravesii was first reported from WA by Owen et al. (206, 207) from ticks 
collected off various marsupials. The rickettsia was named after Dr Stephen Graves by 
Owen et al. in recognition of Graves’ contributions to Australian rickettsiology. Several 
tick species have been implicated but the tick species believed to be the main reservoir 
of  this  new  rickettsia  was  Amblyomma  triguttatum  (206).  A.  triguttatum  has  been 
recorded to have a geographic distribution as far east as Victoria and far north in WA 
(263). The tick species however is made up of 4 different sub-species (262) and the 
prevalence of R. gravesii within A. triguttatum and other tick species that bite humans 
in  WA has yet to be fully established. 
 
Orientia tsutsugamushi 
Even though O. tsutsugamushi was not investigated during the course of this study, its 
inclusion here is due to its very close relationship to members of the genus Rickettsia. 
O. tsutsugamushi is found only in the northern part of Australia covering three states, 
northern Western Australia, Northern Territories and northern Queensland (Figure 1.5). 51 
 
The first reports of scrub typhus (O. tsutsugamushi) in Australia goes back as far as 
1935  (168,  308).  Isolation  of  the  organism  itself  was  reported  in  1955  by  mouse 
inoculation (47) thus confirming presence of O. tsutsugamushi which till then had only 
been reported by the Weil-Felix test. Since then scrub typhus had been reported in WA 
(239), Torres Strait islands of northern QLD (79) and NT (196). The latter was a strain 
(Litchfield) characterised as distinct genotypically and serologically from the three main 
strains of Karp, Kato and Gilliam. 
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2 - General Materials and Methods 
 
2.1  Laboratory Conditions Used for Studies 
All  experiments  were  performed  in  laboratories  adhering  to  PC2  guidelines  unless 
stated otherwise.  
 
2.2  Identification of Tick Species 
Identification  of  tick  species  was  performed  by  light  microscopy  using  a  Wild  M3 
stereomicroscope (Leica, Germany). Standard morphological criteria and dichotomous 
keys (Figures 2.1 and 2.2) as described by Roberts (262) were used for identification of 
tick genus and species. 
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Figure 2.1 – Morphological characteristics of an Ixodidae tick. (A) Dorsal and (B) 
ventral anatomy of a male Ixodidae tick used in determining genera and species. 
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Palpi elongate, article 2 not 
salient basolaterally; 
scutum frequently ornate; 
tarsi of male conspicuously 
humped and armed with 
ventral spurs 
 
Ixodes 
Yes  No 
Aponomma 
Palpi short, conicle, article 
2 salient basolaterally; 
scutum inornate; tarsi of 
male not conspicuously 
humped and usually 
unarmed 
 
Eyes present? 
 
Haemaphysalis 
Anal grooves 
obsolete; festoons 
absent; palpi short 
and transversely 
ridged 
 
Anal grooves 
distinct; festoons 
present; palpi not 
transversely ridged 
 
Boophilus 
Palpi short; basis capituli 
hexagonal dorsally frequently 
with strong, lateral points; 
scutum inornate; male with 
adanal and accessory plates 
 
Palpi short; basis capituli 
hexagonal dorsally frequently 
with strong, lateral points; 
scutum inornate; male with 
adanal and accessory plates 
 
Rhipicephalus  Amblyomma 
Anal groove distinct, embracing anus 
anteriorly; festoons and eyes absent; 
inornate; male with sclerotized plates 
covering almost entire ventral surface 
 
Anal groove obsolete or embracing anus 
posteriorly; festoons and eyes maybe present; 
ornate/inornate; male with sclerotized plates on 
ventral surface when present, only circumanal 
 
Figure 2.2 – Dichotomous key for the identification of Australian Ixodidae genera. Adapted from Roberts (262). 55 
 
2.3  DNA Extraction 
DNA extraction from arthropods and cell culture was performed using the QIAamp® 
DNA Mini Kit (Qiagen, Germany) according to the manufacturer’s instructions. 
 
Live arthropod samples were immersed in 70% ethanol for 2-3 minutes and allowed to 
air dry on a glass slide. Preserved arthropod samples were dried in the same manner. 
Samples were cut to small pieces with a sterile scalpel blade on a glass slide prior to 
resuspension in 200µL of sterile phosphate buffered saline (PBS) in an eppendorf tube. 
Extracted DNA was eluted in elution buffer (70µL) and stored at -20ºC for later use. 
 
DNA was extracted from infected tissue cell culture supernatant (200µL) and eluted in 
100µL of elution buffer and stored at -20ºC for later use. 
 
2.4  Rickettsial Culture 
Three different cells lines were used for rickettsial culture; L929 (mouse fibroblasts), 
Vero (green monkey kidney cells) and XTC-2 (African clawed toad epithelial cells) 
cells. 
 
2.4.1  Cell Monolayer Cultures 
L929 and Vero cells were grown in 25cm
2 vented tissue culture flasks at 35ºC with 5% 
CO2. Growth media (9ml) used was RPMI 1640 (Gibco, Australia) containing 5% foetal 
bovine  serum  (Gibco,  Australia),  2mM  L-glutamine  (Gibco,  Australia)  and  25mM 
HEPES buffered media (Gibco, Australia). XTC-2 cells  were  grown in  25cm
2  non-
vented  tissue  flasks  at  28ºC.  Cells  were  grown  in  11mL  of  Leibovitz  L-15  media 56 
 
(Gibco,  Australia)  containing  5%  foetal  bovine  serum  (Gibco,  Australia),  2mM  L-
Glutamine (Gibco, Australia) and 1% tryptose phosphate broth (Oxoid, England).   
 
Flasks  with  80%  confluency  were  used  for  rickettsial  infection  (sections  2.4.2  and 
2.4.3).  Cells  were  passaged  1/10  using  trypsin.  Cell  monolayers  with  100%  cell 
confluency were gently washed with 5mL of sterile PBS and then 1ml of 0.5% Trypsin 
solution with 5.3mM EDTA4Na (Gibco, Australia) was added and incubated at room 
temperature for 1 minute, followed by a couple of hard knocks on the flask to remove 
any  adherent  cells.  Growth  media  (10mL)  was  added  to  the  cells  which  were  then 
incubated at appropriate temperature and CO2 content. 
 
2.4.2  Rickettsia Isolation 
Rickettsia isolation was mainly performed from arthropods in this study. Arthropods 
were identified  as  described in  section  2.2. Removal of potential contaminants  was 
done by immersion in 95% sodium hypochlorite solution for 10min, followed by 70% 
ethanol and air dried in a level 2 biohazard hood. Arthropods were then halved with a 
sterile scalpel blade and placed in microcentrifuge tubes with PBS for PCR analysis 
(500µL PBS) and rickettsia isolation (1mL PBS). Rickettsia isolation involved crushing 
the arthropod with the blunt end of a sterile plastic inoculation loop (Sarstedt, Germany) 
and thus releasing the rickettsiae harbored within the arthropod as a suspension in the 
PBS. Tick homogenate was then passed through a 0.45µm filter (Millex, Ireland) and 
inoculated into monolayers of Vero, L929 and/or XTC-2 cells with 80-90% confluency 
in 25cm
2 flasks. Flasks were then centrifuged at 600g for 20min to induce entry of 
rickettsia into the cell monolayer. Cultures were incubated for up to two months at 35C 
in 5% CO2 (L929/Vero) or 28˚C (XTC-2), with fortnightly media changes. Cultures 
were examined microscopically weekly and by microimmunofluorescence monthly. If 57 
 
cell cultures were thought to be positive, by virtue of a CPE, DNA was extracted and 
the presence of rickettsia confirmed by PCR. 
 
2.4.3  Rickettsia Culture Maintenance 
Isolated rickettsial cultures were maintained for DNA extraction and antigen preparation 
for genetic and phenotypic characterisation. When an existing rickettsial culture had 
destroyed the cell monolayer, 0.5mL to 2mL of rickettsial suspension was inoculated 
into  a  new  flask  containing  a  similar  cell  monolayer  with  80-90%  confluency 
centrifuged  at  600g  for  20min  and  incubated  as  appropriate.  Residual  rickettsial 
suspensions  were  used  for  DNA  extraction  (section  2.3)  and  PCR  (section  2.6)  or 
antigen prepared for serology (section 2.5). 
 
2.5  Serology  
2.5.1  Rickettsial Antigen Preparation 
Cell suspensions from rickettsial cultures were heat inactivated at 56ºC for 30 minutes 
prior  to  use  as  antigens  for  IFA.  Antigen  concentrations  were  titrated  in  order  to 
optimise fluorescence intensity. 
 
2.5.2  Immunofluorescence Assay 
Paired human sera (when applicable) were analyzed using the indirect IFA. Rickettsial 
whole cell antigen preparations (R. australis strain JC, R. akari strain Kaplan, R. conorii 
strain Malish, R. honei strain RB, R. rickettsii strain Bitteroot, R. sibirica strain 246, R. 
typhi strain 18 and R. prowazekii strain Breinl) were acetone fixed to 40 well slides. 
Sera were diluted 1:128 with 2% casein buffer (PBS with 2% skim milk powder) and 58 
 
incubated with antigen slides in a humid environment at 35˚C for 30min. Slides were 
washed 3 times with 10% PBS solution and air-dried. Goat fluorescein isothiocyanate 
(KPL,  USA)  labelled  antibodies  specific  for  human  antibodies  (IgM  +  IgA  +  IgG) 
(diluted 1:100 in 2% casein buffer) were applied and incubated for 30min in a humid 
environment at 35˚C. The slides were washed as described previously and mounted with 
a coverslip (Biolab Scientific, Australia) using fluorescent mounting fluid (Dako, USA). 
Antibody titres were read using an illuminator-equipped microscope (Leica, Germany). 
Positive  values  were  reported  for  endpoint  titres  ≥1:128.  This  cut  off  value  was 
recommended by the Australian Rickettsial Reference Laboratory (ARRL) to  reduce 
influence of non-specific binding and cross-reacting antibodies (112). 
 
2.6  Rickettsial PCR 
2.6.1  Conventional PCR 
Conventional PCR analysis was performed on DNA extracts from materials suspected 
of harbouring rickettsiae including arthropods, rickettsial cultures and infected tissues. 
Products  were  subsequently  sequenced  to  identify  the  rickettsia  detected  within  the 
samples. Gene targets used in the PCR assays were gltA, ompA, ompB, sca4, orf17 and 
tsa56. 
 
Each  conventional  rickettsial  PCR  was  performed  using  the  same  reagent  mix  and 
cycling  conditions  with  the  exception  of  primer  types,  MgCl2  concentrations  and 
annealing  temperatures  (Table  2.1).  Reactions  contained  1M  of  each  primer 
(GeneWorks, Australia), 200M of each deoxyribonucleotide triphosphate (dNTP), 10 
reaction buffer, 2U Taq polymerase (Invitrogen, Australia), 1.5L of DNA extract and 
water made up to a 25μL final reaction volume. The amplification were performed in a 59 
 
GeneAmp PCR thermal cycler (Perkin Elmer, USA) with an initial denaturation at 95C 
for 3min, followed by 40 cycles of denaturation at 95C for 30s, 30s at the appropriate 
annealing temperature (Table 2.1) and extension at 72˚C for 1min followed by a final 
extension at 72˚C for 10min. 
 
PCR products were electrophoresed in a 1% Tris acetate EDTA agarose gel (Sigma-
Aldrich,  USA),  stained  with  ethidium  bromide  (Sigma-Aldrich,  USA)  for  30min  at 
100V and visualized using an ultraviolet transilluminator for comparative analysis with 
known positive and negative controls. 
 
2.6.2 Sequence Analysis of PCR Product 
PCR amplicons positive for rickettsial DNA were excised from gels and purified using 
the QIAquick DNA clean up kit (Qiagen, Germany) and sequenced using facilities at 
the  State  Agricultural  Biotechnology  Centre  (SABC)  (Perth,  Western  Australia). 
Sequencing  reactions  were  performed  using  an  ABI  Prism  Dye  Terminator  Cycle 
Sequencing Core Kit (Applied Biosystems, California) according to the manufacturer’s 
instructions. 
 
All sequenced products were analysed using the computer program Chromas Lite and 
were compared to sequence data available from GenBank, using the BLAST 2.2.14 
program. Phylogenetic alignment of DNA sequences utilised the programme ClustalX. 
Determination of the genetic difference between the Rickettsia spp. by phylogenetic 
analysis was conducted using Mega2 software (using Tamura and Nei and neighbour-
joining algorithms). 
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Table 2.1 – Summary of PCR conditions for Rickettsial DNA amplification. 
Primer  Nucleotide sequence   Gene 
MgCl2  
concentration (mM) 
Annealing 
temperature (C)  Reference 
RpCS877p  GGGGGCCTGCTCACGGCGG  gltA  3  51  (253) 
RpCS1258n  ATTGCAAAAAGTACAGTGAACA  gltA  3  51  (253) 
Rr190.70p  ATGGCGAATATTTCTCCAAAA  ompA  2  48  (253) 
Rr190.602n  AGTGCAGCATTCGCTCCCCCT  ompA  2  48  (253) 
120M59  CCGCAGGGTTGGTAACTGC  ompB  2  51  (270) 
120807  CCTTTTAGATTACCGCCTAA  ompB  2  51  (270) 
MTO-1  GCTCTTGCAACTCTATGTT  orf17  3  51  (325) 
MTO-2  CATTGTTCGTCAGGTTGGCG  orf17  3  51  (325) 
D1f  ATGAGTAAAGACGGTAACCT  sca4  2  51  (279) 
D928r  AAGCTATTGCGTCATCTCCG  sca4  2  51  (279) 61 
 
3 - Serological Typing of a Novel Spotted Fever Group 
Rickettsia: Rickettsia gravesii 
 
3.1  Introduction 
Serological typing or serotyping is a classification method based on the bacterial cell 
antigen  reactivity  with  antisera.  It  is  used  to  classify  viruses,  bacteria  and  other 
microorganisms.  A  single  species  can  have  multiple  serological  types  (serovars)  as 
demonstrated in Salmonella enterica with more than 2,500 serovars (272). By using 
serotyping  of  a  Rickettsia  against  closely  related  members  within  the  genus,  it  is 
possible to classify the organism as either a separate species or serovar. Philip et al. 
(227)  introduced  a  method  by  which  rickettsiae  could  be  serotyped  and  thus 
phenotypically differentiated. This serotyping method has been accepted as the method 
of phenotypically describing a new species of Rickettsia, based on antigenic differences 
(250). 
 
This  study  was  undertaken  to  demonstrate  R.  gravesii  differs  antigenically  from  R. 
australis and R. honei as they are all found in Australia. R. massiliae was chosen as a 
representative of the R. massiliae sub-group of SFG rickettsia as it is phylogenetically 
the most closest related to R. gravesii (206) (Figure 3.1).  
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Figure  3.1  –  Unrooted  neighbour-joining  tree  based  on  ompA  sequences  from 
Rickettsia species with validly published names. Bootstrap values are indicated at 
the nodes. Genbank accession numbers used listed in Appendix 9.2. 
 
 
 
 
The main bulk of the work described in this chapter was performed at the Faculty of 
Tropical Medicine, Mahidol University, Bangkok, with the help of Stuart Blacksell and 
his team, who kindly provided the BSL3 facilities for rickettsial culture and animal 
holding facilities. Animal ethics approvals for the work performed were obtained from 
Murdoch  University  (NS2049/07)  and  Mahidol  University  (FTM-ACUC  007/2007) 
(Appendix 9.1). 
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3.2  Materials and Methods 
3.2.1  Rickettsial Suspension Preparation 
Rickettsial strains used in this chapter were R. gravesii strain BWI-1, R. australis strain 
JC, R. honei strain RB and R. massiliae strain Mtu1. They were grown as previously 
described in 2.4.3. Rickettsial cultures were removed from their flasks using a scraper 
and transferred to a sterile centrifuge tube and centrifuged at 1500g for 10min to pellet 
Vero cell debris. The supernatant was transferred to a fresh tube and centrifuged again 
at 8500g for 30 minutes to pellet rickettsiae in the suspension. The supernatant was then 
discarded  and  the  pellet  resuspended  in  5mL  of  sterile  PBS  and  snap-frozed  in 
cryotubes  (Nunc,  USA)  at  -80ºC  in  1mL  aliquots.  Aliquots  were  then  used  for  the 
plaque assay, mouse inoculations, serology and qPCR. 
 
3.2.2  Plaque Assay Culture 
Vero cells were used for the plaque assay and were grown as described in section 2.4.1 
before passage into 12 well plates. Monolayers were allowed to develop overnight with 
an initial seed of 1.5mL of 4.0 x 10
4 cells/mL and incubated at 32ºC with CO2. When 
confluent,  the  medium  was  removed  and  wells  were  seeded  with  200μL  rickettsial 
suspension in dilutions ranging from 10
-1 to 10
-6 with one ten-fold dilution per plate 
(Figure 3.1). An undiluted aliquot of each rickettsial suspension was also seeded into a 
25cm
2 flask with a Vero cell monolayer (Section 2.4.1) as a positive control to ensure 
viability  of  rickettsial  organisms.  Plates  were  then  placed  on  a  mechanical  rocking 
platform  at  room  temperature  for  1  hour  to  allow  rickettsial  entry  into  the  cell 
monolayer  and  the  rickettsial  suspension  was  then  removed.  1.5mL  of  1%  agarose 
overlay with RPMI 1640 and 10% FCS was applied to the monolayers and the plates 64 
 
were then incubated at 32ºC with 5% CO2 for 6 days. A second overlay medium (1% 
agarose, RPMI 1640, 10% FCS and 0.01% neutral red dye) was added to the wells on 
day 6. Plates were wrapped in aluminium foil and incubated at 32ºC with 5% CO2 for 4 
days and observed for visible plaques every 24 hours. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 – Illustration of plaque assay plate at dilution 10
-1. Similar plates were 
prepared for each ten-fold dilution up to 10
-6.  
 
 
3.2.3  Measurement  of  Protein  (Rickettsial  Antigen)  Concentration  of 
Rickettsial Preparation 
Protein  concentration  was  used  as  a  surrogate  measure  of  approximate  antigen 
concentration used when inoculating rickettsiae into mice (Section 3.2.4). The Biorad 
DC Protein Assay kit (based on the Lowry assay) was used with a slight variation to the 
manufacturer’s protocol. Four dilutions of a BSA protein standard were prepared with 
concentrations  of  0.5mg/mL,  1.0mg/mL,  1.5mg/mL  and  2.0mg/mL  to  produce  a 
C  10
-1  10
-1 
R. australis 
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standard  curve.  Standards  and  samples  were  prepared  using  carbonate-bicarbonate 
buffer of pH 9.6. 50uL of standards and samples were placed in 5mL plastic test tubes 
and 250uL of Reagent A added to each tube. Tubes were vortexed and 2mL of Reagent 
B was added to each. Tubes were allowed to stand for 15 minutes at room temperature 
and their absorbance read at 750nm. Protein concentration of samples was extrapolated 
from the standard curve. 
 
3.2.4  Inoculation of Rickettsiae into Mice and Harvesting Anti-Sera 
Four week old female BALB/c mice were split into 5 groups of 5-8 mice each as shown 
in Table 3.1. Rickettsiae were prepared as detailed in section 2.4.1 and quantified as 
described in section 3.2.2. Rickettsial inocula were administered into mice via the intra-
peritoneal route.  
 
Table  3.1  –  Mouse  groups  and  rickettsial  inoculum  size  (original  and  booster) 
given via the intra-peritoneal route. 
 
Anti-serum Mouse 
Group 
Number of Mice 
Inoculum  
(Volume = 0.1mL) 
Control  5  Sterile PBS 
Anti-R. australis  7  R. australis 
Anti-R. gravesii  8  R. gravesii 
Anti-R. honei  7  R. honei 
Anti-R. massiliae  8  R. massiliae 
 
Inoculated mice were kept in metal shoe box sized containers in an isolated animal 
holding facility after the first inoculation on day 0. A booster shot with the same antigen 
preparation as the original inoculum was given to each mouse on day 7. On day 10, 
mice were anaesthetized using a glass beaker (air tight lid included) with isofluorane, in 66 
 
a fume hood, before blood was collected via the orbital sinus. Blood were collected in 
1.5mL eppendorf tubes and allowed to clot at room temperature. 
 
3.2.5  Microimmunofluorescence 
As described in section 2.5.2. 
 
3.2.6  ELISA 
Enzyme  linked  immunosorbent  assays  (ELISA)  were  performed  on  the  samples  to 
compare the results with those obtained from the IFA. The ELISA method was adapted 
from  the  protocol  developed  by  Tanganuchitcharnchai,  Mahidol  University  (pers. 
comm.). Flat bottomed ELISA plates were coated with 50μL of antigen suspension, 
comprising 10μg/mL of semi-purified antigen (see section 3.2.1 for antigen preparation 
and section 3.2.3 for measurement of protein concentration), in carbonate-bicarbonate 
buffer  (coating  buffer)  per  well  at  4ºC  overnight  in  a  moist  chamber.  Plates  were 
washed three times the next day with 0.05% PBS-Tween20 and the wells blocked with 
3% skim milk for 1 hour at room temperature. Wells were washed again three times and 
50μL of serum sample or control were added to appropriate wells as detailed in Figure 
3.2. Plates were incubated for 1 hour at 32ºC in a moist chamber followed by another 
four washes with 0.05% PBS-Tween20. Anti-mouse antibodies conjugated with horse 
radish peroxidase were added to each well and the plates incubated at room temperature 
in a moist chamber for 1 hour. Plates were then washed another 4 times with 0.05% 
PBS-Tween20 before 50μL of tetramethylbenzidine (TMB) substrate was added to each 
well and placed in a dark chamber at room temperature for 30min. The reaction was 
stopped using 50μl of 1M HCl in each well and the optical density (O.D.) read at 450nm 
in a spectrophotometer. 67 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 – Figure showing serum sample dilutions and control locations. Samples 
were tested in duplicate with two-fold serum dilutions starting from 1/8 to1/4096. 
Wells in each plate were coated with rickettsial antigen as shown 
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3.2.7  Statistical Methods 
The serotypic differences between the 4 rickettsial strains tested in this chapter were 
compared  by  determining  the  differences  between  homologous  and  heterologous 
antibody  titres.  The  difference  between  the  titres  were  presented  as  specificity 
difference (SPD) as described by Fraser (94). This method was applied to rickettsial 
serotyping by Philip (227). 
 
SPD = (Aa + Bb) – (Ab + Ba) 
 
 
Figure 3.4 – Formula for calculation of Specificity Difference (SPD).  Aa  is the 
antibody titre of serum A with the homologous antigen a. Bb is the antibody titre of 
serum B with the homologous antigen b. Ab is the antibody titre of serum A with the 
heterologous  antigen  b.  Ba  is  the  antibody  titre  of  serum  B  with  the  heterologous 
antigen a. 
 
 
Working units used in determining the SPD were arithmetic instead of geometric and 
converted as shown in Table 3.2. Any sera that were negative for antibody titre at titre 
1/8 were given a numerical value of 0 and considered to lack any antibody against the 
tested antigen. 
 
Table 3.2 – Table of conversion from geometric to arithmetic antibody titres for 
rickettsial antigen-antibody reactions.  
 
Geometric 
value 
1/8  1/16  1/32  1/64  1/128  1/256  1/512  1/1024  1/2048 
Arithmetic 
value 
1  2  3  4  5  6  7  8  9 
 
 
The SPD of serotypically similar strains would have a value of 0 to 2 when the sum of 
the heterologous interactions was subtracted from the sum of homologous interactions. 
An SPD value of 3 or higher was defined as denoting a significant antigenic difference 
between the two rickettsial strains/species i.e. they were different serotypes.  69 
 
3.3  Results 
3.3.1  Plaque Assay  
Using  the  method  described  in  section  3.2.2,  attempts  at  plaque  assay  by  counting 
plaque forming units (pfu) were generally unsuccessful in measuring the concentration 
of rickettsiae. However plaque formation was observed in two of five attempts (Table 
3.3). Of the three unsuccessful attempts, one resulted in a generalized CPE rather than 
plaques and the other two yielded neither plaques nor CPE. 
 
Table  3.3  –  Successful  plaque  formations  in  two  of  five  attempts  and  the 
concentration in pfu/mL. 
 
Organism  Concentration of rickettsiae obtained in pfu/mL 
(a)  (b) 
R. australis  70  20 
R. gravesii  ND  40 
R. honei  70  40 
R. massiliae  390  0 
ND – Not done. 
 
3.3.2  Protein Concentrations 
Absorbance values plotted against BSA protein standards yielded a linear graph (Figure 
3.4). From this graph, rickettsial protein/antigen concentrations were determined to fall 
within between 0.70mg/mL and 0.85mg/mL (Table 3.4). These were later diluted to 
50ug/mL for the coating of ELISA plates used in sections 3.2.6 and 3.3.4.  
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Figure 3.5 – Relationship between bovine serum albumin (BSA) concentration and 
absorbance at 750nm. 
 
 
 
 
 
Table 3.4 – Summary of absorbance values of rickettsial inocula used and their 
respective protein antigen concentrations. 
 
Organism  O.D. (750nm)  Concentration 
R. australis  0.111  0.70mg/mL 
R. gravesii  0.136  0.85mg/mL 
R. honei  0.129  0.80mg/mL 
R. massiliae  0.122  0.78mg/mL 
 
 
 
3.3.3  Microimmunofluorescence 
Serology results are shown in Table 3.5. Antibody titre values were converted to a 
numerical value based on the conversion recommended by Philip et al. (227) (Table 
3.2). 
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Table 3.5 – Microimmunofluorescence antibody titres against rickettsial antigens 
with arithmetic numerical values in parentheses. 
 
Antigen  Sera 
R. australis  R. gravesii  R. honei  R. massiliae 
R. australis  1:256 (6)  1:32 (3)  1:256 (6)  1:16 (2) 
R. gravesii  1:128 (5)  1:512 (7)  1:256 (6)  1:32 (3) 
R. honei  1:64 (4)  1:32 (3)  1:256 (6)  1:16 (2) 
R. massiliae  1:8 (1)  1:8 (1)  1:8 (1)  1:64 (4) 
 
 
Calculated  SPD  values  are  summarised  Table  3.6.  Surprisingly,  R.  honei  and  R. 
australis were shown to be not antigenically distinct (SPD=2*). SPD of  R. gravesii 
against the other rickettsiae were shown to be at 4 or higher. As expected, R. massiliae 
has a high SPD of 7 when compared to the other rickettsiae tested. 
 
Table  3.6  –  Table  of  SPD  values  for  homologous  and  heterologous 
antibody/antigen interactions showing level of antigenic difference between various 
rickettsiae obtained by MIF (SPD ≥ 3 indicates distinct serotypical difference). 
 
Antigen  Sera 
R. australis  R. gravesii  R. honei  R. massiliae 
R. australis  0  5  2*  7 
R. gravesii  5  0  4  7 
R. honei  2*  4  0  7 
R. massiliae  7  7  7  0 
*R. australis and R. honei not antigenically distinct by this method. 72 
 
3.3.4  ELISA 
ELISA serology conducted using the same principles showed higher antibody titres and 
higher numerical values for SPD calculation (Table 3.7). 
 
Table  3.7  –  ELISA  antibody  titres  against  rickettsial  antigens  with  arithmetic 
numerical values in parentheses. 
 
Antigen  Sera 
R. australis  R. gravesii  R. honei  R. massiliae 
R. australis  1:2048 (9)  1:256 (6)  1:1024 (8)  1:256 (6) 
R. gravesii  1:512 (7)  1:4096 (10)  1:512 (7)  1:256 (6) 
R. honei  1:256 (6)  1:64 (4)  1:512 (7)  1:32 (3) 
R. massiliae  1:256 (6)  1:512 (7)  1:256 (6)  1:256 (6) 
 
 
SPD values derived from the ELISA results (Table 3.8) showed a similar trend to the 
MIF results. R. australis and R. honei were again demonstrated to be not antigenically 
distinct (SPD=2*). R. gravesii was significantly distinct from the 3 other rickettsiae 
tested. R. massiliae was antigenically distinct from other 3 rickettsiae tested but with a 
much lower SPD value as compared to those derived from MIF. 
 
Table  3.8  –  Table  of  SPD  values  for  homologous  and  heterologous 
antibody/antigen interactions showing level of antigenic difference between various 
rickettsiae obtained by ELISA (SPD ≥ 3 indicates distinct serotype).  
 
Antigen  Sera 
R. australis  R. gravesii  R. honei  R. massiliae 
R. australis  0  6  2*  3 
R. gravesii  6  0  6  3 
R. honei  2*  6  0  4 
R. massiliae  3  3  4  0 
*R. australis and R. honei not antigenically distinct by this method. 73 
 
3.4  Discussion 
Because Rickettsia are obligate intracellular organisms, plaque assay is the best method 
of  quantifying  them.  Developed  initially  for  quantifying  viruses,  the  main  factor 
required for plaque assays to work is that the target organism causes cell lysis or CPE. 
Other  methods  that  allow  for  the  quantification  of  rickettsial  organisms,  such  as 
electron-microscopy, haemagglutination, ELISA and real-time qPCR, are not capable of 
determining the number of viable infectious particles (36, 311).  
 
Due to time constraints and limited availability of facilities to conduct the study only 
five  attempts  at  plaque  assays  were  made,  three  with  disappointing  results.  This 
highlighted  the  need  for  a  rickettsial  quantitative  tool  that  was  reliable  and  easily 
performed with average technical competency. We were able to observe some plaque 
formation in two assays. However the concentration of plaques was much lower and 
more variable than expected. This could not simply be attributed to a low rickettsial 
count as one attempt with the same rickettsial culture preparation showed a generalised 
CPE even at the highest dilution. All non-infected controls had an intact monolayer 
without CPE.  
 
An alternate approach to quantifying the concentration of rickettsial protein (surrogate 
for antigens) used to inoculate mice was the Lowry assay (Section 3.2.3). Purification 
prior  to  quantification  was  performed  using  differential  centrifugation.  The  main 
purpose  of  the  Lowry  assay  was  to  ensure  that  the  crude  rickettsial  suspensions 
inoculated into the mice were all of a similar protein concentration and hence could be 
assumed  to  be  antigenically  equivalent.  To  ensure  viability  of  rickettsiae  after 
purification, an aliquot of each rickettsial species tested was inoculated into cell culture 74 
 
to test for viability. Viability was confirmed within 7 days post-inoculation via CPE and 
IFA. 
 
A  more  appropriate  method,  had  time  been  available,  would  have  been  the 
quantification of rickettsial organisms using the TCID50 assay (291). The TCID50 assay 
has been used to quantify R. australis and with centrifugation was found to be the most 
sensitive  method  for  obtaining  counts  of  viable  rickettsiae  when  compared  to  other 
assay systems tested, e.g. LD50 (lethal dose 50%) and SD50 (seroconversion dose 50%). 
Stenos et al. (291) used a different host cell system and a different surface area of the 
monolayer for plaque formation to this current study.  
 
Even though antibody titres of mice infected with R. massiliae and R. gravesii were 
low,  when  titrated  against  R.  gravesii  and  R.  massiliae  antigens  respectively,  the 
antibody response was considered to be type-specific rather than group-specific. and 
induced antibodies did not cross-react with heterologous species of rickettsiae in the 
SFG (229). 
 
Analysis  of  the  mouse  sera  to  determine  the  specificity  difference  between  the  4 
different tested species of Rickettsia showed a significant difference in serotype (SPD 
≥3) between R. massiliae and all 3 Australian isolates (R. gravesii strain BWI-1, R. 
honei and R. australis). R. gravesii sp. BWI-1 was demonstrated to be serologically 
distinct from the other Australian isolates (R. honei and R. australis). R. honei however 
demonstrated  a  close  antigenic  relationship  with  R.  australis.  This  information  was 
surprising considering the distinct genotypic differences between the two species. 
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Based on the geographic distribution of the Australian strains of R. australis and R. 
honei (Figure 1.6), we observed overlaps with regards to vector distribution and known 
clinical cases that have been described in the literature. Of particular interest was the 
presence  of  R.  honei  strain  “marmionii”  (not  used  in  this  study)  which  shares 
geographic  distributions  with  R.  honei  and  R.  australis.  All  three  organisms  have 
different known vectors, thus the unexpected serotypic similarity between R. australis 
and R. honei cannot be explained by the experiments conducted in this study. Further 
work needs to be done to explain this phenomenon. There is evidence in the literature of 
the sharing of genomic material between rickettsial species (33). However no evidence 
of R. australis and R. honei dual infections in humans or animals have been observed in 
the  literature,  potentiating  physical  transfer  of  nucleic  acids  that  might  explain  the 
antigenic similarities between the two species observed in this chapter. 
 
Similar  specificity  differences  were  generated  when  tested  with  MIF  and  ELISA. 
However antibody levels were much higher with ELISA suggesting that it may be more 
sensitive than MIF. In spite of the higher titres obtained with ELISA (Table 3.8), the 
SPD values generated were similar to those obtained via IFA (Table 3.6). There were 
some differences, i.e. the SPD between R. massiliae and all Australian isolates were 
lower. However, the SPD value obtained was still enough to classify them as different 
serotypes.  The  debate  as  to  methodology  is  ongoing  (73,  164).  However  IFA  has 
become accepted as the gold standard worldwide for rickettsial serology (88). 
 
The  findings  of  this  study  clearly  demonstrated  that  R.  gravesii  strain  BWI-1  is 
serotypically distinct from its closest genotypic relative sub-group, represented by R. 
massiliae, and from the other recognised Australian species, R australis and R. honei. 
This indicates that incorporating R. gravesii strain BWI-1 antigens into future routine 76 
 
IFAs for rickettsial diagnostics in Australia may be warranted especially if R. gravesii 
strain BWI-1 is shown to be pathogenic for humans. 
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4 - Amblyomma triguttatum as the Main Arthropod 
Reservoir of Rickettsia gravesii sp. nov. in Western 
Australia 
 
 
4.1  Introduction 
The  role  of  ticks  acting  as  potential  reservoirs  and  vectors  for  spotted  fever  group 
rickettsiae in WA was clearly demonstrated by Owen et al. (206-208). Of particular 
interest was the reporting of two novel rickettsial strains, tentatively named Rickettsia 
gravesii and Rickettsia antechini, in ticks found in southwest Western Australia (WA) 
and Barrow Island (208). A larger sample size of ticks biting humans and animals was 
needed to ascertain the prevalence of these rickettsiae in ectoparasites from the WA 
bush.  Of  particular  interest  was  the  prevalence  within  ticks  known  to  bite  larger 
mammals including humans. The tick species of interest were Amblyomma triguttatum 
and Ixodes australiensis as they are common and widely distributed in WA (262). There 
are a total of twenty-three recorded tick species in WA (262). The natural hosts of the 
ticks are varied, ranging from native mammals and marsupials to feral and introduced 
animals in the bush. Further investigation into other tick species in WA was required to 
paint a clearer picture of prevalence of infection in ticks that could potentially act as a 
vector or reservoir of R. gravesii and R. antechini. 
 
The study reported in this chapter aims to address the question of the prevalence of 
rickettsiae in those tick species with an affinity for larger mammals in southwest WA 
and Barrow Island.    78 
 
4.2  Materials and Methods 
4.2.1  Ectoparasite Sampling 
Collection  of  ectoparasites  was  performed  opportunistically  as  part  of  other  studies 
conducted  on  large  mammals  (Figure  4.1A)  in  WA  by  staff  of  the  Department  of 
Environment and Conservation (DEC) and the School of Veterinary and Biomedical 
Sciences, Murdoch University. Samples were also obtained from wildlife rehabilitation 
centres on the outskirts of Perth and from various human (Figure 4.1B) recreational and 
occupational groups located throughout WA. A map showing areas from which ticks 
were sampled is shown in figure 4.2. Ectoparasites were stored in either a humidified 
container or in 70% (v/v) ethanol and sent to Murdoch University for identification and 
analysis. 
 
4.2.2  Ectoparasite Identification 
Ectoparasite identification was performed using the method outlined in section 2.2. 
 
4.2.3  Ectoparasite Dissection 
Ectoparasite dissection was performed by attaching the ectoparasite to Blu-Tack under a 
dissecting microscope. A sterile scalpel blade was then inserted into one side of the tick 
and used to cut along the circumference of the tick’s body/scutum as shown in Figure 
4.3. Using a pair of sterile metal forceps, the top part of the tick’s body/scutum was 
pulled forward or removed to expose the internal organs as shown in Figure 4.4. 
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Figure 4.1 – Pictures of ticks on various mammals. (A) Two different tick species 
(I. australiensis and A. triguttatum) feeding at the same time on the same feral pig. 
(B) A. triguttatum prior to attachment on a human. 
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Figure 4.2 – Figure showing locations of tick sampling sites. 1 - Barrow Island, 2 – 
Perth metropolitan areas (including Whiteman Park and Kanyana Wildlife Rescue 
Centre), 3 – Water catchment areas of Dwellingup, Serpentine and Mundaring, 4 – 
Southwest WA including Bibulman track and roganing areas, 5  – Two Peoples 
Bay, Albany.   81 
 
 
 
 
Figure 4.3 – Figure showing location and direction of cut using a scalpel blade 
along the circumference of the tick scutum and body. 1  – Point of insertion of 
scalpel blade. 2 – End point of cut on opposite side of start site. 
 
 
 
 
 
 
Figure 4.4 – Figure showing the location of the three main organs removed and 
analysed  for  rickettsial  DNA.  Organs  were  removed  in  the  order  of  salivary 
glands, mid-gut and ovaries to prevent cross-contamination. 
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The  tick  organs  of  interest  were  removed  using  a  clean  pair  of  metal  forceps,  the 
salivary glands first, followed by the mid-gut and finally the ovaries. Extra care was 
taken not to break the tissues while handling them to avoid cross-contamination from 
one organ to the next. Changing of metal forceps and cleaning with sterile 70% ethanol 
in between organs was performed to reduce the likelihood of carryover of rickettsial 
organisms. Removed organs were placed in sterile PBS and kept at 4˚C prior to DNA 
extraction in separate eppendorf tubes. 
 
4.2.4  Transfer of Rickettsiae from Female Parent to Larvae 
To demonstrate the ability of rickettsiae to transfer from an adult female to tick larvae 
via vertical (ovarial) transmission, engorged live adult female ticks were maintained in 
containers in humid conditions at room temperature (~22-26°C) until eggs were laid. 
Adult females were then removed, their DNA was extracted and PCR detection for 
rickettsiae was conducted. Eggs were maintained in the same containers with similar 
conditions and allowed to hatch into tick larvae. Live larvae were collected and their 
DNA was extracted and PCR detection for rickettsiae performed. 
 
4.2.5  Rickettsial Isolation by Cell Culture 
Attempts at cell culture were made to isolate rickettsial organisms from ectoparasite 
samples using the methods detailed in section 2.4.2. 
 
4.2.6  DNA Extraction 
The protocol for DNA extraction of sampled ectoparasites is described in section 2.3. 
DNA was extracted from whole ticks, tick organs and eggs. 83 
 
4.2.7  Rickettsial PCR Screening 
PCR  screening  for  rickettsial  DNA  from  ectoparasite  samples  were  conducted  as 
described in section 2.6.1. Targets used for identification of rickettsiae in tick samples 
were the gltA and ompA genes.   
 
4.2.8  DNA Sequencing 
PCR products from 4.2.7 were sequenced as described in section 2.6.2. 
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4.3  Results 
4.3.1  Rickettsia gravesii prevalence in ticks 
 
Five tick species were identified during the course of this study, of which one of the 
species, Haemaphysalis longicornis, is “newly” introduced into WA (28). The other 
four species collected were Amblyomma albolimbatum (a reptile tick common in WA), 
Amblyomma triguttatum (kangaroo tick), Ixodes australiensis and Ixodes fecialis (Table 
4.1). A total of 304 ticks were characterised in this study, of which A. triguttatum made 
up the majority with 187 isolates (Table 4.1). Of interest was the high number of A. 
triguttatum  ticks  collected  from  humans  of  which  76%  (25/33)  were  found  to  be 
positive for SFG rickettsiae. No SFG rickettsiae were found in I. australiensis infesting 
humans, but observed in feral pigs and the Gilbert’s Pottoroo. Attempts at isolating R. 
gravesii in culture from ticks during the study were unsuccessful. 
 
A. triguttatum had the highest prevalence for R. gravesii in WA with a prevalence of 
75.3% and 56.8% in southwest WA and Barrow Island respectively (Table 4.2). The 
only H. longicornis tick examined was negative for rickettsiae. 
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Table 4.1 – Tick species collected by animal host and their respective habitat. 
 
Tick Species 
Vertebrate 
Host 
W.A.  
Region 
SFG 
Prevalence* 
Amblyomma 
albolimbatum 
 
Carpet Python 
(Morelia spilota) 
 
Dwellingup  2/13  15.3% 
Bobtail lizard 
(Tiliqua rugosa) 
Kanyana  4/32  12.5% 
      6/45  13.3% 
Amblyomma 
triguttatum 
Human 
(Homo sapiens) 
 
Southwest WA  25/33  75.8% 
Barrow Island  12/22  54.5% 
Feral Pig 
(Sus scrofa) 
 
 
Dwellingup  6/7  85.7% 
Serpentine  42/54  77.8% 
Mundaring  21/27  77.8% 
Kangaroo 
(Macropus rufus and 
Macropus fuliginosus) 
Perth and surrounds  19/29  65.5% 
Barrow Island  9/15  60.0% 
      134/187  71.7% 
Haemaphysalis 
longicornis 
Feral Pig 
(Sus scrofa) 
Dwellingup  0/1  0% 
Ixodes 
australiensis 
Human 
(Homo sapiens) 
 
Southwest WA  0/5  0 
Barrow Island  0/9  0 
Feral Pig 
(Sus scrofa) 
 
Dwellingup  9/15  60.0% 
Serpentine  8/13  61.5% 
Gilbert’s Pottoroo 
(Potorous gilbertii) 
Two People’s Bay  4/21  19.0% 
      21/63  33.3% 
Ixodes fecialis  Gilbert’s Pottoroo 
(Potorous gilbertii) 
Two People’s Bay  2/8  25% 
*Amplicons detected for PCR targets ompA and gltA. All samples were positive for 
both ompA and gltA. 
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Table 4.2 – Prevalence of R. gravesii in ticks by area/region. 
 
Tick Species  W.A. Region  R. gravesii Prev.  % Prevalence 
Amblyomma albolimbatum  Dwellingup  2/13  15.4 
Kanyana  4/32  12.5 
Amblyomma triguttatum  Southwest WA*  113/150  75.3 
Barrow Island  21/37  56.8 
Haemaphysalis longicornis  Southwest WA*  0/1  0.0 
Ixodes australiensis  Barrow Island  0/9  0.0 
Southwest WA*  17/33  51.5 
Two People’s Bay  4/21  19.0 
Ixodes fecialis  Two People’s Bay  2/8  25.0 
*Southwest WA include regions of Perth suburbs, Dwellingup, Mundaring, Serpentine, 
Kanyana and the “wheat-belt” between Perth and Albany. 
 
 
 
4.3.2  Prevalence of R. gravesii in organs of A. triguttatum 
 
Four individual  A. triguttatum  ticks’ organs (salivary  glands,  ovaries  and gut) were 
screened  for  SFG  gene  targets  (gltA  and  ompA).  All  the  ticks  were  female  and 
unengorged. All organs examined from three of the four ticks (salivary glands, ovaries 
and gut) had rickettsial DNA present. Sequencing of the PCR amplicons confirmed it to 
be R. gravesii.  
 
4.3.3  Transovarial transmission of R. gravesii in A. triguttatum ticks 
 
Four of the six engorged female Amblyomma triguttatum ticks laid eggs. The two ticks 
that  did  not  lay  any  eggs  died  prematurely  and  they  were  both  discarded  and  not 
analysed for R. gravesii as the focus of this experiment was to observe transovarial 
transmission. All four egg clusters successfully hatched and produced viable larvae. Out 
of  the  four  larval  cohorts,  three  were  positive  for  SFG  rickettsiae,  which  were 
determined to be R. gravesii. 87 
 
4.4  Discussion 
The ectoparasites obtained for this study were made up mostly of ticks that commonly 
infest humans and large mammals such as kangaroos. Thus a priority was to collect 
ticks from the southwest region of WA where the majority of humans live and human 
activities occurred. Reptile ticks were also collected (A. albolimbatum), and although 
different from the ticks (B. hydrosauri) harbouring R. honei (292), their potential to 
harbour rickettsiae was demonstrated by Owen (206-208) and hence they were included 
in this study. 
 
The predominant tick found on humans and other large mammals such as kangaroos and 
feral pigs was A. triguttatum. This tick demonstrated an affinity for larger mammals as 
host. As A. triguttatum had the highest prevalence of R. gravesii, the transmission of R. 
gravesii by A. triguttatum is possible. The apparent absence of locally acquired spotted 
fever illness in WA raises the question as to whether effective transmission occurs or 
whether infections are asymptomatic or mild and therefore undiagnosed. The hypothesis 
that rickettsial exposure of large mammals and humans occurs in the bush is tested in 
the next two chapters via a sero-prevalence study. 
 
Rickettsia gravesii was observed in two additional tick species (I. australiensis and I. 
fecialis) neither described by Owen in her thesis, thus expanding the range of potential 
host  vectors  and  reservoirs  for  novel  Rickettsia  spp.  Owen  only  received  a  single 
individual I. australiensis and this would explain why the significant prevalence of R. 
gravesii in the tick species was not reported in her work (208). 
 
The  high  prevalence  of  R.  gravesii  in  A.  triguttatum  (75.3%)  and  I.  australiensis 
(51.5%) in southwest  WA and the high affinity these ticks have for  biting humans 88 
 
compared to other ticks make them the most likely vectors for R. gravesii. However, 
spotted fever infections in humans in WA are rarely reported and the disease is not 
legally  notifiable.  This  could  be  attributed  to  a  low  efficacy  of  transmission  of  the 
organism or the self-limiting nature of the illness, typical of spotted fevers, resulting in 
under-reporting or misdiagnosis. 
 
R. gravesii was not observed in I. australiensis ticks obtained from humans. However 
on  feral  pigs,  R.  gravesii  was  found  in  60.7%  (17/28)  of  that  tick  species.  This 
prevalence was similar to the prevalence of R. gravesii in A. triguttatum from humans 
(67.3%;  37/55)  and  feral  pigs  (78.4%;  69/88).  The  high  prevalence  found  in  A. 
triguttatum  from  humans  and  feral  pigs  gives  credence  to  the  hypothesis  that  A. 
triguttatum is the main arthropod reservoir of R. gravesii. The absence of R. gravesii in 
I. australiensis from humans but similarly high prevalence from feral pig to those of A. 
triguttatum points towards the possibility of I. australiensis being a vector although 
possibly not a reservoir. The R. gravesii observed in I. australiensis ticks could possibly 
have been acquired via horizontal transmission. The close proximity of feeding sites as 
observed on trapped feral pigs (Figure 4.1A) would allow for transfer of rickettsial 
organisms from an infected tick to a naive tick of another species. Recent studies have 
demonstrated the ability of animal hosts to act as amplifiers of Rickettsia spp. and to 
infect naive ticks without themselves becoming rickettsaemic (132, 233, 287). 
 
The decision to use A. triguttatum to investigate the presence of R. gravesii in the three 
major organs (salivary glands, gut and ovaries) was mainly due to (i) the adult tick’s 
relative size compared to other tick species and (ii) the abundance of live A. triguttatum 
collected.  The  other  tick  species  of  comparative  size  to  A.  triguttatum  was  A. 
albolimbatum, however, most of the A. albolimbatum ticks were engorged or preserved 89 
 
in 70% ethanol (v/v). Only 12 A. triguttatum ticks were deemed suitable for dissection 
in terms of size, viability and unfed state. Out of the twelve, four were dissected and 
PCR of extracted DNA was performed. The results of the four “successful” dissections 
demonstrated that R. gravesii was present in all three organs of A. triguttatum analysed. 
Its  presence in the salivary  glands implies  transmission while feeding;  in  ovaries  it 
would suggest transovarial and possibly sexual transmission while its presence in the 
gut  points  at  maintenance  of  R.  gravesii  within  the  tick  itself  via  transstadial 
transmission.  
 
Questions  may  arise  concerning  cross-contamination  between  tick  organs  during 
removal and between different tick samples. Considerable care was taken to reduce the 
risk  of  contamination  and  the  presence  of  a  tick  that  was  entirely  negative  for  R. 
gravesii in all its organs suggests that cross contamination was absent. All ticks were 
dissected in one session using the same set of tools. The tools were cleaned between 
organs  within  the  same  tick  and  between  tick  samples.  However  the  risk  of 
contamination as a result of breakage of organs during removal was possible. To reduce 
this risk as much as possible, organs were removed in the sequence in which they were 
most accessible; salivary glands, mid gut and ovaries. Removal of organs in any other 
sequence would have  caused the organ to  be forced through other more superficial 
organs and thus increase the risk of contamination.  
 
Positive  results  for  SFG  rickettsiae  and  subsequent  sequencing  of  the  product  that 
demonstrated  R.  gravesii  in  both  adult  female  and  larval  A.  triguttatum  indicates 
transovarial  transmission  of  R.  gravesii  to  viable  offspring.  For  transovarial 
transmission to occur successfully the rickettsiae must remain viable through all stages 
of development. To prevent cross contamination from parent to larvae, parents were 90 
 
removed  after  successful  laying  of  the  eggs  and  the  eggs  were  allowed  to  hatch 
undisturbed. 
 
The question still remains as to whether R. gravesii can be transmitted transstadially. Its 
presence in the mid-gut of A. triguttatum suggests that this is likely. However we were 
not  able to  attempt long term maintenance of  ticks  across their complete life  cycle 
stages and subsequent generations due to laboratory restrictions. 
  
The presence of Haemaphysalis longicornis on a feral pig in Western Australia suggests 
that H. longicornis infests animals in the WA bush. H. longicornis is of significant 
veterinary concern in QLD and NSW, and has been demonstrated to be a vector for 
Theileria  mutans  (259,  262).  First  reported  in  WA  by  Besier  and  Wroth  (28),  the 
introduction of H. longicornis was purported to be from a domestic pet from the eastern 
states of Australia. Its potential to be a vector of rickettsiae is unknown, though work 
performed by Smith et al (286) has demonstrated its capacity to be an experimental 
vector for Coxiella burnetii. Even though our study showed a negative PCR result for 
Rickettsia in a single H. longicornis, its potential as a vector for rickettsiae must not be 
overlooked due to the extremely small sample size. 
 
Despite the current knowledge of rickettsiae in Australia, H. longicornis has yet to be 
attributed as a vector of rickettsiae in the eastern states. With its “recent” introduction 
into  WA,  the  potential  of  H.  longicornis  to  be  infected  with  R.  gravesii  is  worth 
investigating.  No  reports  of  R.  gravesii  have  been  made  in  tick  populations  in  the 
eastern states. R. gravesii is abundant in WA, involving most tick populations so far 
investigated by Owen (208) and in this study. A future finding of R. gravesii in H. 91 
 
longicornis would support the hypothesis that it may be transmitted to other tick species 
from a main invertebrate reservoir i.e. A. triguttatum.  
 
With  the  evidence  presented  in  this  chapter,  the  tentative  conclusion  is  that  A. 
triguttatum  is  a  strong  candidate  as  the  reservoir  and  main  vector  for  R.  gravesii. 
Further  investigation  is  warranted.  We  have  established  (i)  the  viability  of  A. 
triguttatum  eggs  and  larvae  with  R.  gravesii  present,  (ii)  the  high  prevalence  of  R. 
gravesii in A. triguttatum populations from various parts of southwest WA and Barrow 
Island especially in those ticks biting humans, and (iii) the presence of R. gravesii in the 
three main organs of A. triguttatum. The list of potential vectors of R. gravesii has also 
been expanded from four (208) to six (Table 4.3). Of potential concern is the very high 
prevalence of R. gravesii in A. triguttatum ticks found on humans. To investigate this 
further, a sero-prevalence and risk study in humans was designed and the results are 
presented in Chapter 6. 
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Table 4.3 – Western Australian recorded tick species in the literature and those 
with potential as vectors of R. gravesii. 
 
Genus  Species  R. gravesii  Recorded in WA  Reference 
         
Ixodes  eudyptidis    ●  (262) 
  tasmani    ●  (262) 
  hydromyidis    ●  (262) 
  australiensis  ☼  ●  (262) 
  fecialis  ☼  ●  (262) 
  vestitus    ●  (262) 
  myremecobii    ●  (262) 
  antechini    ▼  (208) 
         
         
Haemaphysalis  ratti  ▼  ●  (262) 
  humerosa    ●  (262) 
  lagostrophi    ●  (262) 
  longicornis    ●  (28) 
         
         
Boophilus  microplus    ●  (262) 
         
         
Rhipicephalus  sanguineus    ●  (262) 
         
         
Amblyomma  calabyi    ●  (262) 
  postoculatum    ●  (262) 
  limbatum  ▼  ●  (262) 
  australiense    ●  (262) 
  triguttatum  ☼ ▼  ●  (262) 
  albolimbatum  ☼ ▼  ●  (262) 
         
         
Aponomma  fimbriatum    ●  (262) 
         
         
Bothriocroton  hydrosauri    ●  (262) 
         
         
Ornithodoros  gurneyi    ●  (262) 
         
● Published in the literature 
▼ Described in Owen (2007) thesis 
☼ Observed in this study 
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5 - Serological Study of Spotted Fever Group Rickettsial 
Exposure in Feral Pigs (Sus scrofa) of South West WA 
 
5.1  Introduction 
There is evidence of spotted fever group rickettsiae in the Western Australian bush 
(206, 208), however, as yet there is no published evidence of animal or human exposure 
to rickettsial organisms. This study was designed to investigate the prevalence of SFG 
rickettsial antibodies in a large animal species highly exposed to the main tick vector of 
a  newly-recognised  spotted  fever  group  rickettsia  in  WA.  Several  criteria  were 
formulated to select animal species suitable for this study. These included; 
i)  High exposure rate to the tick species that feed on large mammals in the 
bush  and  also  humans  i.e.  Amblyomma  triguttatum  and  Ixodes 
australiensis. 
ii)  Similar physiological constitution to humans and same approximate size 
of organs. 
iii)  Animal’s  limited  ability  to  groom  itself.  This  allows  for  maximum 
duration of the ectoparasite attachment to the animal. 
iv)  Target  population  is  sufficiently  abundant  for  a  statistically  viable 
sample size. 
v)  Part  of  a  culling  or  research  programme  to  allow  for  opportunistic 
collection of samples thus reducing logistical and funding constraints. 
vi)  Conjugated species specific antibody readily available.    
 
The only mammal that fulfilled all of the criteria was the feral pig (Sus scrofa) (see 
Table  5.1).  Samples  were  collected  from  feral  pigs  trapped  within  the  Perth  water 
catchment  area  as  part  of  a  Department  of  Environment  and  Conservation  (DEC) 94 
 
trapping and culling program. Animal ethics approval was obtained from the Murdoch 
University Animal Ethics Committee, approval number R1155/05 (Appendix 9.1). 
 
Table 5.1 – Four animal species considered for study and their fulfilment of five 
criteria. 
 
Criteria  Kangaroo  Feral Pigs  Feral Goats  Feral Cats 
I  ●  ●  ●   
II    ●     
III    ●  ●   
IV  ●  ●    ● 
V  ●  ●  ●  ● 
VI    ●  ●  ● 
 
 
 
5.2  Materials and Methods 
5.2.1  Sample Collection 
Collection of samples was conducted collaboratively in south-west Western Australia 
with the DEC. Traps were set by the DEC in water catchment areas in Serpentine, 
Dwellingup and Mundaring (Figure 5.1) where feral pigs were known to inhabit in 
large numbers. 
 
Ten to fifteen live traps were set up in  each trapping area using apples as the bait 
(Figure  5.2).  Traps  were  checked  and  reset  on  a  daily  basis  as  part  of  the  ethics 
requirement so as not to cause unnecessary distress to captured animals, and to release 
animals other than feral pigs. Feral pigs were euthanized/culled via a shotgun shot to the 
temple. Trapping and collection of samples was conducted between November 2006 95 
 
and  April  2007.  Domestic  pig  samples  were  obtained  from  an  abattoir  in  Gingin, 
approximately 20km north of Perth. Ectoparasites were removed from carcases as part 
of a post mortem protocol, and these were stored in alcohol until analysed at Murdoch 
University (Chapter 4). 
 
5.2.2  DNA Extraction 
DNA was extracted from the liver and spleen of feral pigs. Organs were homogenized 
using  sterile  scalpel  blades  prior  to  start  of  extraction.  Extraction  was  performed 
according to  the manufacturer’s protocol  (QIAamp®  DNA Mini  Kit) as  outlined in 
section 2.3. 
 
5.2.3  Rickettsial PCR Screening 
PCR screening for rickettsial DNA from samples is described in section 2.6.1. 
 
5.2.4  Microimmunofluorescence 
Serological analysis of collected serum samples for SFG rickettsial antibodies using 
microimmunofluorescence is described in section 2.5.2. 96 
 
 
 
Figure  5.1  –  Three  main  trapping  sites  named  after  the  general  region  they 
encompass (i) Mundaring, (ii) Serpentine and (iii) Dwellingup. Water catchment 
areas  appear  as  coloured  regions  and  actual  trapping  areas  are  highlighted  in 
transparent grey. 
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Figure  5.2  –  Feral  pig  live  trapping  using  wire  cages  with  apples  as  bait  (A). 
Multiple  pigs  were  often  trapped  at  the  same  time  (B).  Post  mortem  and 
ectoparasite sampling performed on site after euthanasia of feral pigs at trap sites 
(C). 
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5.3  Results 
 
Domestic pig sera (non-feral) used as controls were positive up to a titre of 1:64 (Table 
5.2). Thus the cut off-point for positive sera among feral pig samples was determined to 
be at a titre of 1:128 for both SFG and TG antigens. Of the 149 feral pig samples tested, 
70 (46.9%) had titres greater than 1:128 for SFG antigen. Of these, 48 (32.2%) were 
positive at 1:128 titre; 15 (10.1%) at 1:256 titre and 7 (4.7%) at 1:512 titre. Sixty-two 
(41.6%) samples were positive at 1:128 (only) against TG antigen. All TG-positive sera 
were also SFG-positive. 
 
Table 5.2 – Rickettsial sero-prevalence in feral and domestic pigs against SFG and 
TG antigens. 
 
Type  Grouping 
Antibody End Point Titre  Total 
+ve 
(%) 
1/32*  1/64*  1/128  1/256  1/512  1/1024 
Dom. 
Pig 
(n=56) 
SFG  9  12  0  0  0  0  0  (0%) 
TG  7  9  0  0  0  0  0  (0%) 
Feral 
Pig 
(n=149) 
SFG  NT  NT  48  15  7  0  70  (47%) 
TG  NT  NT  62  0  0  0  62  (42%) 
 
*  Positive  results  obtained  at  these  dilutions  were  treated  as  non-specific  antigen-
antibody  binding  and  regarded  as  false-positives,  not  indicative  of  SFG  rickettsia 
exposure. NT – Not Tested 
 
Titration  of  positive  feral  pig  sera  against  4  different  SFG  rickettsia  antigens  was 
performed to determine if any had a higher titre against a particular SFG rickettsial 
species (Table 5.3). The four rickettsial species chosen were R. australis, R. honei, R. 
gravesii and R. rickettsii.  
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Table 5.3 – Titration of feral pig sera against Rickettsia antigens. 
Antigen  1/128  1/256  1/512  1/1024  Total 
R. australis  62  3  0  0  65 
R. gravesii sp. nov.  48  15  7  0  70 
R. honei  60  4  0  0  64 
R. rickettsii  59  1  0  0  60 
 
Prevalence  was  higher  in  adult  feral  pigs  (≥12  months)  with  an  average  of  66.7% 
compared to the young (<12 months), with a prevalence of 33.7% (p<0.02) (Table 5.4). 
The higher prevalence in older feral pigs was observed in feral pigs from Dwellingup, 
Serpentine (approximately 1.5 times higher) and Mundaring (approximately 3.5 times 
higher) (Table 5.4). 
 
Table 5.4 – Sero-prevalence in feral pigs by age and location. 
Age Group  Mundaring  Dwellingup  Serpentine  Total 
Adult 
(>12 mths) 
6/7 
86% 
18/24 
75% 
16/29 
55% 
40/60* 
67% 
Young 
(<12 mths) 
4/16 
25% 
9/26 
35% 
17/47 
36% 
30/89* 
34% 
Total 
10/23 
44% 
27/50 
54% 
33/76 
43% 
70/149 
47% 
 
*p value < 0.02 
PCR  conducted  on  DNA  extracts  from  129  liver  and  spleen  samples  revealed  4 
positives (3.1% prevalence) for rickettsial DNA (gltA) in the liver only. A summary of 
the information available for each sample that was PCR positive is shown in Table 5.5. 
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Table 5.5 – Summary of four feral pigs positive by rickettsial citrate synthase gltA 
gene PCR. 
 
Sample No.  Age  Gender  Area Trapped  SFG Serology 
1  Adult (~3 years)  Male  Mundaring  Negative 
2  Young (4-5 months)  Female  Dwellingup  Negative 
3  Young (6-8 months)  Male  Serpentine  Positive* 
4  Adult (>3 years)  Male  Serpentine  Negative 
 
*Serology result was equivocal with titres at 1/128 to  R. gravesii and R. honei and 
negative to R. australis and R. rickettsii antigens. 
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5.4  Discussion 
The high rickettsial seroprevalence among feral pigs in and around the water catchment 
areas of Perth demonstrates a high rate of exposure to rickettsial organisms. This may 
be due to ticks in these regions harbouring a high prevalence of the novel rickettsia, 
Rickettsia gravesii sp. nov. (172).  A high cut-off titre (≥1:128) was based on the control 
group (domestic pigs never exposed to ticks in the bush) which exhibited no reactivity 
at >1:128 dilution. This is similar to the cut-off used for human diagnostics. In spite of 
this relatively high cut-off, a sero-prevalence of 47% at a cut-off titre of 1/128 was 
observed.  Cross-reactivity  between  species  of  the  SFG  is  well  established  in  the 
literature and hence makes it difficult to differentiate the infecting rickettsia from other 
members  of  the  SFG.  As  no  other  SFG  rickettsiae  had  been  found  in  the  water 
catchment areas and higher titres were observed against R. gravesii antigens, it is most 
likely that exposure to R. gravesii, was responsible for the high seroprevalence in the 
feral pigs.  
 
Typhus group antibodies were observed in 41.6% of the test group however the titre 
was not above 1/128. All TG-positive sera were SFG-positive. Also, no typhus group 
rickettsia or R. felis have been reported from ectoparasites in the WA bush. Thus it was 
concluded that the typhus group antibodies observed were a result of cross-reactivity 
between the SFG and TG. 
 
Adult feral pigs in all three locations had rickettsial antibodies prevalence of at least 1.5 
times  higher  than  the  young.  Mundaring  adult  feral  pigs  had  a  prevalence  of  85%, 
compared  to  only  25%  among  the  young.  The  large  difference  in  prevalence  of 
rickettsial antibodies observed between adult and young feral pigs suggests that as the 
feral pig population ages, more pigs are exposed to rickettsial organisms probably by 102 
 
increasing  risk  of  exposure  to  infected  ticks.  No  other  studies  have  reported  this 
previously, as they have tended to focus on general prevalence of rickettsial antibodies 
to determine exposure levels. A similar trend was observed in the other two trapping 
sites. However, the numbers in each area are too low to provide a significant result on 
their own. Anti-SFG antibodies when compared between young and adult feral pigs as a 
whole showed a doubling in prevalence as a feral pig ages. Statistical analysis of the 
total  prevalence  between  the  age  groups  using  the  student  t-test  demonstrated  a 
significant result with p < 0.02 (Table 5.4).  
 
Various organs have been reported to harbour rickettsiae such as the brain (2), kidney 
(55), lymph nodes (281), liver (178) and spleen (278). The organs sampled (liver and 
spleen) and tested for rickettsial DNA was chosen due to ease of access at post-mortem, 
a major role played in the circulatory system and as such is the most likely location of 
infections. The low prevalence of 3.1% (4/129) observed in the liver indicates that feral 
pigs probably act as an incidental host rather than a reservoir for rickettsiae in WA. No 
rickettsiae were observed in the spleen indicating possible rapid degradation of foreign 
DNA in the pigs’ spleen. The presence of SFG rickettsia in the liver (but not the spleen) 
is difficult to explain as both organs are major components of the reticulo-endothelial 
system, which readily clears microbes from the blood system. 
 
Only  one  of  the  feral  pigs  positive  for  rickettsial  DNA  was  also  positive  for  anti-
rickettsial antibodies. However, it should be noted that the antibody levels were only 
1/128 for two of the rickettsial organisms tested against (R. gravesii and R. honei). This 
fits with the hypothesis that antibodies raised as a result of natural infection are only 
observed  weeks  after  the  initial  exposure  as  the  immune  system  requires  time  to 
produce antibodies to a detectable level. As the levels of antibodies rise, the amount of 103 
 
rickettsial organisms in  the host is expected to  drop. The level of antibodies in the 
animal/human host is expected to stay at detectable levels for weeks if not months after 
the organism has been cleared from the host. Although we were unable to perform a 
longitudinal study on a controlled population, the evidence from this study suggests that 
a high number of feral pigs are exposed to rickettsial organisms but a very low number 
have the organism present in their organs at any point in time. Thus the timeframe for 
detecting rickettsia in these animals may be very small. 
 
Recent reports in the literature have demonstrated the transfer of rickettsial organisms 
from one tick to another via horizontal transmission through an animal host without the 
animal becoming rickettsaemic (132, 233, 287). With the low prevalence of rickettsiae 
observed in feral pig organs, compared to the high sero-prevalence levels, it is possible 
that feral pigs do not act as a reservoir for rickettsia but can potentially be an amplifier 
for rickettsial organisms in the WA bush without harbouring the organism itself. The 
low prevalence of rickettsial DNA in feral pigs, in spite of high exposure demonstrated 
by the high sero-prevalence, suggests that the maintenance of rickettsial organisms in 
the feral pig is transitional. The feral pig thus fills the role as an amplifier for rickettsiae 
by exposing uninfected ticks to rickettsiae it is harbouring, thus potentially increasing 
the prevalence of the rickettsiae in tick populations infesting the pigs. The ticks affected 
may or may not be effective vectors and/or reservoir of rickettsial organisms. 
 
This  study  represents  the  first  investigation  of  rickettsial  sero-prevalence  in  a  wild 
animal population in Australia. Other sero-prevalence studies investigating Rickettsia 
exposure in Australia has only looked at dogs and cats as companion animals (21, 138).  
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6 - Rickettsial Exposure in High Risk Occupational and 
Recreational Groups Western Australia 
 
6.1  Introduction 
The discovery of two novel spotted fever group rickettsiae (R. antechini and R. gravesii) 
by Owen et al. (206, 207) provides a new focus on endemic rickettsial organisms and 
their public health importance in Western Australia. Based on the known epidemiology 
of rickettsial infections, there is the potential for both organisms to affect the health of 
both humans and animals. In view of the potential risk posed by such organisms, an 
investigation to determine their geographical range  and other ecological information 
was undertaken.  
 
Earlier  chapters  have  investigated  the  potential  for  feral  pigs  to  act  as  rickettsial 
reservoirs, and have discussed the diversity of vectors that may harbour and transmit 
rickettsial  organisms  in  the  bush.  With  various  industries  located  in  these  natural 
environments, including those related to mining and agriculture, there are concerns over 
the risk of exposure to rickettsial organisms in an occupational setting. Additionally, the 
increasing number of WA residents pursuing recreational activities in the bush increases 
the risk of tick bites and hence possibly exposure to vector-borne rickettsioses. In order 
to the address the potential risks through occupational and recreational activities, this 
study was designed to expand on Owen’s (208) tick exposure study by including the 
following groups: 
(i)  Employees  of  various  organisations  and  companies  working  on  Barrow 
Island  
(ii)  Employees of Whiteman Park wildlife sanctuary in Perth  
(iii)  Members of a rogaining organisation – an outdoor recreational sport.   105 
 
Barrow Island lies 50km off the northwest coast of the Pilbara region of WA. The 
closest major town is Onslow. The island is classified as a class A nature reserve, and as 
a result, has very strict quarantine measures. Oil and gas extraction is however allowed 
under strictly managed conditions. The human population on the island, at the time of 
this study, was approximately 200, most of them involved in drilling and mining work. 
Visits to the island are restricted to employees of the oil company and Department of 
Environment and Conservation (DEC) staff. 
 
Whiteman Park (wildlife sanctuary) is located within the northern Perth suburbs and has 
a large wildlife population within its boundaries. The research interest in Whiteman 
park was generated by reports of illnesses related to tick bites among their employees. 
They reported a high incidence of tick bites (mainly A. triguttatum) on site, probably 
related to the large number of free roaming macropods. 
 
Rogaining is an outdoor recreational sport that was first developed in 1947 by students 
of Melbourne University. The sport itself mainly resembles orienteering, with the main 
difference being a larger cross-country element. Rogaining events may last between 6 to 
24 hours with participants travelling through the bush around a designated course. It is 
not uncommon for groups to stay out in the bush for the entire duration of the event, 
including sleeping under trees or in bushes with minimal protection from arthropods. 
Rogaining events occur within a 200km range of the outskirts of Perth. All rogaining 
volunteers  who  took  part  in  this  study  were  members  of  the  Western  Australia 
Rogaining Association (WARA).  
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For  each  of  these  three  distinctive  exposure  groups,  sera  were  examined  for  SFG 
rickettsia.  A  control  (urban)  group  was  recruited  from  Murdoch  University  for 
comparison. 
 
6.2  Materials and Methods 
6.2.1  Study Design 
The study was designed as a (i) cross-sectional analysis/serosurvey with an external 
comparator group; in conjunction with (ii) a prospective component for some subjects 
to assess rates of seroconversion and seroreversion. The serological survey involved the 
collection  of  up  to  two  blood  samples  from  each  volunteer:  one  at  the  time  of 
recruitment, and (for a subset) a second sample 10-14 months later.  
 
Collection of blood samples coincided with the completion of a questionnaire enquiring 
about the participant’s outdoor activities, symptoms associated with rickettsioses, other 
risk factors and demographic details. 
 
Samples  were  collected  from  volunteers  from  three  main  groups:  (i)  Occupational 
Group (OG), (ii) Recreational Group (RG) and (iii) Control Group (CG). Volunteers 
from  two  organisations  contributed  samples  as  part  of  the  OG  group  cohort:    staff 
working on Barrow Island and at Whiteman Park (WP) in Perth. The RG cohort was 
made up of members of the Western Australian Rogaining Association (WARA). Staff 
and students of Murdoch University were recruited as a control group (CG).  
 
There were no strict recruitment criteria for volunteers from the OG and RG cohorts 
have  no  strict  criteria  other  than  being  employed  in  the  areas  under  study  or  as  a 107 
 
member of their respective organisations and over the age of 18 years at the time of 
sampling. More stringent criteria were set for the CG baseline control group to ensure 
that they were of comparable age and had been WA residents for a reasonable period of 
time. Criteria for their admission into the study were: 
1)  Minimum 18 years old at time of recruitment. 
2)  Residing within the Perth metropolitan area. 
3)  Not having resided outside of WA for more than 6 months cumulatively within 
the last 5 years prior to sample collection. 
 
Follow-up sample collections were performed 10-14 months after the first collection, 
although only a limited number of volunteers from WP and WARA were available. 
 
Human  ethics  approval  was  obtained  from  the  Fremantle  Hospital  and  Murdoch 
University Human Ethics Committees (see Appendix 9.1). 
 
6.2.2  Blood Collection 
Eight to ten millilitre blood samples were collected from the study participants between 
2006 and 2009. After clotting, blood samples were centrifuged and between two-three 
millilitres  of  serum  were  recovered  from  each  sample.  Where  possible,  blood  was 
collected on site together with questionnaire completion, with the exception of the first 
group  of  rogainers,  who  had  their  serum  collected  by  PathWest  and  questionnaires 
completed by telephone. Subsequently, the follow-up collection for rogainers involved 
on-site  collection  and  questionnaire  completion  similar  to  all  study  groups.  Barrow 
Island workers’ blood samples were collected by a registered nurse at the onsite medical 
centre. Whiteman Park employees, rogainers and Murdoch staff and students had their 
blood collected onsite by a qualified phlebotomist. 108 
 
6.2.3  Microimmunofluorescence 
Serological  analysis  of  human  serum  samples  for  rickettsial  antibodies  via 
microimmunofluorescence was performed as described in section 2.5.2. Titration was 
performed  on  serum  samples  that  were  positive  to  SFG  and  TG  antigens  at  the 
screening  dilution  of  1/128.  SFG  positive  samples  were  titrated  against  total  SFG 
antigens  containing  equal  concentrations  of  R.  honei,  R.  australis  and  R.  gravesii 
antigen. TG positive samples were titrated against R. typhi. Control sera and antigens 
were provided by the Australian Rickettsial Reference Laboratory, Geelong. 
 
6.2.4  Questionnaire Design 
Questionnaires were designed to establish whether patterns of tick exposure in the bush 
including  activities  that  involved  a  high-risk  of  tick  exposure,  duration  of  such 
exposures  and  the  frequency  of  tick  bites  during  such  activities.  Information  on 
presentation of any symptoms or signs that may have been attributable to a rickettsiosis, 
was also obtained. Other information collected in the questionnaire included travel and 
medical  histories  and  demographic  information  (Questionnaires  are  included  in 
Appendix 9.4, 9.6 and 9.8). 
 
A  second  questionnaire  was  also  designed  for  follow-up  with  the  volunteers  10-14 
months after the first questionnaire to coincide with the second blood sample. The focus 
of the second questionnaire was  to determine any changes to the participant’s data from 
the  first  questionnaire  and  the  development  of  any  rickettsiosis-like  symptoms 
following  activities  in  the  bush  during  the  (approximately)  one  year  time  interval 
(Appendix 9.5 and 9.7). 
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6.2.5  Questionnaire Implementation 
All potential volunteers were given either a presentation or an informal briefing on the 
study  giving them an overview of rickettsiae and rickettsioses, describing rickettsial 
organisms in Western Australia and discussion of the potential public health impact of 
such organisms. Details were provided on the procedures to be undertaken i.e. a blood 
sample  and  questionnaire  at  recruitment,  and  a  follow  up  blood  sample  and 
questionnaire 10-14 months after. Volunteers were then asked to fill out the consent 
form before their participation in the study proceeded (Appendix 9.3). 
 
6.2.6  Statistical Analysis 
Using the data gathered from the serological analysis and questionnaire, a statistical 
analysis was performed on the relationship between the predictive variables and major 
outcome variable (seropositive to SFG Rickettsia sp. at 1/128). Descriptive statistics 
were  generated  for  occupational  and  recreational  groups,  other  activity-related 
descriptors and the age and gender of the study population. To determine the risk of 
infection in the WA bush, final risk estimates were generated using logistic regression. 
The outcomes of the survey conducted on participants were converted to binary data 
(“Yes” or “No” answers) and odds ratios were calculated from the collated information. 
Odds ratios were used to compare various exposure groups with reference to the control 
(baseline) group. Other risk factors were also assessed, such as bush activities in other 
States and overseas and the presence of major health issues. Both crude and adjusted 
risk estimates were calculated by statistical modelling using Stata/MP 10 (USA). 
 
Odds ratios were chosen to demonstrate the relative risk of each group of being infected 
by an SFG rickettsia in the WA bush. Odds ratio analysis was adjusted for age and 
gender. The choice of odds ratio was made because it allows examining of the effects of 110 
 
other variables on a particular relationship. Presentation of odds ratio is in the form of 
probability (35). The calculation of odds ratio in this study was by logistic regression 
with adjustment for age and gender. The control group was used as a baseline (odds 
ratio 1.0). 
 
 
6.3  Results 
 
6.3.1 Serology (IFA) Results 
A total of 60 sera were collected for the base-line control group, 104 from rogainers, 67 
from Barrow Island workers and 12 from Whiteman Park staff (Table 6.1).  Positives 
were regarded as SFG titres of 1:128 as determined by MIF. Whiteman Park employees 
were observed to have the highest rickettsial antibody prevalence at 50% (6/12) (but the 
sample  size  was  small),  with  Barrow  Island  workers  showing  a  comparative  result 
(44.8%; 30/67). The seroprevalence for rogainers was 23.1% (24/104), whereas that of 
the baseline “control” group sero-prevalence was 1.7% (1/60). 
 
Table 6.1 – Seroprevalence for SFG rickettsia from primary and secondary blood 
sampling of humans residing in WA with IF titres to SFG of 1:128. 
 
Group 
First Sample  Follow-Up Sample 
Collected  Positive  Prevalence  Collected  Positive  Prevalence 
Control Group 
(Baseline) 
60  1  1.7%  -  -  - 
Recreational Group 
(Rogainers) 
104  24  23.1%  62  18  29% 
Occupational Group 
(Barrow Island) 
67  30  44.8%  -  -  - 
Occupational Group 
(Whiteman Park) 
12  6  50%  8  3  37.5% 
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A follow-up blood sample was collected from the rogainers (n=62) and Whiteman Park 
employees only (n=8) (Table 6.1). Follow up samples were not possible for Barrow 
Island staff due to the transient nature of employment, the difficulties of getting to the 
island  and  the  wide  range  of  areas  that  the  fly-in  fly-out  workers  came  from.  The 
seroprevalence for rogainers was slightly higher at 10-14 months after the first blood 
test (29%; 18/62), whereas the Whiteman Park employees’ seroprevalence had fallen to 
37.5% (3/8). 
 
Seroconversion and seroreversion rates were calculated using the formulae below; 
i)  Seroconversion Rate = (t=0 Negative, t=1 Positive)/(t=1 Positive) X 100 
ii)  Seroreversion Rate = (t=0 Positive, t=1 Negative)/(t=1 Negative) X 100 
Seroconversion  and  seroreversion  rates  for  the  rogainers  were  15.5%  and  35.5% 
respectively (Table 6.2). Whiteman park employees seroconversion and seroreversion 
rates were 0% and 50% respectively (Table 6.3). 
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Table 6.2 – Rogainers’ seroconversion and seroreversion results over a 10-14 
month period (t=0 is serum collected at first collection; t=1 is serum collected at 
follow-up at 10-14 months; N is number of volunteers). 
 
t=0  t=1  N 
-  -  38 
-  +  7* 
+  -  6^ 
+  +  11 
Total  62 
* Seroconversion 
^ Seroreversion 
 
Table 6.3 – Whiteman park employees’ seroconversion and seroreversion results 
over a 10-14 month period (t=0 is serum collected at first collection; t=1 is serum 
collected at follow-up at 10-14 months; N is number of volunteers). 
t=0  t=1  N 
-  -  2 
-  +  0* 
+  -  3^ 
+  +  3 
Total  8 
* Seroconversion 
^ Seroreversion   113 
 
6.3.2  Descriptive Epidemiology 
There  were  approximately  1500  members  in  the  Western  Australian  Rogaining 
Association. A total of 135 questionnaires were completed, giving a participation rate of 
9.0%. Questionnaire completion rates for occupational groups were 29.5% (59/200) for 
Barrow Island employees and 32.1% (9/28) for Whiteman Park employees. Follow-up 
rates  of  34.8%  (47/135)  and  44.4%  (4/9)  were  obtained  with  the  rogainers  and 
Whiteman park employees respectively. We were unable to follow-up on Barrow Island 
employees due to logistical constraints documented above. The populations surveyed 
are summarised in Table 6.4. 
 
From the questionnaire results obtained, the two groups that spent most time in the bush 
has  a  large  male  majority,  with  93%  for  Barrow  Island  employees  and  66.7%  for 
Whiteman park employees. Gender distribution in participants from the control group 
and  rogainers  were  similar  (Table  6.4).  The  majority  of  the  participants  in  the 
recreational and occupational groups were above the age of 40 (median age of each 
group was Barrow Island employees=42, rogainers=50 and Whiteman park employees 
=51). In the control group, the median age was 24. There were further variations in the 
median age male and female participants within each group. Median age for the control 
group  and  the  rogainers  were  fairly  similar  between  male  and  female  participants. 
Wider  variations  in  age  were  observed  in  the  Barrow  Island  workers  (male=42, 
female=28) and Whiteman park employees (male=53, female=38). 
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Table 6.4 – Descriptive categories of populations based on questionnaire data. 
 
Categories 
Control 
Baseline 
Barrow Island 
Employees   Rogainers 
Rogainers 
Follow-Up 
Whiteman 
Park 
Employees 
Whiteman 
Park 
Employees 
Follow-Up 
#  %  #  %  #  %  #  %  #  %  #  % 
Gender 
  Male  20  42.6  55  93.0  66  48.9  25  53.2  6  66.7  3  75.0 
  Female  27  57.4  4  7.0  69  51.1  22  46.8  3  33.3  1  25.0 
Age groups 
  <25 years old  25  53.2  8  13.6  1  0.7  0  0  1  11.1  1  25.0 
  25 to 50 years old  21  44.7  37  62.7  75  55.6  24  51.1  3  33.3  2  50.0 
  >50 years old  1  2.1  14  23.7  59  43.7  23  48.9  5  55.6  1  25.0 
Recreational time in bush in WA 
  Once a month or more  18  38.3  29  49.2  135  100  38  100  7  87.8  2  50.0 
  Rarely (<2 times/year)  29  61.7  30  50.8  0  0  0  0  2  22.2  2  50.0 
Occupational time in bush in WA 
  Once a month or more  2  4.3  50  84.7  11  8.1  3  6.4  7  87.8  3  75.0 
  Rarely (<2 times/year)  45  95.7  9  15.3  124  91.9  44  93.6  2  22.2  1  25.0 
Time in bush in other Australian states 
  More than once per year  4  8.5  15  25.4  14  10.4  0  0  1  11.1  0  0 
  Once per year or less  43  91.5  44  74.6  120  89.6  47  100  8  88.9  4  100 
Time in bush overseas 
  More than once per year  2  4.3  7  11.9  4  3.0  0  0  0  0  0  0 
  Once per year or less  45  95.7  52  86.4  131  97.0  47  100  9  100  4  100 
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Table 6.4 – continued. 
 
Categories 
Control 
Baseline 
Barrow Island 
Employees  Rogainers 
Rogainers 
Follow-Up 
Whiteman 
Park 
Employees 
Whiteman 
Park 
Employees 
Follow-Up 
#  %  #  %  #  %  #  %  #  %  #  % 
Tick bite frequency 
  Most or every time in bush  0  0  1  1.7  14  10.4  2  4.3  2  22.2  0  0 
  Often (25-75%)  0  0  8  13.6  41  30.4  9  19.1  1  11.1  2  50.0 
  Occasionally  2  4.3  33  55.9  60  44.4  16  34.0  5  55.6  2  50.0 
  Never  45  95.7  13  22.0  14  10.4  17  36.2  1  11.1  0  0 
  Don’t know  0  0  4  6.8  6  4.4  3  6.4  0  0  0  0 
Symptoms following tick bite 
  None or one symptom 
NA 
50  84.7  120  88.9  42  89.4  6  66.7  1  25.0 
  Rash unrelated to bite  3  5.1  3  2.2  2  4.3  1  11.1  1  25.0 
  Two symptoms of rash, fever/chills or headache  0  0  5  3.7  0  0  0  0  0  0 
  Any two symptoms of rash, fever, headache, aching, 
tiredness, scab, shortness of breathe 
6  10.2  7  5.2  3  6.4  2  22.2  2  50.0 
Symptoms with no bite history 
  None or one symptom  42  89.4  53  89.8  124  91.9  45  95.7  6  66.7  3  75.0 
  Rash unrelated to bite  1  2.1  1  1.7  5  3.7  0  0  0  0  0  0 
  Two symptoms of rash, fever/chills or headache  2  4.3  0  0  1  0.7  1  2.1  2  22.2  0  0 
  Any two symptoms of rash, fever, headache, aching, 
tiredness, scab, shortness of breathe 
2  4.3  5  8.5  5  3.7  1  2.1  1  11.1  1  25.0 
Medical conditions 
  None 
NA 
47  79.6  98  72.6  37  78.7  8  88.9  2  50.0 
  Major (e.g. heart, asthma, diabetes)  12  20.4  37  27.4  10  21.3  1  11.1  2  50.0 116 
 
All the rogainers who participated in the study reported that they spent time in the bush 
at least once a month for recreational purposes. This contrasted with the other groups: 
only 49.2% of Barrow Island workers and 38.3% of the control group reported spending 
time in the bush recreationally. However, for activities in the bush due to occupational 
activities, the workers on Barrow Island rated the highest with 84.7% spending time in 
the bush at least once a month, as compared to 8.1% of rogainers and 95.7% of the 
control group. Whiteman park employees spent equal time on average in the bush while 
at work and recreationally (87.8%). 
 
Rogainers (40.7%) and Whiteman park employees (33.3%) reported the highest rates of 
tick bites (25-100% of their time in the bush) occurring when they were in the bush for 
both occupational and recreational activities. Only 15.3% of Barrow Island workers 
reported tick bites while in the bush. Reports of symptoms as a result of tick bites that 
may  be linked to a  rickettsiosis  were highest among Whiteman Park staff (22.2%), 
followed by the workers on Barrow Island (10.2%), and lastly the rogainers (8.9%). 
However  very  similar  rates  were  also  observed  for  rickettsiosis-like  symptoms  not 
linked to tick bites. 
 
6.3.3  Odds Ratio (OR) Analysis 
Logistic  regression  and  calculation  of  odds  ratios  demonstrated  that  there  were 
significant associations between age, gender, work related bush activities and specific 
group classifications (occupational and recreational) with positive rickettsial serology. 
No  significant  associations  were  observed  between  variables  such  as  recreational 
activity, tick bite frequency and symptoms related and/or unrelated to tick bites with 
positive serology (Table 6.5). 
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Table 6.5 – Risk estimates for seropositivity to SFG Rickettsia sp. (adjusted for age 
and gender). 
  N 
(Sero +ve/ 
Sero -ve) 
Unadjusted 
Odds Ratio 
95% CI 
(p-value) 
Adjusted  
Odds Ratio 
95% CI  
(p-value) 
Demographic Variables 
Age Strata 
 
 
<25y (baseline)  4/30  1.0  -  1.0  - 
  25-50y  27/70  2.89 
0.93-9.00 
(p=0.066) 
2.39 
0.75-7.64 
(p=0.14) 
  >50y  15/30  3.75 
1.14-12.62 
(p=0.033) 
3.33 
0.95-11.63 
(p=0.059) 
Gender 
 
 
Female 
(baseline) 
9/56  1.0  -  1.0  - 
 
Male  37/74  3.11 
1.39-6.97 
(p=0.006) 
2.91 
1.29-6.57 
(p=0.010) 
Reported Work in W.A. Bushland 
 
 
No  18/95  1.0  -  1.0  - 
  Yes  28/35  4.22 
2.08-8.59 
(p<0.001) 
3.56 
1.63-7.77 
(p=0.001) 
Specific Occupational and Recreational Classifications  
  Control Group 
(baseline) 
1/46  1.0  -  1.0  - 
  Rogainers 
(recreational) 
14/47  13.70 
1.73-108.49 
(p=0.013) 
14.02 
1.38-142.07 
(p=0.025) 
  Workers on 
Barrow Is 
27/32  38.81 
5.02-300.34 
(p<0.001) 
32.24 
3.48-298.80 
(p=0.002) 
  Wildlife park 
employees 
4/5  36.80 
3.41-396.72 
(p=0.003) 
50.89 
2.34-1109.27 
(p=0.012) 
Frequency of Recreational Activities in W.A. Bushland 
  <1x per month 
(baseline) 
14/47  1.0  -  1.0  - 
  ≥1x per month  32/83  1.29 
0.63-2.67 
(p=0.48) 
1.24 
0.58-2.71 
(p=0.57) 
Experienced Frequent Tick Bites in W.A. Bushland 
 
 
No  32/99  1.0  -  1.0  - 
  Yes  12/26  1.43 
0.65-3.15 
(p=0.38) 
1.07 
0.45-2.53 
(p=0.88) 
Reports of Systemic Symptoms Specifically Following Tick Bites˄ 
 
 
No  37/69  1.0  -  1.0  - 
 
 
Yes  6/9  1.24 
0.41-3.76 
(p=0.70) 
1.51 
0.48-4.78 
(p=0.48) 
Reports of Any Systemic Symptoms (Not Necessarily Following Tick Bites)˄ 
 
 
No  41/76  1.0  -  1.0  - 
 
 
Yes  4/8  0.93 
0.26-3.26 
(p=0.91) 
0.96 
0.27-3.46 
(p=0.95) 
 ˄Only for occupational and recreational groups118 
 
6.3.4  Spotted Fever Group Rickettsiosis in a WA Patient 
While two workers on Barrow Island presented to a doctor with possible symptoms of a 
rickettsiosis, only one definitive case of rickettsiosis was reported during the course of 
the  study.  The  diagnosis  was  made  by  Dr  John  Dyer  at  the  Fremantle  Hospital  in 
Western Australia in  May 2006. The patient  presented with  clinical  symptoms  of a 
rickettsiosis (fever, malaise, myalgia, rash and abnormal liver function) and had positive 
serology to SFG rickettsial antibodies. PCR analysis on a biopsy of the patient’s eschar 
was positive for the Rickettsia sp. citrate synthase gene. However, PCR on the patient’s 
EDTA  blood  sample  was  negative  and  this  was  mainly  attributed  to  the  early 
prescription  of  doxycycline.  The  patient  was  hiking  the  Bibbulmun  track,  which 
stretches for more than 500km between Albany and Perth. The patient had spent more 
than 3 weeks in the bush and had become infested with ticks. Shortly after returning, he 
fell ill with fever, chills, rash, hepatitis and eschar (Figure 6.1) at a tick bite site. He 
was admitted to Fremantle Hospital and given a regimen of doxycycline for suspected 
rickettsial disease. The patient’s clinical symptoms cleared up within 3 days of starting 
the treatment. A tick collected from the patient, although not attached anywhere close to 
the eschar, was submitted for analysis as part of this study. The tick was identified as 
belonging to the genus Ixodes, although speciation was not possible due to damage to 
the mouth parts (palp articles) during removal from the patient. PCR analysis of the tick 
was negative for Rickettsia sp. 
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Figure 6.1 – Eschar and swelling on patient’s leg as a result of a tick bite (Courtesy 
of Dr John Dyer, Fremantle Hospital). 
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6.4  Discussion 
 
6.4.1  Sero-positivity and its Link to Bush Activity 
In this study, it was noted that the unadjusted OR for sero-positivity to SFG rickettsia 
was significant for participants over the age of 50 (unadjusted OR=3.75, 95% CI=1.14-
12.62). However, after adjustment for gender, the risk estimate became non-significant 
(Table 6.5). An age-related effect for this cohort was anticipated, given the association 
between   age and sero-positivity, as observed in many infectious disorders, because of 
cumulative seroconversion over time. It is also notable that a significant proportion of 
participants from both the occupational and recreational groups were above the age of 
50, so age was a factor in predicting the likelihood of exposure to ticks (Table 6.4). 
With  respect  to  gender,  males  were  also  observed  to  be  significantly  more  at  risk 
(OR=2.91, 95% CI=1.29-6.57). This occurrence can be attributed to the higher number 
of males in occupational roles that puts them at risk in the bush on Barrow Island (93%) 
and  Whiteman  Park  (66.7%).  As  hypothesized,  there  was  a  significant  risk  to 
participants  who  reported  having  an  occupational  role  in  the  bush  (OR=3.56,  95% 
CI=1.63-7.77).  For specific occupational  and  recreational  groups,  the  risk was  most 
significant in the Whiteman park staff (OR=50.89, 95% CI=2.34-1109.27). The wide 
confidence intervals were a result of the small sample size in this occupational category. 
Workers on Barrow Island were also significantly at risk with an OR of 32.24 (95% 
CI=3.48-298.80), as were rogainers, with an OR of 14.02 (95% CI=1.38-142.07) (Table 
6.5).  
 
The  high  rate  of  sero-prevalence  to  SFG  Rickettsia  sp.  was  unexpected  among  the 
groups studied in WA. It was acknowledged that people performing high risk activities 
would be exposed to ticks and rickettsiae, but the high sero-prevalence points towards a 
higher  exposure  rate/transmission  efficiency  than  that  seen  elsewhere  in  high  risk 121 
 
“healthy”  (asymptomatic)  populations  (57,  232).  In  Australia,  comparably  high 
prevalences  were  more  commonly  observed  in  patients  with  overt  symptoms  of 
rickettsial  infection  (305).  Other  studies  have  demonstrated  high  seroprevalences  to 
rickettsial exposure including; R. africae in Guadeloupe (French West Indies) (217), R. 
japonica in Korea (140) and R. helvetica in Denmark (193). The low sero-prevalence 
observed in the current control group was similar to that observed in other studies of a 
general population, where prevalences of less than 5% have been reported (112).  
 
The mere presence of an endemic rickettsia in an environment does not necessarily 
mean that it will be transmitted to humans and hence a high level of seropositivity in 
humans cannot be assumed. The WA data reflects a high rate of rickettsial transmission 
and  human  infection  in  the  WA  bush.  However,  clinical  disease  from  rickettsia 
exposure appears to be rare. Thus a rickettsiosis caused by SFG infection in WA may be 
mild or asymptomatic. As no other rickettsiae have been found in ticks that commonly 
bite humans in WA (A. triguttatum and I. australiensis) it is postulated that a significant 
proportion of seropositives may be due to exposure to R. gravesii, the most common 
rickettsia identified in ticks in the state. 
 
A previous WA study investigating A. triguttatum tick infestations of humans failed to 
identify a clear  link between any rickettsiosis-like illness and tick bites (223). Only 
delayed hypersensitivity reactions to tick bites (24-48 hours) and secondary bacterial 
infections were reported. Considering that symptoms of rickettsiosis usually present 7-
14 days after infection, any presenting symptoms may not have been attributed to the 
earlier tick bites. Some of the reported symptoms associated with tick bites may be due 
to an allergic reaction which is not uncommonly recorded in Australia (42, 102). 
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The lack of a significant association between self-reported tick bites and seropositivity 
is unlikely to be an accurate reflection of the true exposure profile. The majority of SFG 
rickettsioses worldwide are transmitted by a tick bite, and therefore the exposure event 
must have occurred at some point. The other known SFG rickettsia endemic to WA, R. 
felis, presents serologically as a TG rickettsiae and is transmitted by fleas (1, 332). It is 
more likely that the seroprevalence observed in bush-active groups in south-west WA is 
as a result of exposure to  R. gravesii. However, this hypothesis needs  confirmation 
through the isolation of R. gravesii from a patient diagnosed with SFG rickettsiosis. 
 
Other similar cases to the one reported in Section 6.3.4 have been reported in south-
west  WA,  but  with  little  to  no  clinical  or  microbiological  follow  up  to  confirm 
rickettsial aetiology (John Dyer, pers. comm.). The “lack” of records in WA pertaining 
to rickettsial disease may relate to factors such as: (i) the treatment of patients with 
antibiotics without undertaking pathology testing; and (ii) the endemic SFG rickettsiosis 
may be mainly asymptomatic or very mild and thus may not come to medical attention. 
 
6.4.2  Potential Causes of Bias and Confounding Factors in the Study 
There  were  limitations  to  the  study  that  may  have  introduced  bias  to  the  observed 
results. In this discussion, these are separated into selection bias and information bias. 
 
Selection Bias 
All  participants  in  the  study  were  volunteers  and  thus  may  have  particular 
characteristics  that  could  have  influenced  the  outcome  of  the  result.  People  who 
volunteer in community-based studies have demographic attributes  that may  introduce 
bias to  the study  and the interpretation of results  (100). Although  characteristics of 
volunteers vary between studies, it has often been observed that healthier individuals in 123 
 
the  community  are  more  inclined  to  volunteer.  This  phenomenon  is  known  as  the 
Healthy Volunteer Effect (HVE). HVE has been demonstrated in several studies (12, 
96,  174)  and  is  acknowledged  as  an  important  source  of  bias  in  epidemiological 
research.  HVE  may  explain  the  lack  of  any  link  to  adverse  symptoms  linked  to 
rickettsiosis after a tick bite, given that healthier individuals may be less likely to show 
severe symptoms   of infection. 
 
There were also different gender numbers in the study across the study groups. There 
were  slightly  more  females  in  the  rogainers  (57.4%)  and  control  (51.1%)  groups, 
whereas respondents were overwhelmingly more likely to be male in the Barrow Island 
(93%)  and  Whiteman  park  (66.7%)  groups.  The  slight  bias  towards  females  in  the 
rogainers and control groups was unexpected as both populations were approximately 
equal,  whereas  the  overwhelming  bias  towards  males  in  the  Barrow  Island  and 
Whiteman  park  groups  was  expected  due  to  the  male-oriented  nature  of  the  work 
performed at the two locations. 
 
High participation rates were observed with the control, Barrow Island and Whiteman 
park  groups  because  of  “on  the  spot”  recruitment  and  immediate  follow-up  blood 
collection and questionnaire completion. The rogainers underwent a slightly different 
method of recruitment, in which volunteers were recruited and were followed up with a 
phone interview and blood collection at a pathology centre close to their residence. As a 
result, retention rate was low, with volunteers pulling out or unable to provide a blood 
sample due to problems faced trying to visit or liaise with the pathology laboratory. 
Attempts to rectify this problem were made by subsequent collection of blood samples 
and completion of questionnaires at rogaine sites, although this option was logistically 124 
 
more demanding than collection of samples with full pathology facilities (as occurred 
for the other groups).  
 
Information Bias 
The surveys conducted required participants to recall information going as far back as 
five  years  from  the  time  of  the  questionnaire  application.  The  accuracy  of  the 
information may not be reliable and may be represented as an over-reporting (or under-
reporting) of information deemed useful (or unrelated) to the study. For example, mild 
symptoms following tick bites may not have been accurately recalled or may not have 
been linked to the exposure event. 
 
Confounding Factors 
There were several identified possible confounding factors such as age, gender, location 
of home (bush, suburb, rural), keeping of pets and living in close proximity to wildlife 
that may have affected the patterns of exposure or clinical outcomes. Of these potential 
risk factors, age and gender were identified as the most significant confounding factors 
and were thus adjusted for in the calculation of the odds ratios. 
 
Low Participant Numbers 
The relatively modest sample sizes in some groups were related to the relatively small 
baseline populations in some occupations (Section 6.3.2).  The low numbers resulted in 
wide CI intervals for a number of the risk estimates. 
 
   125 
 
6.4.3  Public Health Implications of the Study 
The information collected from this study demonstrates the potential risk that novel 
SFG rickettsia, R. gravesii, may pose to humans active in the WA bush. The high rate of 
infection/exposure observed among high-risk populations reinforces the hypothesis that 
there are endemic SFG rickettsiae in WA, and that the most likely agent is R. gravesii. 
 
The tick is the main vector of SFG rickettsial transmission similar to other rickettsial 
diseases. Prolonged attachment of ticks to their host have been demonstrated to increase 
the rate of transmission of pathogenic bacteria (152, 230). Although there is currently 
no data on the transmission of Rickettsia sp. in WA, evidence suggests that attachment 
for  longer  than  24  hours  would  result  in  a  high  rate  of  rickettsial  transmission. 
Amblyomma  triguttatum  had  been  identified  previously  in  this  study  as  the  main 
reservoir  and  vector  of  R.  gravesii.  The  affinity  of  this  tick  for  large  vertebrate 
mammals in the bush is well documented (262).  
 
The single confirmed case of SFG rickettsiosis during the course of the study suggests 
that cases of rickettsiosis do occur even though most of those arising through activities 
in the WA bush maybe asymptomatic. However due to the distance between towns and 
cities and the low population in the state, even in the most populated region of the 
southwest, cases of rickettsiosis may have gone unnoticed, unreported or misdiagnosed 
as being caused by another pathogen. This pattern of under-detection  has been observed 
to occur with other Rickettsia sp. elsewhere (126, 212). 
 
In conclusion, the study has led to an increased awareness of arthropod-borne infections 
by the affected populations. By the end of the study, precautionary measures were being 
implemented  by  volunteers  and  those  with  whom  they  come  into  contact.  Simple 126 
 
precautionary measures, such as frequent checking for ticks during prolonged periods in 
the  bush,  were  encouraged  by  the  participating  organisations.  In  some  cases  light 
coloured work clothing was issued to allow spotting of ticks easily. Other methods of 
prevention included treatment of clothing with insect repellents, long trousers tucked 
into socks and the application of effective repellent to exposed skin. An extra precaution 
suggested  by  this  research  would  be  to  avoid  locations  where  large  macropods 
(kangaroos) and feral pigs may wallow or take shelter, thus reducing the likelihood of 
encountering the tick species associated with these animals. 
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7 - Final Discussion 
 
There  has  been  renewed  interest  in  human  rickettsial  disease  in  Western  Australia 
although much is still unknown. There are three groups of rickettsial organisms known 
to be present in WA; spotted fever group, typhus group and scrub typhus. The latter two 
are well characterised with typhus group rickettsia (Rickettsia typhi) mainly reported 
from urban centres (155, 195, 275) and scrub typhus (Orientia tsutsugamushi) in the 
northern,  tropical  regions  of  the  state  (239).  So  far  the  only  spotted  fever  group 
rickettsiae  reported  have  been  Rickettsia  felis  and  more  recently  two  novel  species, 
Rickettsia gravesii and candidatus “Rickettsia antechini” (206, 208). The distribution of 
SFG  rickettsiae  in  WA  required  further  investigation  and  thus  became  this  study’s 
focus. Due to the large size of the state, the study focus was restricted to the most 
populated south-west corner. 
 
7.1  Fulfilment of Study Aims 
 
I.  To characterise phenotypic traits of R. gravesii that are distinct from other 
rickettsiae. 
Rickettsia gravesii sp. nov. was demonstrated to be serotypically distinct from other 
closely related rickettsiae. Serotypical analysis by Specificity Difference (SPD) (227) 
demonstrated that R. gravesii was distinct from R. massiliae, a close genotypic relative. 
Rickettsia gravesii was also compared with two other abundant Australian rickettsiae, R. 
australis and R. honei, as they may have overlapping regions of endemicity. The three 
rickettsiae were serotypically distinct. Other characteristics, such as vector species and 
geographical  distribution,  also  emphasise  the  uniqueness  of  R.  gravesii  (208).  This 
gives support to its acceptance as a novel member of the Rickettsia genus. 128 
 
 
II.  To examine the arthropod host species known to harbour R. gravesii. 
Expanding  the  arthropod  host  species  harbouring  R.  gravesii  from  four  to  six  was 
deemed an important step to further understand the ecology of the organism and its role 
within the West Australian biosphere. Two tick species were added, I. australiensis and 
I. fecialis (Table 4.3). Amblyomma triguttatum’s role as an arthropod reservoir was 
further demonstrated by the high prevalence observed in all populations tested and the 
evidence of potential transtadial, transovarial and horizontal transmission (Chapter 4). 
Other tick species collected had a relatively low prevalence of R. gravesii comparative 
to A. triguttatum (Table 4.2).  
 
Amblyomma  triguttatum’s  abundance  and  affinity  for  larger  vertebrate  mammals 
(including humans) compared to other tick species suggests that it is the principle vector 
for R. gravesii in WA (172, 261). Of the 4 subspecies of A. triguttatum, the subspecies 
A. triguttatum triguttatum (172, 206-208) was investigated in this study. None of the 
other three subspecies has ever been collected or observed in southwest WA or Barrow 
Island i.e. A. triguttatum queenslandense, A. triguttatum ornatissimum or A. triguttatum 
rosei. Amblyomma triguttatum triguttatum has also been reported in other regions of 
Australia, especially in QLD and NSW, however no studies have been performed to 
investigate the presence of Rickettsia sp. in these states. Thus, R. gravesii may or may 
not  be present  in  those tick populations,  for even though the ticks  are of the same 
subspecies, the different populations are separated by desert in the middle of Australia. 
No records of A. triguttatum triguttatum have been found from the Northern Territory, 
South Australia or far western Queensland. One can only theorise on the split and sub-
speciation of A. triguttatum triguttatum on the continent to different areas without a 
visible land connection. Investigating the presence of R. gravesii in tick populations on 129 
 
the eastern part of Australia may shed light on how closely related the populations are to 
each other and whether R. gravesii is unique to WA. 
 
The serendipitous identification of a species of tick (H. longicornis) recently determined 
to be new to WA and possibly introduced via the importation of cattle from SA (28), 
highlights the potential for unintentional spread of rickettsial organisms by humans via 
their normal activities. The report of H. longicornis on a feral pig points to the possible 
establishment of the tick species among local fauna following cattle importation. The 
tick species has yet to be reported from any other vertebrate hosts in WA. As only one 
individual was obtained, further investigation into the encroachment of H. longicornis 
among WA fauna is warranted. More relevant to this study, H. longicornis has been 
implicated as a vector for SFG rickettsiae and Coxiella sp. in Korea (169, 170). Thus it 
has the potential to acquire local rickettsiae and become a rickettsial vector.  
 
III.  To determine the sero-prevalence of R. gravesii in a wild animal population. 
With the high prevalence of R. gravesii in A. triguttatum ticks in WA, and the ticks’ 
affinity for large vertebrate bush mammals (and humans), a bush animal species was 
needed that would give an insight into the A. triguttatum burden and resulting rickettsial 
seroprevalence. The feral pig was the ideal animal for this part of the study.  
 
Results  from  the  study  of  ticks  and  rickettsiae  in  feral  pigs  revealed  a  high  sero-
prevalence to SFG rickettsia (47%) and provided strong evidence of transmission of a 
spotted fever group rickettsia by ticks (Chapter 5). The seroprevalence together with 
the  presence  of  rickettsial  DNA  in  3.1%  of  feral  pig  livers  suggested  that  a  small 
proportion of the feral pig population may be rickettsaemic at any one time. However, 
the duration of rickettsaemia in the animal is unknown. 130 
 
 
The feral pig is widely distributed in Australia, with an estimated size of more than 20 
million free roaming pigs. Its overlap with Australian native mammal populations is 
well documented and thus the ectoparasites found on the feral pig have also been found 
on other mammals (262). The study on the feral pig in south west WA has given an 
indication of probable high rickettsial exposure in other species of local large vertebrate 
mammals. 
 
In Spain, the prevalence of the SFG rickettsia R. slovaca in Dermacentor marginatus 
ticks collected off wild boars, and their anti-rickettsial sero-prevalence was high (203, 
204). The sero-prevalence (~50%) was  similar to  that obtained in  the current  study 
however the prevalence of SFG rickettsiae detected in the tick populations was higher in 
Australia. Nevertheless, no physical rickettsial presence (genomic or culture isolates) 
were reported in the Spanish study.  
 
IV.  To identify the regions within south-west WA endemic for R. gravesii. 
The current study showed that R. gravesii was prevalent throughout southwest WA. As 
the A. triguttatum ticks are also known to infest kangaroo populations in the region 
(262), it is likely that kangaroos in WA may also be involved in the ecology of the 
infections. 
 
With R. gravesii now known to be endemic in southwest WA, the question remains as 
to  its  distribution  elsewhere.  A  similarly  high  prevalence  was  identified  on  Barrow 
Island  in  the  north  of  the  state  (Chapter  5)  (208)  suggesting  a  possible  state-wide 
distribution.  Antibodies  to  spotted  fever  group  rickettsiae  have  been  observed 
previously in the Kimberley region (112). Amblyomma triguttatum and kangaroos are 131 
 
abundant in these areas, as are other larger mammals such as feral pigs, feral goats and 
dogs. It would be valuable to investigate whether the observed seroprevalence was due 
to exposure to R. gravesii or some other SFG rickettsia. 
 
V.  To  investigate  the  relationship  between  sero-prevalence  to  spotted  fever 
rickettsia in humans and their level of bush activity. 
The prevalence of R. gravesii in ticks and feral pigs strengthens the hypothesis that 
humans involved in bush activities are also exposed to the organism. Previous studies in 
WA (112) had shown serological evidence of SFG infections in humans and thus a 
background  level  was  expected.  A  risk  analysis  study  was  designed,  using  logistic 
regression to calculate odds ratios. A bush-associated occupational risk was observed to 
be the highest in the two tested groups. A bush-associated recreational group had lower 
risk of being seropositive for SFG rickettsiae, but were still significantly higher than the 
state baseline. The high rates of seroprevalence observed in the high risks groups tested 
demonstrated  a  clear  risk  for  those  living  and  working  on  Barrow  Island  and  for 
individuals in the southwest region of WA who are active in the bush.  
 
VI.  To  report  and  characterise  any  illness  linked  to  Rickettsia  sp.  infection 
during the period of the study. 
With the high rates of seroprevalence to SFG Rickettsia sp. observed, it was expected 
that human rickettsiosis would occur more frequently. However, only one known case 
occurred during the duration of this study (2005-2009), suggesting that rickettsioses in 
WA are  rare or under-reported.  It is  possible that  R. gravesii infection is  generally 
asymptomatic or causes only a mild illness with insignificant symptoms that diagnostic 
investigations are not undertaken. 
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Another possibility is that ticks are not attached to humans for very long before being 
removed. People who spend time in the bush were observed to be highly aware of ticks 
and removed them promptly when they attached or were found crawling on their bodies. 
SFG Rickettsia sp. transmission does not occur for several hours after tick attachment 
and hence the infectious dose in many cases may be small and below the threshold 
required to cause symptomatic illness but enough to stimulate an immune response and 
seroconversion of the person bitten.  
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7.2  Rickettsia gravesii sp. nov. 
This study has led to a better understanding of the ecology of SFG rickettsiae in WA. 
The predominant SFG rickettsia appears to be R. gravesii sp. nov. that is endemic to 
WA.  The  main  arthropod  vector  and  reservoir  is  Amblyomma  triguttatum  with 
maintenance of the organism by transovarial and transtadial transmission (Figure 7.1 I). 
Vertical  transmission  was  observed  in  this  study  following  the  identification  of 
rickettsial DNA in viable larvae from infected parents and in all other stages of the tick 
(nymph and adult). The transmission of rickettsiae to humans and animals may thus 
occur during all three stages of the life cycle of A. triguttatum’s where a blood meal is 
required (Figure 7.1 I and II). Amblyomma triguttatum is a three-host tick although 
questions remain as to whether the larval and nymphal stages of the tick have a similar 
affinity for host species as the adult. 
 
A high prevalence of anti-SFG rickettsia antibodies occurred in humans and animals 
with high tick exposure suggesting successful transmission via tick bites (Figure 7.1 
II).  No  other  rickettsial  species  was  observed  in  this  study  other  than  R.  gravesii, 
suggesting  that  it  may  be  the  main  cause  of  anti-SFG  rickettsia  sero-prevalence  in 
south-west WA. No significant illness was observed in the animals (feral pigs) and 
humans involved in the study, although sporadic cases of human rickettsiosis have been 
suspected. The illness caused by R. gravesii in humans may be mild or asymptomatic in 
most  cases.  This  study  investigated  prevalence  in  the  feral  pig  only,  but  similar 
prevalences  may  occur  in  other  vertebrate  mammals  that  share  similar  ectoparasite 
burdens within similar geographical boundaries. 
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Figure 7.1 – The transmission cycle of Rickettsia gravesii in Western Australia. 135 
 
Amblyomma triguttatum is  the predominant  tick species collected from  animals  and 
from the environment by flagging. Other tick species such as I. australiensis were only 
observed to harbour R. gravesii when they shared similar hosts with A. triguttatum. This 
may  suggest  that  the  horizontal  transmission  of  rickettsiae  from  A.  triguttatum 
(reservoir) to other tick species can occur. (Figure 7.1 II to IV). Observation of tick 
locations  on  the  host supports  this  hypothesis,  where  the  close  co-proximity  during 
feeding may increase the chance of horizontal transmission. This was however untested 
in the study and would be worth pursuing to demonstrate whether or not it does occur.  
 
This study has revealed a close relationship between R. gravesii and A. triguttatum ticks 
from  south-west  WA.  Its  relationship  to  other  tick  species  and  their  hosts  is  still 
unknown and needs investigation. Evidence presented in this thesis gives support for A. 
triguttatum  as  the  main  reservoir  for  R.  gravesii.  Other  tick  species  may  also  be 
reservoirs, but with the high prevalence of R. gravesii, and its abundance and affinity 
for larger mammals, including humans, it is the most likely tick species associated with 
this newly-recognised rickettsial species. 
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7.3  Future Directions 
Western Australia is approximately a third of the total land mass of Australia, with a 
land area of 2,529,875 km
2 (Figure 4.2). Thus WA is larger than the state of Texas 
(USA), Japan and the UK combined (Figure 7.2A). The total population of WA in 2010 
was 2,296,411 (9). This equate to less than 1 person per square kilometre of land. The 
majority of land in WA is virtually uninhabited, with most of the population (75%; ABS 
2007 data) living in and around Perth and south-west WA (Figure 7.2B). These figures 
demonstrate the massive undertaking it would require to  fully investigate rickettsial 
organisms  and  their  relationship  with  local  animal  populations.  With  current 
knowledge; O. tsutsugamushi occurs in the north (112, 239), R. felis and R. typhi in 
cities and towns (155, 195, 277) and the novel R. gravesii and R. antechini on Barrow 
island and the south-west part of the state (206-208).  
 
The focus of this study was to attempt to understand the mechanics of transmission and 
prevalence of R. gravesii in the bush in south-west WA. Even though the focus was on 
Rickettsia sp., only R. gravesii was observed in samples, with no other members of the 
Rickettsia genus detected. The apparent absence of R. felis and R. typhi in the WA bush 
further  supports  the  hypothesis  that  they  are  “urban  rickettsioses”  involving  fleas 
infesting  domestic  pets  and  urban  rats,  respectively.  A  possible  future  direction  for 
rickettsial research in WA would be investigating rickettsia-like illnesses in the towns 
and cities of WA.  
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Figure 7.2 – Maps of Western Australia showing (A) comparative size of WA to 
other nations or states of the world and (B) population distribution based on data 
from the Australian Bureau of Statistics. 
 
 
 
 
 
There is still much about the novel rickettsia R. gravesii that is not yet known. Little or 
no  investigations  have  been  performed  in  the  regions  between  south-west  WA  and 
Barrow Island. The lack of specimens and information can be attributed to the few 
towns in the area and to conservation efforts that tend to be focused on ecologically rich 
regions of the south-west and the Kimberley in the north. Efforts to collect samples 
from  both  humans  and  animals  in  this  region  should  be  pursued  to  confirm  the 
hypothesis that R. gravesii occurs throughout the state. 
 
There are 23 species of ticks in WA and so far only 6 species have been shown to 
harbour R. gravesii. In addition, only one of the six species (A. triguttatum) has been 138 
 
investigated extensively. The remaining 5 species of ticks harbouring R. gravesii are 
still to be investigated to determine if they are effective reservoirs of R. gravesii and if 
they  can  act  as  vectors.  While  there  is  evidence  for  R.  gravesii  being  transmitted 
transovarially and transstadially in A. triguttatum, this may or may not occur in other 
tick species.  
 
This study focused on the relationship between ticks, rickettsiae and a large vertebrate 
mammal - the feral pig. However, WA has many other mammals that are much smaller 
in stature and less numerous. The ectoparasite burdens of these smaller mammals are 
usually different from those of the feral pig, kangaroos and other large animals that 
roam the West Australian bushland. Investigations into these smaller mammals would 
have  to  be  multi-pronged  due  to  their  diversity.  Animal  behavioural  factors  need 
consideration  as  they  are  highly  variable,  including  nocturnal,  arboreal,  burrowers, 
carnivores, omnivores, varied lifespan and geographical range of each marsupial. These 
factors may influence the tick species found on the various marsupials of WA. Species 
of ticks not observed in this study may give new insights into the ecology of R. gravesii 
and candidatus “R. antechini”.  
 
Much of the sample collecting and analysis for rickettsial organisms prior to this study 
has been opportunistic. The deliberate collection of human, feral pig and ectoparasite 
samples for rickettsial analysis is the first study of its kind in south-west WA. This has 
contributed to an increase in awareness among various groups and organisations in WA, 
either  directly  or  indirectly  linked  to  the  study  of  rickettsial  organisms  and  their 
transmission. This  increased awareness  has  seen the implementation  of strategies to 
prevent tick bites and to treat adverse reactions relating to tick infestation with more 139 
 
concern  (pers.  comm.  Whiteman  Park  staff  and  committee  members  of  Western 
Australia Rogaining Association). 
 
Rickettsia gravesii is genotypically closely related to the massiliae sub-group and this 
close relationship raises the question of how two rickettsiae geographically so far apart 
can be so closely related genetically. There are several possible explanations for such a 
close relationship but the most plausible is the introduction of a common ancestor to 
WA  by  migratory  birds.  Rickettsia  gravesii  has  retained  some  of  the  similarities 
between itself and members of the R. massiliae subgroup. However over time, and due 
to isolation, it has become distinctively different and is thus considered to be a novel 
species.  The best way to examine the close relationship between R. gravesii and its 
distant relatives would be by an in-depth investigation into its genome. Currently work 
is  being  performed  in  collaboration  with  the  Unite  de  Rickettsies  in  Marseille  to 
sequence the entire genome of R. gravesii. 
 
In  conclusion,  there  is  still  much  to  be  learned  about  the  status  and  ecology  of 
rickettsiae in WA. Some questions have been answered in this study with regards to 
SFG prevalence and R. gravesii transmission, but many questions remain unanswered; 
the wealth of information waiting to be discovered makes the discoveries of this study 
seem miniscule. Australia is indeed the “Eldorado of Rickettsiology” (Pierre Edouard 
Fournier, pers. comm.). 
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9.2  GenBank Accession Numbers 
 
Species  16S RNA  gltA  ompA  ompB  sca4 
R. aeschlimanii  U74757  U59722  U43800  AF123705  AF163006 
R. africae  L36098  U59733  U43790  AF123706  AF151724 
R. akari  L36099  U59717  NA  AF123707  AF213016 
R. australis  L36101  U59718  AF149108  AF123709  AF187982 
R. belii  L36103  U59716  NA  NA  NA 
R. canadensis  U15162  U59713  EF160122  NA  NA 
R. conorii  AF541999  U59730  U43806  AF149110  AF163008 
R. felis  L28944  AF210692  AF210694  AF210695  AF196973 
R. gravesii strain  
BWI-1 
DQ269434  DQ269435  DQ269437  DQ269438  DQ269439 
R. heilongjiangii  AF178037  AF178034  AF179362  AY260451  AY331396 
R. honei  L36220  U59726  U43809  AF123724  AF163004 
R. japonica  L36213  U59724  U43795  AF123713  AF155055 
R. massiliae  L36214  U59719  U43799  AF123714  AF163003 
R. montanensis  L36215  U74756  U43801  AF123716  AF163002 
R. parkeri  L36673  U59732  U43802  AF123717  AF155059 
R. prowazekii  M21789  M17149  NA  AF123718  AF200340 
R. raoultii  DQ365810  DQ365804  DQ365801  DQ365798  DQ365808 
R. rhipicephali  L36216  U59721  U43803  AF123719  AF155053 
R. rickettsii  L36217  U59729  U43804  X16353  AF163000 
R. sibirica  L36218  U59734  U43807  AF123722  AF155057 
R. slovaca  L36224  U59725  U43808  AF123723  AF155054 
R. tamurae  AY049981  AF394896  DQ103259  DQ113910  DQ113911 
R. typhi  L36221  U59714  NA  NC006142  NC006142 
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9.3  Rogainer Study Consent Form 
 
Note: The information sheets disseminated to the respective groups were very similar to 
each other, unlike the questionnaires. The rogainer information sheet is thus used as an 
example. The most important part of the information sheets were the Consent Form and 
Revocation of Consent Form, which is the same for all groups. 
 
 
       
 
Identification code: |_|_|_|_|_| 
 
 
STUDY OF INFECTION RISKS FROM TICKS  
 
PATIENT INFORMATION STATEMENT AND CONSENT FORM 
 
__________________________________________________________________ 
 
 
 
 
Principal Investigator:  Dr John Dyer 
Infectious Diseases Physician   
           SMAHS Infectious Diseases Service 
Level 2 B Block, Fremantle Hospital 
Alma St  
Fremantle  WA  6160 
Telephone: 08 9431 2149 
Facsimile: 08 9431 2035 
 
Contact Person:     Dr John Dyer 
Infectious Diseases Physician   
           SMAHS Infectious Diseases Service 
Level 2 B Block, Fremantle Hospital 
Alma St  
Fremantle  WA  6160 
Telephone: 08 9431 2149 
Facsimile: 08 9431 2035 
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Patient Information and Consent Form 
 
You are invited to participate in the research study outlined below. 
 
 
1.  Background to Research Study 
Before  you  decide  whether  or  not  to  take  part  in  this  research  study,  it  is 
important that you understand why the study is being done, the procedures and 
assessments you will undergo, and other important study information.  Please 
read this information carefully and, if you have further questions, please ask the 
Principal Investigator. 
 
Rickettsial  bacteria  that  are  transmitted  to  humans  by  tick  bite  may  be  an 
important  unrecognised  cause  of  infection  in  Western  Australia.  We  plan  to 
investigate  the  occurrence  of  rickettsial  infection  in  rogainers,  who  are 
frequently exposed to ticks in pursuit of their sport. Any rickettsial germs found 
as a result of these studies will be analysed in detail to determine to what extent 
they resemble other species known to cause human disease. 
 
2.  Purpose to Study 
The objective of the study is to identify transmission pathways and disease risks 
of rickettsial spotted fever in Western Australia. We wish to discover whether 
individuals engaged in activities such as rogaining, who have a high risk of tick 
contact, may have increased rates of tick-transmitted rickettsial infection. 
 
The ultimate goals of this research are: 
 
  to  identify  the  transmission  risks  and  occurrence of  rickettsial infection  in 
Western Australia 
  to reduce the risk of rickettsial transmission in individuals residing, recreating 
or working in high-risk areas 
  to develop health and safety guidelines for individuals at high risk of tick-
borne infection  
 
3.  The Study Design 
An  ethics  committee  has  examined  and  approved  this  study  before  any 
participant is allowed to enroll in the study.  A total of approximately 144 active 
rogainers recruited by advertisement through the WA Rogaining Association will 
participate. 
 
This study protocol will consist of: (a) baseline analysis of a blood test obtained 
at  the  beginning  of  the  summer  rogaining  season  to  determine  previous 
exposure to rickettsial infection, and to correlate this with the likely intensity of 
tick  exposure;  (b)  a  second  blood  test  at  least  one  month  after  the  final 
rogaining  event  of  the  summer  season  to  ascertain  any  cases  of  rickettsial 
infection, whether symptomatic or not, that may have occurred over this period 
of time. At the time of collection of the initial blood test, participants in the study 172 
 
will be asked to fill out a self-administered questionnaire to measure previous 
level of tick exposure.  
 
Participants will also  be asked to keep a diary of recognised tick exposures 
during the course of the season, and to report illnesses (especially with fever 
&/or rash) that may represent rickettsial infection to the study co-ordinator, who 
will  arrange  for  further  medical  assessment  and  investigation  as  medically 
indicated. Blood tests obtained from such symptomatic study participants will be 
sent  to  a  reference  laboratory  for  additional  testing  (culture  and  polymerase 
chain  reaction/sequencing  analysis)  so  as  to  identify  the  causative  microbe. 
Finally,  participants  will  be  asked  to  collect  ticks  to  which  they  are  exposed 
during rogaining events and submit them to the study investigators for further 
analysis  for  potentially  pathogenic microbes  at  the  School of  Veterinary  and 
Biomedical Sciences, Murdoch University. 
 
4.  Procedures 
If, after reading this information sheet and discussing the trial with the study 
investigators,  you  decide  to  take  part,  you  will  be  asked  to  sign  a  form 
confirming that you agree to participate. 
 
As part of this study you will have blood drawn (approximately 10mL or 1.5 
tablespoons) at the time of enrolment and a further 10mL sample will be taken 
one or month or more after the final event of the season. At the time of your first 
visit you will be asked to fill in a questionnaire aimed at determining your past 
level of risk for tick exposure.  
 
You will also be asked to keep a diary noting and describing any tick exposures 
during  the  course  of  the  season.  These  documents  will  be  collected  by  the 
study investigators and analysed to determine correlations between blood test 
results and intensity of tick exposure. You will also be asked to collect any ticks 
with which you come in direct contact and submit them for further analysis to 
the study investigators. 
 
 
5.  Risks of Study Procedures 
Risks of Blood Drawing 
 
As part of this study, you will have your blood drawn (approximately 10mL) at 
each  visit.  Blood  will  be  drawn  by  a  medical  doctor  (Dr.  John  Dyer),  with 
extensive experience in blood taking. This procedure is uncomfortable but rarely 
results  in  any  significant  problems.  Side  effects  that  have  been  noted  with 
drawing blood include feeling light-headed or faint, fainting, formation of a blood 
clot, bruising and/or infection at the site of the needlestick. 
 
 
6.  Benefits of Participating in the Study 
We  anticipate  increased  knowledge  of  the  presence  and  transmission  of 
rickettsial infection in WA to result in direct benefits for participants in sports 
such as rogaining that involve significant contact with the natural environment.  173 
 
 
 
7.  Study Expenses 
The only specific cost in this study will be the travel costs for attending the clinic 
on 2 occasions for study specific visits. Reimbursement for these costs will be 
available from the study co-ordinator.     
 
 
8.  Financial Support for the Study 
Financial  support  to  cover  the  costs  of  this  study  is  being  provided  by  a 
research  grant  from  the  Fremantle  Hospital  Medical  Research  Foundation. 
These  funds  are  placed  in  a  nominated  account  of  the  Hospital  and  the 
expenditure of the funds is in accordance with the approval given by the Human 
Research Ethics Committee.  The account is subject to audit by the Auditors to 
Fremantle Hospital. 
 
 
9.  Questions about the Study 
The Principal Investigator will do all that is possible to answer your questions 
and concerns as they arise. 
 
 
10. Statement of Subject Rights 
Your participation in this study is entirely voluntary.  If you decide not to take 
part or to withdraw from the study at any time, you will not be penalised nor lose 
any benefits to which you are otherwise entitled.  
 
Your doctor will have explained the details of this trial to you and answered any 
questions you may have.  You should be satisfied with the information you have 
been given and had adequate time to consider whether you want to participate.  
If you decide you would like to take part in this study, you will be asked to sign a 
consent form.  If you do not want to take part, or if you choose to withdraw from 
the trial at any time, you will continue to receive the best medical care offered 
by your doctor. 
 
All information obtained in connection with this study will remain confidential. 
You will not be identified in any publication or public presentation of data from 
this study.  Only authorised personnel from the SMAHS ethics committee will 
have access to study documents and results.  By signing this form, you give 
permission that these authorised persons may have access to study documents 
if necessary.  
 
If  new  information  becomes  available  during  the  course  of  the  study  that  is 
relevant  to  your  willingness  to  continue  taking  part  in  the  study  you  will  be 
informed promptly. 
 
If you would like more information about the study, do not hesitate to ask  
Dr John Dyer  174 
 
Contact No: 08 9431 2149 
 
If you have a problem during the study and would like to talk to an independent 
person you may contact:  
Fremantle  Hospital  Ethics  Committee  Representative  Contact  No:  08  9431 
2929. 
 
You will be given a copy of this form to keep. 
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CONSENT FORM 
1.  I, ..................................................................... of 
............................................... 
  .......................................................................,  aged  .........................  years, 
agree to participate in the experiment described in the patient information statement 
set out in the attached form. 
 
2.  I acknowledge that I have read the patient information statement, which 
explains why I have been selected, the aims of the experiment and the 
nature and the possible risks of the investigation, and the statement has 
been explained to me to my satisfaction. 
 
3.  Before signing this consent form, I have been given the opportunity of 
asking any questions relating to any possible physical and mental harm I 
might  suffer  as  a  result  of  my  participation  and  I  have  received 
satisfactory answers. 
 
4.  I understand that I can withdraw from the experiment at any time without 
prejudice to my relationship with my doctor. 
 
5.  I agree that research data gathered from the results of the study may be 
published, provided that I cannot be identified. 
 
6.  I understand that if I have any questions relating to my participation in 
this research, I may contact Dr John Dyer on 08 9431 2149, who will be 
happy to answer them. 
 
8.  I acknowledge receipt of a copy of this Consent Form and the Subject 
Information Statement. 
Complaints may be directed to (Chair of South Metropolitan Area Health 
Service – Human Research Ethics Committee on 08 9431 2929. 
 
 
__________________________       _____________________           
Signature of Participant      Please PRINT name    Date 
 
 
__________________________    __________________________       
Signature of Investigator(s)    Please PRINT name    Date 
 
 
__________________________    _________________________  
Signature of Witness      Please PRINT name    Date 
 
 
__________________________ 
Nature of Witness 
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CONSENT FORM 
REVOCATION OF CONSENT 
 
I hereby wish to WITHDRAW my consent to participate in the research proposal 
described above and understand that such withdrawal WILL NOT jeopardise 
any treatment or my relationship with my doctor. 
 
 
 
 
___________________________    _______________________ 
Signature              Date 
 
___________________________ 
Please PRINT Name 
 
 
 
 
__________________________       
Signature of Investigator(s) 
 
__________________________      ______________________ 
Please PRINT name          Date 
 
 
 
 
__________________________       
Signature of Witness 
 
__________________________      ______________________ 
Please PRINT name          Date 
 
__________________________ 
Nature of Witness 
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9.4  Rogainers’ Questionnaire 
 
       
 
 
 
Identification code: 
|_|_|_|_|_| 
 
 
 
 
 
 
 
 
STUDY OF INFECTION RISKS FROM TICKS  
QUESTIONNAIRE 
 
 
 
Thank you for your interest and co-operation in our research.  
 
The  purpose  of  this  questionnaire  is  to  find  out  whether 
rogainers are at risk from bacterial infections carried by ticks.   
 
Please  circle  the  appropriate  answer,  tick  the  box  or  enter  an 
answer as appropriate. 
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GENERAL QUESTIONS 
 
 
1. Date today:    /  / 2006 
 
 
2. Gender:   Male     Female 
 
 
3. Year of birth:  |_|_|_|_| 
 
 
4.  What  is  your  current  occupation  (please  include  paid  or  unpaid 
work):    
              
………………………………….. 
 
 
5. How long have you been an active rogainer?     
 
|_|_| Months  |_|_| Years 
 
 
6. How long have you been a member of the WARA?   
 
                  |_|_| Months  |_|_| Years 
 
 
7. On average, how many times a year do you participate in a rogaining 
event?               
|_|_| times 
 
 
8.   At what level do you currently compete in rogaining?  
 
 
………………………………….. 
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RECORD OF PAST AND CURRENT ACTIVITIES  
 
 
9.     Apart from rogaining, how often do you spend time in the bush or 
scrub for work or recreation? (please tick the answer that most applies to you) 
 
 Very frequently (5 or more days a week) 
 Frequently (1-4 days a week) 
 Often (1-3 times a month) 
 Occasionally (Less than once a month 
 I spend NO time in the bush apart from rogaining 
 
If  you  answered  “I  spend  NO  time  in  the  bush  apart  from 
rogaining ” to question 9, please go straight to question 12 
(next page). 
Otherwise, please proceed to question 10. 
 
 
 
10.   If you spend time in the bush or scrub APART from rogaining, how 
long do you usually go for?   
|_|_| hours at a time 
 
 
11. In the past 2 years, how often have you been bushwalking, hiking 
or camping in other states of Australia or overseas? (tick ALL boxes 
that apply) 
 
 
Interstate 
 
Overseas (outside Australia) 
 
 Not at all in past 2 years 
 
 
 Not at all in past 2 years  
 
 Less than once a year  
            Which 
state(s)/territories?………… 
 
 
 Less than once a year  
       Which 
country/countries?………… 
 
  About once a year  
             Which 
state(s)/territories?………… 
 
  About once a year  
         Which 
country/countries?………… 
 
 
  More than once a year  
      Which state(s)/territories?………… 
 
 
  More than once a year  
           Which 
country/countries?………… 
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RECORD OF TICK BITES  
 
12.   IN THE PAST 2 YEARS, have you EVER been bitten by a tick?
   
  Yes                        No (Go to Q13)   Not sure (Go to Q13)
        If YES: 
 
a.  In which month and year did this occur? (e.g. Feb 2005) 
     
                ……/………. 
b.  Where were you when this occurred?   
                                             Location (eg name of park or district): ……………. 
                     State: ……………. 
 
c. In which part(s) of your body did the bite(s) occur? (TICK ALL THAT 
APPLY) 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders  
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
                                                                  
d.   Did you remove the tick yourself?  
 Yes   
 No: removed at a medical clinic     
 No : removed by someone else: who?.........                     
 
e.  Did you suffer a reaction to the tick bite?   
 Yes        
 No (Go to question 12g)        
Not sure (Go to question 12g) 
 
f.  What was the nature of the reaction to the tick bite? 
 
Nature of reaction  Please tick any symptoms that 
you have had 
Immediate (up to a couple of days after the tick bite) 
- Swelling of the skin around the bite   
- Tenderness of the skin around the bite   
- Discharge, pus or fluid coming out of the skin around the 
bite 
 
In the 7-14 days after tick bite 
- Headache   
- Fever or chills   
- Rash   TICK ALL THAT APPLY 
 around the bite 
 on chest, back or abdomen 
(stomach region) 
 hands, arms or shoulders 
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
- Aching in joints, limbs, back or neck without reason   
- Tiredness/ Feeling „out of energy‟ without reason   
- Shortness of breath or difficulty breathing without reason   
- Blistering/scabbing around skin area where bitten   181 
 
g. Did you seek medical advice for the tick bite?   
                                             Yes                
                                                    No                       
                                                    Not sure 
 
h. Were you treated with antibiotics after the tick bite?    
                                Yes                
                                                    No                       
                                                    Not sure 
 
 ADDITIONAL DETAILS: PLEASE ANSWER THESE QUESTIONS 
FOR ANY OTHER TICK BITES THAT OCCURRED IN THE LAST 2 
YEARS 
 
a.  In which month and year did this occur? (e.g. Feb 2005) 
     
                ……/………. 
b.  Where were you when this occurred?   
                                           Location (eg name of park or district): 
……………. 
                 State: ……………. 
 
c. In which part(s) of your body did the bite(s) occur? (TICK ALL THAT 
APPLY) 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders  
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
                                                                  
d.   Did you remove the tick yourself?  
 Yes   
 No: removed at a medical clinic     
 No : removed by someone else: who?.........                     
 
e.  Did you suffer a reaction to the tick bite?   
 Yes        
 No (Go to question g)        
Not sure (Go to question g) 
 
f.  What was the nature of the reaction to the tick bite? 
 
Nature of reaction  Please tick any symptoms that 
you have had 
Immediate (up to a couple of days after the tick bite) 
- Swelling of the skin around the bite   
- Tenderness of the skin around the bite   
- Discharge, pus or fluid coming out of the skin around the 
bite 
 
In the 7-14 days after tick bite 
- Headache   
- Fever or chills   
- Rash   TICK ALL THAT APPLY 
 around the bite 
 on chest, back or abdomen 
(stomach region) 
 hands, arms or shoulders 182 
 
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
- Aching in joints, limbs, back or neck without reason   
- Tiredness/ Feeling „out of energy‟ without reason   
- Shortness of breath or difficulty breathing without reason   
- Blistering/scabbing around skin area where bitten   
 
g. Did you seek medical advice for the tick bite?   
                                             Yes                
                                                    No                       
                                                    Not sure 
 
h. Were you treated with antibiotics after the tick bite?    
                                 Yes                
                                                    No                       
                                                    Not sure 
 
13.  Have you EVER experienced any of the following symptoms 
since you started rogaining?  
 
Nature of 
reaction 
Please 
tick any 
sympto
ms that 
you 
have 
had 
How many 
times have 
these symptoms 
occurred since 
you began 
rogaining? 
What 
time of 
the year 
did these 
symptom
s occur?  
(eg. 
February) 
Do you 
remember being 
bitten by a tick 
anytime in the 
fortnight before 
these symptoms 
developed? 
 
Skin swelling/ 
tenderness 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
   No                      
  Can‟t remember 
 
Prolonged headache   Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Rash on the arms or 
chest 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
General aching in 
joints, limbs, back or 
neck without reason 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Prolonged tiredness/ 
Feeling „out of energy‟ 
without reason 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Fever or chills    Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Shortness of breath or 
difficulty breathing 
without reason 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
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OTHER MEDICAL HISTORY 
 
 
14. Do you have any major medical conditions?                  
 
  Yes                  No                        
 
 If YES: Please describe 
……………………………….…………………… 
 
 …………………………………………………… 
 
 
 
15. Are you routinely on any medications or treatments?       
 
 Yes           No 
 
 
If YES:  
a. What is the name of the medication?  
 
……………………………….…………………… 
 
…………………………………………………… 
       
   b. What condition or health problem do you take this for? 
……………………………….…………………… 
 
…………………………………………………… 
       
 
 
 
 
 
 
 
 
Thank you for taking the time to complete this survey. 
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9.5  Rogainers’ Follow-up Questionnaire 
 
       
 
 
 
Identification code: |_|_|_|_|_| 
 
 
 
 
 
STUDY OF INFECTION RISKS FROM TICKS  
QUESTIONNAIRE 
 
 
 
 
Thank you for your interest and co-operation in our research.  
 
The purpose of this questionnaire is to find out whether 
rogainers are at risk from bacterial infections carried by ticks.   
 
 
 
Date today:   |_|_|  /|_|_|       / 2008 
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GENERAL QUESTIONS 
 
 
1.  What  is  your  current  occupation  (please  include  paid  or  unpaid 
work):    
              
………………………………….. 
 
 
2. Are you still an active rogainer?     
 
|_|_| Months  |_|_| Years 
 
 
3. Are you still a member of the WARA?   
 
                  |_|_| Months  |_|_| Years 
 
 
4. On average, how many times in the past year do you participate in a 
rogaining event?               
|_|_| times 
 
 
5. When you are at a rogaining event, in the past year, do you usually 
complete: 
  
 The full course 
 Part of the course 
 Other……………………….. 
 
6. On average, in the past year, how long do you participate in an 
event for?  
 
|_|_| hours |_|_| minutes 
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RECORD OF PAST AND CURRENT ACTIVITIES 
 
 
 
7. Apart from rogaining, in the past year how often do you spend time 
in the bush or scrub for work or recreation? (please tick the answer that 
most applies to you) 
 
 Very frequently (5 or more days a week) 
 Frequently (1-4 days a week) 
 Often (1-3 times a month) 
 Occasionally (Less than once a month) 
 I spend NO time in the bush apart from rogaining 
 
If  you  answered  “I  spend  NO  time  in  the  bush  apart  from 
rogaining”  to  question  9,  please  go  straight  to  question  12 
(next page). 
Otherwise, please proceed to question 10. 
 
 
 
8.  If you spend time in the bush or scrub APART from rogaining, what 
activities are you involved in and how long do you usually go for?   
Activity………………………………………|_|_| hours at a time 
Activity………………………………………|_|_| hours at a time 
Activity………………………………………|_|_| hours at a time 
 
 
9. In the past year, how often have you been bushwalking, hiking or 
camping in bushland, forests or other wilderness areas in other states 
of Australia or overseas? (tick ALL boxes that apply) 
 
 
Interstate 
 
Overseas (outside Australia) 
 
 Not at all in the past year 
 
 
 Not at all in the past year 
 
  Once  
             Which 
state(s)/territories?………… 
 
  Once  
         Which 
country/countries?………… 
 
 
  More than once  
      Which state(s)/territories?………… 
 
 
  More than once  
           Which 
country/countries?………… 
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RECORD OF TICK BITES 
 
10.    IN THE PAST YEAR, how often are you been bitten by         ticks 
while rogaining or doing any other activity in bushland?  
This  refers  to  tick  bites  that  may  have  occurred  while  in  Australia  or 
overseas. 
   Most or every time I am in the bush (more than 75% of the time) 
 Often when I am in the bush (25-75% of the time) 
 Occasionally when I am in the bush (Less than 25% of the time) 
 Never (Go to Q13)   
 Not sure (Go to Q13)   
 
If the subject answered “Never” or “Not sure” to question 12, please go 
straight to question 13. Otherwise, please proceed. 
                                                               
a. In which months do the bites usually occur? (e.g. Mar-May) ……. 
 
b.  In what locations were you when you were bitten by ticks IN THE 
PAST YEAR?  This includes while rogaining or doing some other 
activity.  
           
      Location (eg name of park or district): …………….State: ……………. 
       What was the activity?  rogaining  
                                                                                        other.......................... 
 
                Location (eg name of park or district): …………….State: ……………. 
 What was the activity?  rogaining  
                                                                                        other.......................... 
 
c. In which part(s) of your body do the bite(s) usually occur? (TICK ALL 
THAT APPLY) 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders  
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
 
d. Have you experienced any of the following after tick bites IN THE 
PAST YEAR?   
 
Nature of reaction  Please tick any symptoms that you have 
had 
Immediate (up to a couple of days after tick bites) 
- Swelling of the skin around the bite   Most or every time I get bitten (more than 75% of the time) 
 Often when I get bitten (25-75% of the time) 
 Occasionally when I get bitten (Less than 25% of the time) 
 Never   
 Not sure  
- Tenderness of the skin around the bite   Most or every time I get bitten (more than 75% of the time) 
 Often when I get bitten (25-75% of the time) 
 Occasionally when I get bitten (Less than 25% of the time) 
 Never   
 Not sure  
- Discharge, pus or fluid coming out of 
the skin around the bite 
 Most or every time I get bitten (more than 75% of the time) 
 Often when I get bitten (25-75% of the time) 
 Occasionally when I get bitten (Less than 25% of the time) 
 Never   
 Not sure  
- Itchiness around the bite   Most or every time I get bitten (more than 75% of the time) 
 Often when I get bitten (25-75% of the time) 
 Occasionally when I get bitten (Less than 25% of the time) 
 Never   
 Not sure  188 
 
 
At any time during the 2 weeks after tick bites 
- Prolonged headache (> 3 days)*   When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Fever or chills*   When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Rash over any part or all of your body*   TICK ALL THAT APPLY 
 around the bite 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders 
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Tender or painful „glands‟ (lumps or 
nodes under the skin, usually away from 
the bite mark)* 
TICK ALL THAT APPLY 
 in the groin 
 in the armpits 
 in the neck 
 other; where_____________ 
 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Aching in joints, limbs, back or neck 
without reason* 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Tiredness/ Feeling „out of energy‟ 
without reason* 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Shortness of breath or difficulty 
breathing without reason* 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Blistering/scabbing around skin area 
where bitten* 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
 
If the subject answered “At any time in the 2 weeks after the tick bite” to 
ANY OF THE SYMPTOMS, please continue. Otherwise, please go straight 
to question 13. 
 
I would like to ask you in more detail about the [*symptoms/symptoms] 
which occurred in ……/………. (START WITH THE EARLIEST DATE). 
Thinking back to the tick bites that occurred in the two weeks before 
these symptoms:                  
  e.  In what locations were you when you were bitten by ticks in [date]…/….?   
      Location (eg name of park or district): …………….State: ……………. 
       What was the activity?  rogaining  
                                                                                        other.......................... 
 
f. In which part(s) of your body did the bite(s) occur? (TICK ALL THAT APPLY) 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders  
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 189 
 
g.   Did you remove the tick(s) yourself?  
 Yes   
 No: removed at a medical clinic     
 No : removed by someone else: who?.........                     
 
h. Did you seek medical advice for the tick bite(s)?   
                                                  Yes                
                                                  No                       
                                                  Not sure 
   
i. Were you treated with antibiotics after the tick bite(s)?    
                                                  Yes                
                                                  No                       
                                                  Not sure 
 
 
 
 
NOW PROCEED TO THE NEXT DATE ON THE TABLE ABOVE:  
I  would  now  like  to  ask  you  about  the  [*symptoms/symptoms]  which 
occurred in ……/………. Thinking back to the tick bites that occurred in 
the two weeks before these symptoms:         
                 
e.  In what locations were you when you were bitten by ticks in [date]…/….?   
    Location (eg name of park or district): …………….State: ……………. 
 What was the activity?  rogaining  
                                                                                        other.......................... 
 
f. In which part(s) of your body did the bite(s) occur? (TICK ALL THAT APPLY) 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders  
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
 
g.   Did you remove the tick(s) yourself?  
 Yes   
 No: removed at a medical clinic     
 No : removed by someone else: who?.........                     
 
h. Did you seek medical advice for the tick bite(s)?   
                                                  Yes                
                                                  No                       
                                                  Not sure 
   
i. Were you treated with antibiotics after the tick bite(s)?    
                                                  Yes                
                                                  No                       
                                                  Not sure 
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NOW PROCEED TO THE NEXT DATE ON THE TABLE ABOVE: 
I  would  now  like  to  ask  you  about  the  [*symptoms/symptoms]  which 
occurred in ……/………. Thinking back to the tick bites that occurred in 
the two weeks before these symptoms:         
                 
  e.  In what locations were you when you were bitten by ticks in [date]…/….?   
    Location (eg name of park or district): …………….State: ……………. 
       What was the activity?  rogaining  
                                                                                        other.......................... 
 
f. In which part(s) of your body did the bite(s) occur? (TICK ALL THAT APPLY) 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders  
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
 
g.   Did you remove the tick(s) yourself?  
 Yes   
 No: removed at a medical clinic     
 No : removed by someone else: who?.........                     
 
h. Did you seek medical advice for the tick bite(s)?   
                                                  Yes                
                                                  No                       
                                                  Not sure 
   
i. Were you treated with antibiotics after the tick bite(s)?    
                                                  Yes                
                                                  No                       
                                                  Not sure 191 
 
11.  APART  FROM  ANY  SYMPTOMS  YOU  HAVE  MENTIONED 
ALREADY,  have  you  EVER  experienced  any  of  the  following 
symptoms? This may not necessarily be associated with a tick bite that 
you recall.  
Nature of 
reaction 
Please 
tick any 
symptom
s that you 
have had 
How many 
times have 
these symptoms 
occurred since 
you began 
rogaining? 
What 
time of 
the year 
did these 
symptom
s occur?  
(eg. 
February) 
Do you remember 
being bitten by a 
tick anytime in the 
2 weeks before 
these symptoms 
developed? 
 
Skin swelling/ 
tenderness 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
   No                      
  Can‟t remember 
 
Prolonged headache 
(> 3 days) 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Rash over parts or all 
of my body 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
TICK ALL THAT 
APPLY 
 around the bite 
 on chest, back or 
abdomen (stomach 
region) 
 hands, arms or 
shoulders 
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
 
    Yes             
  No                      
  Can‟t remember 
 
General aching in 
joints, limbs, back or 
neck without reason 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Prolonged tiredness/ 
Feeling „out of energy‟ 
(> 3 days) without 
reason 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Fever or chills    Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Shortness of breath or 
difficulty breathing 
without reason 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
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12.  APART  FROM  ANY  SYMPTOMS  YOU  HAVE  MENTIONED 
ALREADY  IN  THE  PAST  YEAR,  have  you  EVER  experienced  any 
other symptoms after spending time in the bush in Western Australia, 
Australia, or overseas? 
 
What symptoms did 
you experience? 
Year  In what locations were 
you when you 
experienced this? 
 
   
Location (eg name of park or district):  
…………….State: ……………. 
  
What  was  the  activity?          
.......................... 
   
Location (eg name of park or district):  
…………….State: ……………. 
  
What  was  the  activity?          
.......................... 
   
Location (eg name of park or district):  
…………….State: ……………. 
  
What  was  the  activity?          
.......................... 
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OTHER MEDICAL HISTORY 
 
 
13. Do you have any major medical conditions?                  
 
  Yes                  No                        
 
 If YES: Please describe 
……………………………….…………………… 
 
         …………………………………………………… 
 
14. Are you routinely on any medications or treatments?       
 
 Yes           No 
If YES:  
a. What is the name of the medication?  
……………………………….…………………… 
…………………………………………………… 
       
   b. What condition or health problem do you take this for? 
……………………………….…………………… 
…………………………………………………… 
       
 
 
Thank you for taking the time to complete this survey. 
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9.6  Whiteman Park Workers’ Questionnaire 
 
 
       
 
 
 
Identification code: |_|_|_|_|_| 
 
 
 
 
 
 
 
 
W WH HI IT TE EM MA AN N   P PA AR RK K   H HE EA AL LT TH H   A AN ND D   
S SA AF FE ET TY Y      
Q QU UE ES ST TI IO ON NN NA AI IR RE E   
 
 
 
 
 
Thank you for your interest and co-operation in our research. We are a group of 
doctors  and  veterinarians from  the  Division  of  Health  at  Murdoch  University, 
Fremantle Hospital, and the School of Population Health at the University of 
Western Australia and are looking at whether contact with ticks affects human 
health.  
 
We have a particular interest in a range of diseases which ticks can carry and 
transmit  to  people,  such  as  Q  fever,  Flinders  Island  spotted  fever  and 
Queensland tick typhus in other parts of Australia. 
 
It is not known whether any of these problems exist in Western Australia. The 
information you give us is vital to understanding whether such diseases affect 
humans and what activities may affect a person‟s chances of catching them. 
The  research  you  are  involved  in  has  never  been  done  before  in  Western 
Australia. 
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GENERAL QUESTIONS 
 
 
1. Date today:    /  / 2006 
 
 
2. Gender:   Male     Female 
 
 
3. Year of birth:  |_|_|_|_| 
 
 
4. What is your current job/role in Whiteman Park:  
   
              
………………………………….. 
 
 
5. What are the main work tasks you do in this job?      
 
…………………………………………………………………………………… 
 
………………..………………………………………………………………… 
 
………………………………………………………………….………………… 
 
 
6. How long have you worked in Whiteman Park?   
   
                  |_|_| Months  |_|_| Years 
 
 
7.  Approximately  how  many  days  or  weeks  a  year  do  you  work  in 
Whiteman Park?   
 
|_|_|_| Days   OR |_|_| Weeks 
             
 
 
8.   Approximately how long do you spend on the park on an average 
working day? 
 
|_|_| Hours 
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RECORD OF PAST AND CURRENT ACTIVITIES IN 
WHITEMAN PARK 
 
 
 
9.     While you are in Whiteman Park, how often do you go into the 
bush or scrub for work? (please tick the answer that most applies to you) 
 
 Very frequently (5 or more days a week) 
 Frequently (1-4 days a week) 
 Often (1-3 times a month) 
 Occasionally (Less than once a month) 
 I spend NO time in the bush for work 
 
 
10.  While you are in Whiteman Park, how often do you go into the 
bush or scrub for recreation (eg bush walking)?  
(please tick the answer that most applies to 
you) 
 
 Very frequently (5 or more days a week) 
 Frequently (1-4 days a week) 
 Often (1-3 times a month) 
 Occasionally (Less than once a month) 
 I spend NO time in the bush for recreation 
 
If you answered “I spend NO time in the bush” to question 9 AND 
10, please go straight to QUESTION 17. 
Otherwise, please proceed to QUESTION 11. 
 
11. How long do you spend in the bush on an average day?  
 
 No time 
 Less than 1 hour              
 1 to 3 hours          
 Greater than 3 hours 
 
 
12. Is time you spend in the bush in Whiteman Park: 
 
 Mainly for work reasons 
 Mainly recreational reasons              
 Equally related to work and recreation        
 
 
13. How often do you wear short-sleeved shirts and/or shorts during 
recreational time spent in bush or scrub in Whiteman Park?  
                 
 Every time I go out for recreational reasons 
 Often (50% or more of the time I go out for recreational reasons) 
 Sometimes (less than 50% of the time I go out for recreational reasons) 
 Never 
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14. How often do you see animals (such as marsupials) or evidence 
that they have been there? 
 
 Every time I go out                            if so, What animals?  
…………………………………..  
 Often (50% or more of the time I go out)             if so, What animals?  
………………………………….. 
 Sometimes (less than 50% of the time I go out  )  if so, What animals?  
………………………………….. 
 Never 
 
15. How often do you find ticks on yourself after time spent in the bush 
in Whiteman Park?          
 
 Every time I go out 
 Often (50% or more of the time I go out) 
 Sometimes (less than 50% of the time I go out) 
 Never 
 
 
16. How often do you apply tick repellent before spending time in the 
bush or scrub? 
                        
 Every time I go out 
 Often (50% or more of the time I go out) 
 Sometimes (less than 50% of the time I go out  ) 
 Never 
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17. In the past 2 years, how often have you been bushwalking, hiking, 
camping or working in the bush or forest in other parts of Australia or 
overseas? This does NOT include your time in Whiteman Park.  
 
 
 
Bushwalking, hiking, camping or working 
in the bush or forest in other parts of 
Western Australia (except for 
Whiteman Park) or interstate 
 
(please tick the answer  
that most applies to you) 
 
 
Bushwalking, hiking, camping or working 
in the bush or forest overseas (outside 
Australia) 
 
 
(please tick the answer  
that most applies to you) 
 
 Not at all in past 2 years 
 
 
 Not at all in past 2 years  
 
 Less than once a year  
            Which 
state(s)/territories?………… 
 
 
 Less than once a year  
       Which 
country/countries?………… 
 
  About once a year  
             Which 
state(s)/territories?………… 
 
  About once a year  
         Which 
country/countries?………… 
 
 
  More than once a year  
      Which state(s)/territories?………… 
 
 
  More than once a year  
           Which 
country/countries?………… 
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RECORD OF TICK BITES 
 
18. IN THE PAST 2 YEARS, how often have you been bitten by         
ticks? This refers to tick bites that may have occurred while in Whiteman Park, 
or while in some other location in Australia or overseas. 
 
 Most or every time I am in the bush (more than 75% of the time) 
 Often when I am in the bush (25-75% of the time) 
 Occasionally when I am in the bush (Less than 25% of the time) 
 Never (Go to Q19)   
 Not sure (Go to Q19)   
 If the subject answered “Never I spend no time in the bush part from work 
at  Whiteman  Park”  or  “Not  sure”  to  question  18,  please  go  straight  to 
question 19. Otherwise, please proceed. 
                                                               
a. In which months do the bites usually occur? (e.g. Mar-May) ……. 
 
b. In what locations have you been training when you were bitten by ticks IN 
THE PAST 2 YEARS?  (TICK ALL THAT APPLY) 
 
 in Whiteman Park 
 elsewhere in Australia or overseas  
                           Location (eg name of area, park or district): ……………. 
                  State: …………….              Country: ……………. 
 
c. In which part(s) of your body do the bite(s) usually occur? (TICK ALL THAT 
APPLY) 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders  
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
 
d. Have you experienced any of the following after tick bites IN THE PAST 2 
YEARS?   
Nature of reaction  Please tick any symptoms that you have 
had 
Immediate (up to a couple of days after tick bites) 
 
- Local swelling of the skin around the 
bite 
 Most or e very time I get bitten (more than 75% of the time) 
 Often when I get bitten (25-75% of the time) 
 Occasionally when I get bitten (Less than 25% of the time) 
 Never   
 Not sure  
 
- Tenderness of the skin around the bite   Most or e very time I get bitten (more than 75% of the time) 
 Often when I get bitten (25-75% of the time) 
 Occasionally when I get bitten (Less than 25% of the time) 
 Never   
 Not sure  
 
- Discharge, pus or fluid coming out of 
the skin around the bite 
 Most or e very time I get bitten (more than 75% of the time) 
 Often when I get bitten (25-75% of the time) 
 Occasionally when I get bitten (Less than 25% of the time) 
 Never   
 Not sure  
 
- Itchiness around the bite   Most or e very time I get bitten (more than 75% of the time) 
 Often when I get bitten (25-75% of the time) 
 Occasionally when I get bitten (Less than 25% of the time) 
 Never   
 Not sure  
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At any time during the 2 weeks after tick bites  
- Prolonged headache (> 3 days)*   When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Fever or chills*   When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Rash*   TICK ALL THAT APPLY 
 around the bite 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders 
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Tender or painful „glands‟ (lumps or 
nodes under the skin, usually away from 
the bite mark)* 
TICK ALL THAT APPLY 
 in the groin 
 in the armpits 
 in the neck 
 other; where_____________ 
 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Aching in joints, limbs, back or neck 
without reason* 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Tiredness/ Feeling „out of energy‟ 
without reason* 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Shortness of breath or difficulty 
breathing without reason* 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Blistering/scabbing around skin area 
where bitten* 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
 
If the subject answered “At any time in the 2 weeks after the tick bite” to 
ANY OF THE SYMPTOMS, please continue. Otherwise, please go straight 
to question 13. 
 
I would like to ask you about the [*symptoms/symptoms] which occurred in 
……/………. (START WITH THE EARLIEST DATE). Thinking back to the 
tick bites that occurred in the two weeks before these symptoms:   
                   
e. Where were you when you were bitten?        
 in Whiteman Park 
 elsewhere in Australia or overseas  
                           Location (eg name of area, park or district): ……………. 
                  State: …………….              Country: ……………. 
 
f. In which part(s) of your body did the bite(s) occur? (TICK ALL THAT 
APPLY) 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders  
 feet or legs 201 
 
 on neck, face or scalp 
 on groin or buttocks 
 
g.   Did you remove the tick(s) yourself?  
 Yes   
 No: removed at a medical clinic     
 No : removed by someone else: who?.........                     
 
h. Did you seek medical advice for the tick bite(s)?   
                                             Yes                
                                             No                       
                                             Not sure 
 
i. Were you treated with antibiotics after the tick bite(s)?    
            Yes                
                                No                       
                                Not sure 
 
      j. Did you miss any work because of the tick bite(s)? 
                                           Yes  if yes, How many days in total? . . . . . . . . . .   
                                               No                       
 
 
NOW PROCEED TO THE NEXT DATE ON THE TABLE ABOVE: I would 
now  like  to  ask  you  about  the  [*symptoms/symptoms] which  occurred  in 
……/………. Thinking back to the tick bites that occurred in the two weeks 
before these symptoms:               
         
e. Where were you when you were bitten?        
 in Whiteman Park  
 elsewhere in Australia or overseas  
                           Location (eg name of area, park or district): ……………. 
                  State: …………….              Country: ……………. 
 
f. In which part(s) of your body did the bite(s) occur? (TICK ALL THAT 
APPLY) 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders  
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
 
g.   Did you remove the tick(s) yourself?  
 Yes   
 No: removed at a medical clinic     
 No : removed by someone else: who?.........                     
 
h. Did you seek medical advice for the tick bite(s)?   
                                             Yes                
                                             No                       
                                             Not sure 
 
i. Were you treated with antibiotics after the tick bite(s)?    
           Yes                
                               No                       
                               Not sure 
 
      j. Did you miss any work because of the tick bite(s)? 
                                          Yes  if yes, How many days in total? . . . . . . . . . .   
                                              No                       202 
 
NOW PROCEED TO THE NEXT DATE ON THE TABLE ABOVE: I would 
now  like  to  ask  you  about  the  [*symptoms/symptoms] which  occurred  in 
……/………. Thinking back to the tick bites that occurred in the two weeks 
before these symptoms:               
           
e. Where were you when you were bitten?        
                      in Whiteman Park 
 elsewhere in Australia or overseas  
                           Location (eg name of area, park or district): ……………. 
                  State: …………….              Country: ……………. 
 
f. In which part(s) of your body did the bite(s) occur? (TICK ALL THAT 
APPLY) 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders  
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
 
g.   Did you remove the tick(s) yourself?  
 Yes   
 No: removed at a medical clinic     
 No : removed by someone else: who?.........                     
 
h. Did you seek medical advice for the tick bite(s)?   
                                             Yes                
                                             No                       
                                             Not sure 
 
i. Were you treated with antibiotics after the tick bite(s)?    
            Yes                
                                No                       
                                Not sure 
 
      j. Did you miss any work because of the tick bite(s)? 
                                            Yes  if yes, How many days in total? . . . . . . . . . .   
                                                No                       203 
 
19.  APART  FROM  ANY  SYMPTOMS  YOU  HAVE  MENTIONED 
ALREADY, have you EVER experienced any of the following since you 
started working in Whiteman Park?  
 
(Please tick all the symptoms you have had and answer the questions in that row. 
If you haven‟t had any of the following symptoms then please go straight to 
question 20) 
 
Nature of 
reaction 
Please 
tick any 
symptoms 
that you 
have had 
How many times 
have these 
symptoms occurred 
since you started 
working in 
Whiteman Park? 
What time of 
the year did 
these 
symptoms 
occur?  (eg: 
February) 
Do you remember 
being bitten by a tick 
anytime in the 2 weeks 
before these symptoms 
developed? 
 
Skin swelling/ 
tenderness 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
   No                      
  Can‟t remember 
 
Prolonged headache 
(> 3 days) 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Rash over parts or all 
of my body 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
 
TICK ALL THAT 
APPLY 
 around the bite 
 on chest, back or 
abdomen (stomach 
region) 
 hands, arms or 
shoulders 
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
 
    Yes             
  No                      
  Can‟t remember 
 
General aching in 
joints, limbs, back or 
neck without reason 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Prolonged tiredness/ 
Feeling „out of energy‟ 
(> 3 days) without 
reason 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Fever or chills    Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Shortness of breath or 
difficulty breathing 
without reason 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
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CHEMICAL EXPOSURE HISTORY 
 
20. Are you routinely in contact with any potentially toxic or dangerous 
chemicals  either  in  or  out  of  work  hours?  (e.g.  pesticides,  herbicides, 
fungicides, industrial cleaners etc.) 
 
 Yes                  No                        
If YES: Please describe type or names of chemicals  
 
…………………….…………………… 
 
Between which years did you use these chemicals? |_|_|_|_| - |_|_|_|_| 
        
During this time, how often were/are you exposed? 
 
   Daily 
   Weekly 
   Monthly 
      
Approximately how many minutes or hours are you in contact with these 
chemicals at a time?  
 
|_|_| Hours  OR |_ |_|_| Minutes 
 
21. Have you ever been involved in an accident involving  potentially 
toxic or dangerous chemicals? 
(e.g. pesticides, herbicides, fungicides) 
 
 Yes                  No            
If YES: Please describe type or names of chemicals  
 
…………………….……………… 
             
In which year did this occur?      |_|_|_|_| 
 
Approximately how many minutes or hours are you in contact with these 
chemicals?  
 
|_|_| Hours  OR |_ |_|_| Minutes 
         
        Were you given/seek medical attention after the incident? 
 
   Yes                  No            
  If YES: Were you ever diagnosed with any illness related to the  
 
accident, please describe 
…………………….…………………… 
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MEDICAL HISTORY 
 
 
 
22.  I  would  now  like  to  ask  you  about  whether  you  have  had  any 
particular kinds of infections in the past few years. In the past 5 years, 
Have  you  ever  been  diagnosed  with  an  attack  of  gastroenteritis 
(„gastro‟‟/ a stomach infection)?  
 
 Yes                  No                        
 
 If YES:  
 
         Date or Year of diagnosis ……………… 
 
        Was the cause of the infection or the bug ever  identified?  If yes: 
what was the cause/ name of the 
bug……………………………….…………………… 
 
         
        Were you prescribed any medication after this illness?         
 
 Yes                  No                        
 
If YES: Please describe ……………………………………… 
 
23.  In  the  past  5  years,  have  you  ever  been  diagnosed  with  any 
infections of the urinary tract, including the kidney, bladder or urethra 
(which is the tube that drains the bladder)?  
 
 Yes                  No                        
 
 If YES:  
 
         Date or Year of diagnosis ……………… 
 
        Was the cause of the infection or the bug ever  identified?  If yes: 
what was the cause/ name of the 
bug……………………………….…………………… 
 
         
        Were you prescribed any medication after this illness?         
 
 Yes                  No                        
 
If YES: Please describe ……………………………………… 
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24. I am now going to read out a list of medical conditions that you may 
or may not have had in the past. Do not worry if you have not heard of 
many of them. Have you ever been diagnosed with any of the following 
medical conditions? (tick for any that apply)  
 
 Unexplained pain, redness or irritation of one or both eyes in the past 
5 years 
                     yes: Date or Year of diagnosis ……………… 
Are you taking any prescribed medication for this condition?         
               Yes                  No                        
       If YES: Please describe 
……………………………………… 
 
 ankylosing spondylitis (AS)  
If yes: Date or Year of diagnosis ……………… 
Are you taking any prescribed medication for this condition?         
               Yes                  No                        
       If YES: Please describe 
……………………………………… 
 
  rheumatoid  arthritis  (this  is  different  from  so-called  'wear-and-tear' 
arthritis, or osteoarthritis) 
If yes: Date or Year of diagnosis ……………… 
Are you taking any prescribed medication for this condition?         
               Yes                  No                        
       If YES: Please describe 
……………………………………… 
 
 Reiter‟s disease (INTERVIEWER NOTE: may need to spell out) 
If yes: Date or Year of diagnosis ……………… 
Are you taking any prescribed medication for this condition?         
               Yes                  No                        
       If YES: Please describe 
……………………………………… 
 
 Crohn‟s disease or ulcerative colitis 
If yes: Date or Year of diagnosis ……………… 
Are you taking any prescribed medication for this condition?         
               Yes                  No                        
       If YES: Please describe 
……………………………………… 
 
 Psoriasis 
If yes: Date or Year of diagnosis ……………… 
Are you taking any prescribed medication for this condition?         
               Yes                  No                        207 
 
       If YES: Please describe 
……………………………………… 
 
25. Apart from those mentioned, have you ever been diagnosed with 
arthritis or any long-term joint, back or neck conditions ? 
 
  Yes                  No                        
 
 If YES: Please describe which joints or parts of your neck or spine 
are affected 
 ……………………………….…………………… 
         
        Date or Year of diagnosis ……………… 
 
 
        Are you still experiencing this medical condition?  Yes                  
No                        
 
 
                     Are you taking any prescribed medication for this condition?         
 Yes                  No                        
If YES: Please describe ……………………………………… 
 
 
 
26.  Have  any  of  your  close  family  members  and/or  relatives  been 
diagnosed with any form of arthritis or any long-term joint, back or neck 
conditions? 
 
 
 Yes           No 
 
If YES:  
 
a. What is his/her relation to you? 
 
……………………………….…………………… 
 
 
b. What is the name of the condition?  
 
……………………………….…………………… 
 
…………………………………………………… 
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OTHER MEDICAL HISTORY 
 
 
 
27. Do you have any major medical conditions not already mentioned?                  
 
  Yes                  No                        
 
 If YES: Please describe 
……………………………….…………………… 
 
         …………………………………………………… 
 
 
 
28.  Are  you  routinely  on  any  medications  or  treatments  not  already 
mentioned?       
 
 Yes           No 
 
If YES:  
 
a. What is the name of the medication?  
 
……………………………….…………………… 
 
…………………………………………………… 
       
   b. What condition or health problem do you take this for? 
……………………………….…………………… 
 
…………………………………………………… 
       
 
 
 
 
Thank you for the time to complete this survey. 
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9.7  Whiteman Park Workers’ Follow-up Questionnaire 
 
 
       
 
 
Identification code: |_|_|_|_|_| 
 
 
 
 
 
 
 
WHITEMAN PARK 
STUDY OF INFECTION RISKS FROM TICKS  
QUESTIONNAIRE 
 
 
 
 
Thank you for your interest and co-operation in our research.  
 
The  purpose  of  this  questionnaire  is  to  find  out  whether 
rogainers are at risk from bacterial infections carried by ticks.   
 
 
 
 
Date today:   |_|_|  /|_|_|       / 2008 
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GENERAL QUESTIONS 
 
 
1. What is your current job/role in Whiteman Park:  
   
              
………………………………….. 
 
 
2. What are the main work tasks you do in this job?      
 
…………………………………………………………………………………… 
 
………………..………………………………………………………………… 
 
………………………………………………………………….………………… 
 
 
3. How long have you worked in Whiteman Park?   
   
                  |_|_| Months  |_|_| Years 
 
 
4.  Approximately  how  many  days  or  weeks  a  year  do  you  work  in 
Whiteman Park?   
 
|_|_|_| Days   OR |_|_| Weeks 
             
 
 
5.   Approximately how long do you spend on the park on an average 
working day? 
 
|_|_| Hours 
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RECORD OF PAST AND CURRENT ACTIVITIES IN 
WHITEMAN PARK IN THE PAST YEAR 
 
 
6.     While you are in Whiteman Park in the past year, how often do 
you go into the bush or scrub for work? (please tick the answer that most 
applies to you) 
 
 Very frequently (5 or more days a week) 
 Frequently (1-4 days a week) 
 Often (1-3 times a month) 
 Occasionally (Less than once a month) 
 I spend NO time in the bush for work 
 
 
7.  While you are in Whiteman Park in the past year, how often do you 
go into the bush or scrub for recreation (eg bush walking)?  
(please tick the answer that most applies to 
you) 
 
 Very frequently (5 or more days a week) 
 Frequently (1-4 days a week) 
 Often (1-3 times a month) 
 Occasionally (Less than once a month) 
 I spend NO time in the bush for recreation 
 
If you answered “I spend NO time in the bush” to question 6 AND 
7, please go straight to QUESTION 14. 
Otherwise, please proceed to QUESTION 8. 
 
8. How long do you spend in the bush on an average day?  
 
 No time 
 Less than 1 hour              
 1 to 3 hours          
 Greater than 3 hours 
 
 
9. Is time you spend in the bush in Whiteman Park: 
 
 Mainly for work reasons 
 Mainly recreational reasons              
 Equally related to work and recreation        
 
 
10. How often do you wear short-sleeved shirts and/or shorts during 
recreational time spent in bush or scrub in Whiteman Park?  
                 
 Every time I go out for recreational reasons 
 Often (50% or more of the time I go out for recreational reasons) 
 Sometimes (less than 50% of the time I go out for recreational reasons) 
 Never 
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11.  In  the  past  year,  how  often  do  you  see  animals  (such  as 
marsupials) or evidence that they have been there? 
 
 Every time I go out                            if so, What animals?  
…………………………………..  
 Often (50% or more of the time I go out)             if so, What animals?  
………………………………….. 
 Sometimes (less than 50% of the time I go out  )  if so, What animals?  
………………………………….. 
 Never 
 
12. In the past year, How often do you find ticks on yourself after time 
spent in the bush in Whiteman Park?          
 
 Every time I go out 
 Often (50% or more of the time I go out) 
 Sometimes (less than 50% of the time I go out) 
 Never 
 
 
13. How often do you apply tick repellent before spending time in the 
bush or scrub? 
                        
 Every time I go out 
 Often (50% or more of the time I go out) 
 Sometimes (less than 50% of the time I go out  ) 
 Never 
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14. In the past 1 year, how often have you been bushwalking, hiking, 
camping or working in the bush or forest in other parts of Australia or 
overseas? This does NOT include your time in Whiteman Park.  
 
 
 
Bushwalking, hiking, camping or working 
in the bush or forest in other parts of 
Western Australia (except for 
Whiteman Park) or interstate 
 
(please tick the answer  
that most applies to you) 
 
 
Bushwalking, hiking, camping or working 
in the bush or forest overseas (outside 
Australia) 
 
 
(please tick the answer  
that most applies to you) 
 
 Not at all in past 1 year 
 
 
 Not at all in past 1 year 
 
 Less than once a year  
            Which 
state(s)/territories?………… 
 
 
 Less than once a year  
       Which 
country/countries?………… 
 
  About once a year  
             Which 
state(s)/territories?………… 
 
  About once a year  
         Which 
country/countries?………… 
 
 
  More than once a year  
      Which state(s)/territories?………… 
 
 
  More than once a year  
           Which 
country/countries?………… 
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RECORD OF TICKBITES 
 
15.  IN  THE  PAST  1  YEAR,  how  often  have  you  been  bitten  by         
ticks? This refers to tick bites that may have occurred while in Whiteman Park, 
or while in some other location in Australia or overseas. 
 
 Most or every time I am in the bush (more than 75% of the time) 
 Often when I am in the bush (25-75% of the time) 
 Occasionally when I am in the bush (Less than 25% of the time) 
 Never (Go to Q19)   
 Not sure (Go to Q19)   
 If the subject answered “Never I spend no time in the bush part from work 
at  Whiteman  Park”  or  “Not  sure”  to  question  15,  please  go  straight  to 
question 16. Otherwise, please proceed. 
                                                               
a. In which months do the bites usually occur? (e.g. Mar-May) ……. 
 
b. In what locations have you been training when you were bitten by 
ticks IN THE PAST 2 YEARS?  (TICK ALL THAT APPLY) 
 
 in Whiteman Park 
 elsewhere in Australia or overseas  
                           Location (eg name of area, park or district): ……………. 
                  State: …………….              Country: ……………. 
 
c. In which part(s) of your body do the bite(s) usually occur? (TICK ALL 
THAT APPLY) 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders  
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
 
d. Have you experienced any of the following after tick bites IN THE 
PAST 1 YEARS?   
 
Nature of reaction  Please tick any symptoms that you have 
had 
Immediate (up to a couple of days after tick bites) 
 
- Local swelling of the skin around the 
bite 
 Most or e very time I get bitten (more than 75% of the time) 
 Often when I get bitten (25-75% of the time) 
 Occasionally when I get bitten (Less than 25% of the time) 
 Never   
 Not sure  
 
- Tenderness of the skin around the bite   Most or e very time I get bitten (more than 75% of the time) 
 Often when I get bitten (25-75% of the time) 
 Occasionally when I get bitten (Less than 25% of the time) 
 Never   
 Not sure  
 
- Discharge, pus or fluid coming out of 
the skin around the bite 
 Most or e very time I get bitten (more than 75% of the time) 
 Often when I get bitten (25-75% of the time) 
 Occasionally when I get bitten (Less than 25% of the time) 
 Never   
 Not sure  
 
- Itchiness around the bite   Most or e very time I get bitten (more than 75% of the time) 
 Often when I get bitten (25-75% of the time) 
 Occasionally when I get bitten (Less than 25% of the time) 
 Never   
 Not sure  215 
 
 
At any time during the 2 weeks after tick bites 
 
- Prolonged headache (> 3 days)*   When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Fever or chills*   When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Rash*   TICK ALL THAT APPLY 
 around the bite 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders 
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Tender or painful „glands‟ (lumps or 
nodes under the skin, usually away from 
the bite mark)* 
TICK ALL THAT APPLY 
 in the groin 
 in the armpits 
 in the neck 
 other; where_____________ 
 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Aching in joints, limbs, back or neck 
without reason* 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Tiredness/ Feeling „out of energy‟ 
without reason* 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Shortness of breath or difficulty 
breathing without reason* 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
- Blistering/scabbing around skin area 
where bitten* 
 When did this occur?  (e.g. Feb 2005)    
         
  ……/………. 
 
 
If the subject answered “At any time in the 2 weeks after the tick bite” to 
ANY OF THE SYMPTOMS, please continue. Otherwise, please go straight 
to question 17. 
 
I would like to ask you about the [*symptoms/symptoms] which occurred in 
……/………. (START WITH THE EARLIEST DATE). Thinking back to the 
tick bites that occurred in the two weeks before these symptoms:   
     
                 
e. Where were you when you were bitten?        
 in Whiteman Park 
 elsewhere in Australia or overseas  
                           Location (eg name of area, park or district): ……………. 
                  State: …………….              Country: ……………. 
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f. In which part(s) of your body did the bite(s) occur? (TICK ALL THAT 
APPLY) 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders  
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
 
g.   Did you remove the tick(s) yourself?  
 Yes   
 No: removed at a medical clinic     
 No : removed by someone else: who?.........                     
 
h. Did you seek medical advice for the tick bite(s)?   
                                             Yes                
                                             No                       
                                             Not sure 
 
i. Were you treated with antibiotics after the tick bite(s)?    
            Yes                
                                No                       
                                Not sure 
 
      j. Did you miss any work because of the tick bite(s)? 
                                   Yes  if yes, How many days in total? . . . . . . . . . .   
                                               No                       
NOW PROCEED TO THE NEXT DATE ON THE TABLE ABOVE: I would 
now  like  to  ask  you  about  the  [*symptoms/symptoms] which  occurred  in 
……/………. Thinking back to the tick bites that occurred in the two weeks 
before these symptoms:               
         
e. Where were you when you were bitten?        
 in Whiteman Park  
 elsewhere in Australia or overseas  
                           Location (eg name of area, park or district): ……………. 
                  State: …………….              Country: ……………. 
 
f. In which part(s) of your body did the bite(s) occur? (TICK ALL THAT 
APPLY) 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders  
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
 
g.   Did you remove the tick(s) yourself?  
 Yes   
 No: removed at a medical clinic     
 No : removed by someone else: who?.........                     
 
h. Did you seek medical advice for the tick bite(s)?   
                                             Yes                
                                             No                       
                                             Not sure 
 
i. Were you treated with antibiotics after the tick bite(s)?    
           Yes                
                               No                       
                               Not sure 
 
      j. Did you miss any work because of the tick bite(s)? 
                                   Yes  if yes, How many days in total? . . . . . . . . . .   
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NOW PROCEED TO THE NEXT DATE ON THE TABLE ABOVE: I would 
now  like  to  ask  you  about  the  [*symptoms/symptoms] which  occurred  in 
……/………. Thinking back to the tick bites that occurred in the two weeks 
before these symptoms:               
           
e. Where were you when you were bitten?        
                      in Whiteman Park 
 elsewhere in Australia or overseas  
                           Location (eg name of area, park or district): ……………. 
                  State: …………….              Country: ……………. 
 
f. In which part(s) of your body did the bite(s) occur? (TICK ALL THAT 
APPLY) 
 on chest, back or abdomen (stomach region) 
 hands, arms or shoulders  
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
 
g.   Did you remove the tick(s) yourself?  
 Yes   
 No: removed at a medical clinic     
 No : removed by someone else: who?.........                     
 
h. Did you seek medical advice for the tick bite(s)?   
                                             Yes                
                                             No                       
                                             Not sure 
 
i. Were you treated with antibiotics after the tick bite(s)?    
            Yes                
                                No                       
                                Not sure 
 
      j. Did you miss any work because of the tick bite(s)? 
                                            Yes  if yes, How many days in total? . . . . . . . . . .   
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16.  APART  FROM  ANY  SYMPTOMS  YOU  HAVE  MENTIONED 
ALREADY, have you EVER experienced any of the following  in the 
past year?  
 
(Please tick all the symptoms you have had and answer the questions in that row. 
If you haven‟t had any of the following symptoms then please go straight to 
question 17) 
 
Nature of 
reaction 
Please 
tick any 
symptoms 
that you 
have had 
How many times 
have these 
symptoms occurred 
since you started 
working in 
Whiteman Park? 
What time 
of the year 
did these 
symptoms 
occur?  (eg: 
February) 
Do you remember 
being bitten by a tick 
anytime in the 2 
weeks before these 
symptoms 
developed? 
 
Skin swelling/ 
tenderness 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
   No                      
  Can‟t remember 
 
Prolonged headache 
(> 3 days) 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Rash over parts or all 
of my body 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
 
TICK ALL THAT 
APPLY 
 around the bite 
 on chest, back or 
abdomen (stomach 
region) 
 hands, arms or 
shoulders 
 feet or legs 
 on neck, face or scalp 
 on groin or buttocks 
 
    Yes             
  No                      
  Can‟t remember 
 
General aching in 
joints, limbs, back or 
neck without reason 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Prolonged tiredness/ 
Feeling „out of energy‟ 
(> 3 days) without 
reason 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Fever or chills    Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Shortness of breath or 
difficulty breathing 
without reason 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
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OTHER MEDICAL HISTORY 
 
 
17. Do you have any major medical conditions?                  
 
  Yes                  No                        
 
 If YES: Please describe 
……………………………….…………………… 
 
         …………………………………………………… 
 
 
 
18. Are you routinely on any medications or treatments?       
 
 Yes           No 
 
 
If YES:  
a. What is the name of the medication?  
 
……………………………….…………………… 
 
…………………………………………………… 
       
   b. What condition or health problem do you take this for? 
……………………………….…………………… 
 
…………………………………………………… 
       
 
 
 
 
 
 
 
 
Thank you for taking the time to complete this survey. 
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9.8  Control/Baseline Group Questionnaire 
 
 
       
 
Identification code: |_|_|_|_|_| 
 
RISK OF TICK-BORNE 
INFECTIONS IN WESTERN 
AUSTRALIA 
 
 
 
 
Thank you for your interest and co-operation in our research.  
 
The purpose of this questionnaire is to assess the risk of the 
average Western Australian resident at contracting a tick-borne 
bacterial infection. 
 
Please  circle  the  appropriate  answer,  tick  the  box  or  enter  an 
answer as appropriate. Should you have any clarifications needed 
while  completing  the  questionnaire,  please  forward  them  to  the 
study facilitator present. 
 
 
 
SCREENING QUESTION   
Before completing the interview, please inform the study facilitator 
with the answer to the question below. 
 
S-1.  In the past 5 years, have you mainly been living in Western 
Australia? This means living in this State without going away 
for longer than 12 months altogether over the last 5 years. 
  (Single response)  
  1. Yes – START INTERVIEW 
    2. No– Thank you very much for your time. That is all we need to 
ask you today.  
    998.  Unsure/Don‟t  know/Can‟t  remember  -Thank  you  very  much  for 
your time. That is all we need to ask you today. 
    999. Refused – Thank you very much for your time. That is all we 
need to ask you today. 
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GENERAL QUESTIONS 
 
 
1. Date today:     /  / 2008 
 
 
2.  What is your gender?:   Male     Female 
 
 
3. What is your year of birth: |_|_|_|_| 
 
 
4. What is your current occupation:  
   
………………………………….. 
 
 
5. What are the main work tasks you do in this occupation?  
   
…………………………………………………………………………………………... 
 
………………..………………………………………………………………………...... 
 
………………………………………………………………….………………………… 
 
6.  Have you ever lived overseas for longer than 6 months? 
  (Single response)  
  (Single response)  
    1. Yes – Go to Q6.1 
    2. No– Go to Q7 
    998. Unsure/Don‟t know/Can‟t remember – Go to Q7 
    999. Refused – Go to Q7 
 
 6.1 Please tell me which countries and which years you lived 
there? 
  (Single Response) 
Country: ____________|_|_| Year arrived |_|_| Year departed 
Country: ____________|_|_| Year arrived |_|_| Year departed 
Country: ____________|_|_| Year arrived |_|_| Year departed 
 
7.  In the past 2 years, have you lived in country areas or in 
areas on the outskirts of town? 
  (Single response)  
  (Single response)  
    1. Yes – Go to Q7.1 
    2. No– Go to Q8 
    998. Unsure/Don‟t know/Can‟t remember – Go to Q8 
    999. Refused – Go to Q8 
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 7.1 How many months did you live in these areas over the past 2 
years? 
  (Single Response) 
   
|_|_| months  
 
The next section is about any pets you may have: 
 
8.  At any time in the past 2 years, have you kept any cats? 
  (Single response)  
    1. Yes – Go to Q8.1 
    2. No– Go to Q9 
    998. Unsure/Don‟t know/Can‟t remember – Go to Q9 
    999. Refused – Go to Q9 
 
  8.1  Did  any  of  your  cats  ever  go  into    bushland  or  other 
wilderness areas? 
  (Single Response) 
  1. Yes  
  2. No 
          998. Unsure/Don‟t know/Can‟t remember  
          999. Refused  
 
9.  At any time in the past 2 years, have you kept any dogs? 
  (Single Response) 
  1. Yes – Go to Q9.1 
  2. No Go to Q10 
  998. Unsure/Don‟t know/Can‟t remember – Go to Q10 
  999. Refused – Go to Q10 
 
  9.1  Did  any  of  your  dogs  ever  go  into    bushland  or  other 
wilderness areas? 
  (Single Response) 
  1. Yes  
  2. No 
  998. Unsure/Don‟t know/Can‟t remember  
  999. Refused  
 
 
10. At any time in the past 2 years, have you regularly kept any 
other  animals  on  your  property  that  you  have  not  already 
mentioned? 
  (Single Response) 
  1. Yes – What type of animals? __________________________ Go to Q10.1 
  2. No Go to Q11 
  998. Unsure/Don‟t know/Can‟t remember – Go to Q11 
  999. Refused – Go to Q11 
 
10.1  Did  any  of  these  animals  ever  go  into   bushland or  other 
wilderness areas? 
  (Single Response) 
  1. Yes  
  2. No 
  998. Unsure/Don‟t know/Can‟t remember  
  999. Refused  223 
 
11. In the past 2 years, how often have you been bushwalking, 
hiking, camping or working in  the bush  or forest  in  WA and 
other parts of Australia or overseas?  
 
 
 
Bushwalking, hiking, camping or 
working in the bush or forest in other 
parts of Western Australia or 
interstate 
 
(please tick the answer that most 
applies to you) 
 
 
Bushwalking, hiking, camping or 
working in the bush or forest overseas 
(outside Australia) 
 
 
(please tick the answer that most 
applies to you) 
 
 Not at all in past 2 years  go to 
Q.12 
 
 
 Not at all in past 2 years  go to 
Q.12 
 
 Less than once a year  
            Which 
state(s)/territories?………… 
 
 
 Less than once a year  
       Which 
country/countries?………… 
 
  About once a year  
             Which 
state(s)/territories?………… 
 
  About once a year  
         Which 
country/countries?………… 
 
 
  More than once a year  
      Which 
state(s)/territories?………… 
 
 
  More than once a year  
           Which 
country/countries?………… 
 
11.1. IN THE PAST 2 YEARS, how often have  you been bitten by 
ticks?  
 
 Most or every time I am in the bush (more than 75% of the time) 
 Often when I am in the bush (25-75% of the time) 
 Occasionally when I am in the bush (Less than 25% of the time) 
 Never  
 Not sure   
 
12. Except for anything you have already mentioned, in the past 
2  years  have  you  regularly  come  into  contact  with  animals 
through your work or hobbies? 
  (Single Response) 
  1. Yes –  
What is the work or hobby that brings to into contact with animals? 
What type of animals? __________________________ Go to Q12.1 
   
  2. No Go to Q13 
  998. Unsure/Don‟t know/Can‟t remember – Go to Q13 224 
 
  999. Refused – Go to Q13 
 
12.1 On average, how many hours per month are you in contact 
with these animals? 
  (Single Response) 
 
  |_|_|_| hours per month 
 
13.  APART  FROM  ANY  SYMPTOMS  YOU  HAVE  MENTIONED 
ALREADY, have you EVER experienced any of the following right 
after a trip into the bush or after contact with animals?  
 
(Please tick all the symptoms you have had and answer the questions in 
that  row.  If  you  haven‟t  had  any  of  the  following  symptoms  then 
please go straight to question 14) 
 
Nature of reaction  Please tick 
any 
symptoms 
that you 
have had 
How many times 
have these 
symptoms 
occurred in the 
past 3 years? 
What time of 
the year did 
these 
symptoms 
occur?  (e.g.: 
February) 
Do you remember 
being bitten by a 
tick anytime in the 
2 weeks before 
these symptoms 
developed? 
 
Skin swelling/ 
tenderness 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
   No                      
  Can‟t remember 
 
Prolonged headache 
(> 3 days) 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Rash over parts or all of 
my body 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
 
TICK ALL THAT 
APPLY 
 around the bite 
 on chest, back or 
abdomen (stomach 
region) 
 hands, arms or 
shoulders 
 feet or legs 
 on neck, face or 
scalp 
 on groin or buttocks 
    Yes             
  No                      
  Can‟t remember 
 
General aching in joints, 
limbs, back or neck 
without reason 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Prolonged tiredness/ 
Feeling „out of energy‟ (> 
3 days) without reason 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Fever or chills    Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
Shortness of breath or 
difficulty breathing 
without reason 
 Yes 
 No                       
 Not sure 
 
if YES: 
 
|_|_|_| 
    Yes             
  No                      
  Can‟t remember 
 
 225 
 
  
 
14. Have you ever seen a doctor as a result of symptoms linked 
to a tick bite?  
 
   YES  
 
   NO 
 
If YES: 
Month/Year of consultation  
 
……………………………………………………………………………………… 
 
Please describe the symptoms or diagnosis and any medication prescribed by the attending physician. 
 
………………..…………………………………………………………………… 
 
………………………………………………………………….…………………… 
 
 
 
 
Thank you for the time taken to complete this survey. 
 
 
 
 
 